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ABSTRACT 
 
During a screening of seaweed associated marine micro organisms, for their ability to 
produce antimicrobial compounds, an organism was isolated, producing antibacterial 
metabolite(s) and was found to be active against gram positive pathogens, multi-drug 
resistant pathogenic bacteria, and food borne spoilage fungi. The strain was identified as a 
gram-negative, short rod, which produced red-pigmented colonies and proved to be both 
catalase and oxidase positive. Ribotyping, indicated that this strain demonstrated a high 
sequence identity (99%) to Serratia plymuthica. Tests with a type strain of Serratia 
plymuthica, revealed that the strain did not produce a similar spectrum of antimicrobial 
activity. Preliminary characterisation of the inhibitory molecule(s) produced by this 
marine isolate, demonstrated that it was heat stable, low molecular weight, with pH 
resistant compound(s). Moreover, the activity was unaffected by prolonged incubation 
with enzymes such as Proteinase K. Transposon, mutagenesis was utilised, in an attempt 
to identify the genes involved, in antimicrobial production, to hopefully gain an insight 
into the nature of the antimicrobial compound. Fourteen mutants, unable to produce 
antimicrobial compound(s) were isolated, and the preliminary sequence analysis of three 
of the mutants, highlighted that they had transposon insertions within gene(s) homologous 
to polyketide synthase. Size exclusion chromatography (Gel filtration) was utilised in an 
attempt to purify and characterise the antimicrobial compound(s). 
 
 
 
 
 
 
 
 
 
 
 
 iii 
DEDICATION 
 
I dedicate this thesis to my parents, my half, my children (Razan, Faisal, Rawan and 
Fahad), and Professor Khalid Jamal al-Layl. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iv 
 
ACKNOWLEDGMENTS 
 
I would like to thank my supervisor Dr. Derek Jamieson, for his grateful guidance and 
encouragement. 
 
Thanks also go to Umm Al-Qura University for financial support. 
 
I am really grateful for the guidance, encouragement and support of Professor Khaled 
Jamel al-Layl, Dr. Peter Mories and Dr. Joanne Porter, throughout the duration of this 
project.  
 
I also wish to thank Mr. Paul Cyphus for his advice and support. He is also a great friend 
with whom I share some wonderful memories, both work and non-work related. Cheers 
Paul. Also thanks to Fiona for being my lab buddy (briefly). 
 
Special thanks must go to Dr. Hafizur Rahman and Dr. Mike Winson  
 
I would also like to thank all my buddies who made my lab work extremely enjoyable, 
especially Callum, Naïf, Omar, Ali, Majde, Salem, Majed and Mohammed. 
 
I would like to thank Narges Khalaf for initial isolation of the antimicrobial producer (P). 
 
Finally, many thanks to everyone who has given support during this project. 
 
 
 
 
 
 
 v 
DECLARATION 
 
 
 vi 
 
CONTENTS 
ABSTRACT ........................................................................................................................ II 
DEDICATION ................................................................................................................... III 
ACKNOWLEDGMENTS ................................................................................................. IV 
DECLARATION ................................................................................................................ V 
CONTENTS ....................................................................................................................... VI 
LIST OF TABLES ............................................................................................................. XI 
LIST OF FIGURES ......................................................................................................... XII 
ABBREVIATIONS ......................................................................................................... XV 
CHAPTER 1. INTRODUCTION .......................................................................................... 1 
1.1 Antimicrobial Agents .......................................................................................... 1 
1.1.1 Antimicrobial agents from Micro-organisms .................................................. 1 
1.2 Secondary metabolites ......................................................................................... 2 
1.2.1 Control of secondary metabolite compounds by growth media composition . 2 
1.2.2 Control of secondary metabolite compounds by physical factors .................. 2 
1.3 Antibiotics ........................................................................................................... 3 
1.3.1 The need for new antibiotics ........................................................................... 3 
1.3.2 Antibiotic resistance ........................................................................................ 4 
1.3.3 The mechanism of action of antibiotics .......................................................... 6 
1.4 Diversity of natural products from the marine environment ............................... 8 
1.5 Marine micro-organisms as a source of bioactive compounds ........................... 9 
1.6 The genus Serratia: taxonomy, distribution and characteristics ........................ 12 
1.6.1 Historical aspects of S. plymuthica ............................................................... 14 
1.6.2 Bioactive compounds produced by the terrestrial isolates of S. plymuthica 15 
1.6.3 Antimicrobial mechanisms of S. plymuthica ................................................ 17 
1.6.3.1 Antibiotics .............................................................................................. 18 
1.6.3.2 Chitinase .................................................................................................... 22 
1.6.3.4 Siderophores .............................................................................................. 22 
1.7 Polyketides (PKs) and Non-ribosomal peptides (NRPs) ................................... 23 
1.7.1 PKs and NRPs produced by the terrestrial isolates of S. plymuthica ........... 24 
1.8 Quorum sensing (QS) ........................................................................................ 25 
 vii 
1.8.1 Quorum sensing and antimicrobial production in S. plymuthica ................. 27 
1.9 Aims of this study ............................................................................................. 28 
CHAPTER 2. MATERIALS AND METHODS ..................................................................... 30 
2.1 General Methods .................................................................................................. 30 
2.1.1 Microbial strains used in the study ............................................................... 30 
2.1.1.1 Marine microorganisms ......................................................................... 30 
2.1.1.2 Test microorganism strains .................................................................... 31 
2.1.1.3 Established bacterial strains used in the study ....................................... 33 
2.1.1.4 Bacterial strains created during this study ............................................. 34 
2.1.1.5 Established plasmids and constructed plasmids used in this study ........ 35 
2.1.1.6 Maintenance of microbial cultures ......................................................... 36 
2.1.2 Antibiotics used in the study ......................................................................... 36 
2.1.3 Bacterial growth, media and culture conditions ........................................... 36 
2.1.4 Cultivation conditions ................................................................................... 37 
2.1.5 Spot test and disc diffusion assays for antimicrobial activity ....................... 37 
2.1.6 Gram reaction, colony morphology and microscopy .................................... 38 
2.1.7 Sensitivity tests ............................................................................................. 38 
2.1.8 Total Viable cell count .................................................................................. 38 
2.2 DNA techniques ................................................................................................... 39 
2.2.1 Extraction of genomic DNA ......................................................................... 39 
2.2.2 Extraction of plasmid DNA .......................................................................... 39 
2.2.3 Concentration of DNA .................................................................................. 39 
2.2.4 Restriction enzyme digestion of DNA .......................................................... 40 
2.2.5 DNA ligation ................................................................................................. 40 
2.2.6 The Polymerase Chain Reaction (PCR) ........................................................ 41 
2.2.7 Ribotyping .................................................................................................... 45 
2.2.8 DNA separation by gel electrophoresis ........................................................ 45 
2.2.9 DNA Sequencing of plasmid DNA ............................................................... 46 
2.2.10 Gene cloning ............................................................................................... 46 
2.2.11 Random priming ......................................................................................... 48 
2.2.12 Southern blot hybridisation ......................................................................... 48 
2.2.13 Preparation and transformation of chemically competent cells .................. 52 
2.2.13.1 Preparation of chemically competent E. coli cells ............................... 52 
2.2.13.2 Transformation of Competent Cells ..................................................... 52 
2.2.14 Bacterial mutagenesis (Tn5 mutagenesis) .................................................. 53 
 viii 
2.2.14.1 Tn5 mutagenesis .................................................................................. 53 
2.2.14.2 Screening for potential mutants ........................................................... 56 
2.2.14.3 Cloning and recovery of transposon insertion mutants ........................ 58 
2.3 Protein methods ................................................................................................... 61 
2.3.1 Ultra filtration ............................................................................................... 61 
2.3.2 Concentration of spent culture media ........................................................... 61 
2.3.3 Size exclusion chromatography (SEC) ......................................................... 62 
2.3.4 Anion exchange chromatography (AEC) ...................................................... 62 
2.3.5 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
................................................................................................................................ 63 
2.3.5.1 Sample preparation for SDS-PAGE ....................................................... 63 
2.3.5.2 SDS PAGE ............................................................................................. 63 
2.3.5.3 Staining of SDS page gels...................................................................... 63 
2.4 Quorum sensing assay .......................................................................................... 65 
RESULTS 
CHAPTER 3. IDENTIFICATION OF THE MARINE BACTERIUM ‘P’ ..................................... 67 
3.1 Introduction .......................................................................................................... 67 
3.2 Results .................................................................................................................. 68 
3.2.1 Screening for Antimicrobial Compound Production .................................... 68 
3.2.2 Bacterial identification .................................................................................. 71 
3.2.2.2 Salt Tolerance ........................................................................................ 72 
3.2.2.3 Production of extracellular enzymes ...................................................... 73 
3.2.2.4 The effect of growth medium on the production of antimicrobial activity
............................................................................................................................ 75 
3.2.2.5 The effect of growth temperature on the production of antimicrobial 
activity ................................................................................................................ 76 
3.2.2.6 Antibiotic sensitivity tests ...................................................................... 78 
3.2.3 Ribotyping .................................................................................................... 79 
3.2.4 Quorum sensing bioassay ............................................................................. 84 
CHAPTER 4. ISOLATION AND PRELIMINARY CHARACTERISATION OF MUTANTS UNABLE 
TO PRODUCE THE ANTIMICROBIAL (S) ............................................................................. 86 
4.1 Introduction .......................................................................................................... 86 
4.2 Results .................................................................................................................. 86 
4.2.1 Tn5 mutagenesis ........................................................................................... 86 
 ix 
4.2.2 Ensuring that mutants result from the insertion of the transposon into the 
genome of strain P ................................................................................................. 89 
4.2.3 Characterisation of the transposon mutants .................................................. 91 
4.2.4 Cloning and recovery of the transposon insertion and flanking genomic 
DNA ....................................................................................................................... 94 
4.2.5 Sequencing the flanking regions ................................................................... 97 
4.2.6 Attempt to clone the genomic DNA region containing the antimicrobial 
gene(s) (ang) .......................................................................................................... 98 
4.2.6.1 PCR amplification of genomic DNA defining the antimicrobial gene(s)
............................................................................................................................ 98 
4.2.6.2 Cloning of the ang .................................................................................. 99 
CHAPTER 5. CHARACTERISATION OF THE ANTIMICROBIAL AGENT (S) ........................ 101 
5.1 Introduction ........................................................................................................ 101 
5.2 Results ................................................................................................................ 102 
5.2.1 The effect of different cultivation conditions on the production of the 
antimicrobial compound(s) .................................................................................. 102 
5.2.1.1 The effect of growth media on antimicrobial production .................... 102 
5.2.1.2 The effect of different surface attachment substrates on antimicrobial 
production ........................................................................................................ 104 
5.2.1.3 The effect of modified roller bottle (rb) cultures on antimicrobial 
production ........................................................................................................ 105 
5.2.1.4 Does the presence of a sensitive strain enhance antimicrobial 
production? ...................................................................................................... 106 
5.2.2 Effect of physiochemical factors on the inhibitory molecule(s) ................. 107 
5.2.2.1 Effect of temperature on antimicrobial activity ................................... 108 
5.2.2.2. Effect of proteinase K, amylase and lysozyme on antimicrobial activity
.......................................................................................................................... 108 
5.2.2.3 Effect of pH on antimicrobial activity ................................................. 108 
5.2.2.4 Effect of storage at 9oC on the antimicrobial molecules’ stability ...... 109 
5.2.3 Preliminary characterisation and purification of inhibitory molecule(s) .... 111 
5.2.3.1 Ultra filtration of the spent culture medium ........................................ 111 
5.2.3.2 Purification of the antimicrobial molecule by size exclusion 
chromatography (SEC) .................................................................................... 113 
5.2.3.3 Anion exchange chromatography (AEC) ............................................. 116 
5.2.4 SDS-PAGE analysis ................................................................................... 118 
 x 
5.2.5 Is the inhibitory molecule bacteriostatic or bactericidal? ........................... 119 
CHAPTER 6. DISCUSSION ........................................................................................... 122 
6.1 Screening for Antimicrobial Compound Production and Identification of the 
Antimicrobial Producing Marine Isolate (P) ............................................................ 123 
6.2 Isolation and preliminary characterisation of mutants unable to produce the 
antimicrobial(s) ........................................................................................................ 127 
6.3 Preliminary characterisation of the antimicrobial agent(s) ................................ 129 
CHAPTER 7. CONCLUSION .......................................................................................... 134 
CHAPTER 8. APPENDICES ........................................................................................... 136 
8.1 Appendix (1) ...................................................................................................... 136 
8.1.1 Partial DNA sequence of mutant 5 (17-1direcion) ..................................... 136 
8.1.2 Partial DNA sequence of mutant 7 (17-1direcion) ..................................... 139 
8.1.3 Partial DNA sequence of mutant 8 (17-1direcion) ..................................... 142 
8.2 Appendix (2) Blast results ................................................................................. 145 
CHAPTER 9. LITERATURE CITED IN THIS THESIS ......................................................... 150 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xi 
 
LIST OF TABLES 
  Page 
Table 1.1 Numbers of annual estimated cases of bacterial 
food borne disease in the USA 
3 
Table 1.2 Mechanisms of action and resistance of commonly 
used antibiotics 
6 
Table 1.3 List of Serratia species 13 
Table 1.4 Overview of antimicrobial metabolites produced 
by S. plymuthica strains 
18 
Table 1.5 Examples of quorum sensing systems identified in 
S. plymuthica strains. 
27 
Table 2.1 Micro-organisms used in this study 32 
Table 2.2 Established bacterial strains used in the study 33 
Table 2.3 Bacterial strains created during this study 34 
Table 2.4 Established plasmids and constructed plasmids 
used in this study 
35 
Table 2.5 PCR conditions 41 
Table 2.6 PCR components 41 
Table 2.7 List of Primers used in this study 43 
Table 3.1 Table to accompany Figure 3.1 70 
Table 3.2 Table to accompany Figure 3.6 77 
Table 3.3 Table to accompany Figure 3.8 80 
Table 3.4 Table to accompany Figure 3.9 83 
Table 4.1 Table to accompany Figure 4.7 94 
Table 5.1 Table to accompany Figure 5.5 110 
Table 5.2 Table to accompany Figure 5.6 112 
 
 
 
 
 
 
 
 
 
 
 xii 
 
LIST OF FIGURES 
  
 
Page 
Figure 1.1 The rate of discovery of Beta-lactamase enzymes during the 
age of antibiotics.  
5 
Figure 1.2 The chemical structures of some antimicrobial substrates 
produced by S. plymuthica.  
21 
Figure 1.3 The chemical structures of polyketide and non-ribosomal 
peptide compounds. 
24 
Figure 1.4 The chemical structure of the most intensively studied 
autoinducer system in Gram-negative bacteria and Gram-
positive bacteria. 
26 
Figure 2.1 Initial nutrient agar plate with unknown colony (P), 
inhibiting the growth of filamentous microorganism (F). 
31 
Figure 2.2 Graphic map (circular) of the cloning vector pBluescript 
(pBS) plasmid.  
47 
Figure 2.3 A diagram, highlighting the transfer of DNA to a nylon 
membrane by capillary action. 
49 
Figure 2.4 Graphic map (circular) of delivery vector (pRL27) plasmid 53 
Figure 2.5 Random transposon mutagenesis protocol. 55 
Figure 2.6 Screening for the potential mutant strains (PM). 57 
Figure 2.7 Diagram summarising the cloning, recovery and sequencing 
of the transposon junction plasmids (TJP). 
59 
Figure 2.8 Diagram showing of primer sites (tpn RL17-1 and tpn 
RL13-2) to identify pag. 
60 
Figure 2.9 Graphic map (circular) of transposon. 60 
Figure 2.10 Graphic map (linear) of Transposons digesting map with 
unique enzyme. 
61 
Figure 3.1 Disc test and a spot test, showing the antimicrobial effect of 
marine isolate P. 
69 
Figure 3.2 Pure culture of marine isolate P (Antimicrobial producer) on 
a NA plate, grown at 21 oC for 24hrs. 
72 
Figure 3.3 Cell survival of marine isolate P cells on exposure to 
increasing concentrations of sodium chloride. 
73 
Figure 3.4 Enzymatic producing assays.  74 
Figure 3.5 Effect of growth media on antimicrobial activity.  76 
Figure 3.6 Effect of growth temperature on antimicrobial production 
and red pigment production. 
78 
Figure 3.7 Antibiotic sensitivity disc tests for the marine isolate P. 79 
Figure 3.8 Phylogenetic tree based on the 16S rRNA gene sequences, 
highlighting that the marine antimicrobial producer is a 
variant of Serratia plymuthica. 
81 
Figure 3.9 Antimicrobial activity of marine bacterium S. plymuthica P 
(A) and S. marcescens (ATCC13880) (B). 
83 
 
Figure 3.10 AHL production bioassay.  85 
Figure 4.1 A plate showing antibiotic-resistant transconjugants of 
marine isolate S. plymuthica (P) colonies growing on 
Nutrient agar + (Kan) + (Amp). 
87 
Figure 4.2 Screening for potential non-antimicrobial mutant strains, 88 
 xiii 
indicator micoorganism; B. cereus var mycodies. 
Figure 4.3 A plate showing the lack of antimicrobial production 
phenotype of the transposon mutants, with test 
microorganism B. cereus var mycodies. 
88 
Figure 4.4 A plate showing the non-antimicrobial producing mutants 
growing on Nutrient agar + 50µg/ml Kan + 20µg/ml Amp 
to confirm they were all resistant to  
Kanamycin as well as Ampicillin. 
89 
Figure 4.5 Agarose gel electrophoresis of the PCR amplified 
Kanamycin resistance gene (KmR) from the non-
antimicrobial producing mutants.  
90 
Figure 4.6 The Agarose gel electrophoresis of BamH1cut genomic 
DNA from mutant No. 4-19, respectively.  
92 
Figure 4.7 Southern blot hybridisation with BamHI, digested DNA 
prepared from mutants (Nos. 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 
14, 15, 16 and 19).  
93 
Figure 4.8 Gel electrophoresis of BamHI digested transposon junction 
plasmids (minipreps).  
96 
Figure 4.9 The blastx search result obtained from the partial 
sequencing the flanking genomic DNA from mutant No 5, 
showing that transposon had inserted into a gene, with 
similarity to a gene encoding a Polyketide synthesis. 
97 
Figure 4.10 Amino acid sequence line-ups (Blastx) between Serratia 
plymutica (P) flanking end of transposon insertion site, 
mutant 5, sequence from primer 13-2(Query) and 
Polyketide synthesis, from Serratia plymuthica (Sbjct). 
97 
Figure 4.11 Analysis of the long PCR products from mutants 4, 5 and 8.  100 
Figure 5.1 Effect of different growth media on antimicrobial 
production.  
103 
Figure 5.2 The effect of growth on a solid substrate on antimicrobial 
production.  
105 
Figure 5.3 Effect of growth on an agar surface on antimicrobial 
production.  
106 
Figure 5.4 The effect of proteinase K on antimicrobial activity.  109 
Figure 5.5 The effect of shelf-life on the antimicrobial molecule 
stability 
111 
Figure 5.6 Zones of growth inhibition produced by spent medium after 
ultrafiltration.  
113 
Figure 5.7 Gel filtration (GF).  115 
Figure 5.8 Anion Exchange Chromatography (AEC).  117 
Figure 5.9 SDS-PAGE gel analysis.  118 
Figure 5.10 Cell survival of sensitive strain MRSA cells on exposure to 
increasing concentrations of CSM.  
120 
Figure 8.1 Graphic map of sequence contig obtained from Mutant 
No.5, primer tpnRL17–1 direction.  
138 
Figure 8.2 Graphic map of sequence contig obtained from Mutant 
No.7, primer tpnRL17–1 direction.  
141 
Figure 8.3 Graphic map of sequence contig obtained from Mutant 
No.8, primer tpnRL17–1 direction.  
144 
Figure 8.4 The BLASTX search result obtained from the partial 
sequencing the flanking genomic DNA from mutant No 8. 
145 
Figure 8.5 The blastx search result obtained from the partial 146 
 xiv 
sequencing the flanking genomic DNA from mutant No 
7(primer tpnRL13-2 direction). 
Figure 8.6 Amino acid sequence line-ups produced from BLASTX 
between Serratia plymutica (P) using the translated mutant 
5, sequence contig from primer direction 17-1(Query) and 
Polyketide synthase, from Serratia plymuthica (Sbjct). 
 
147 
Figure 8.7 The blastx search result obtained from the partial 
sequencing the flanking genomic DNA from mutant No 7 
(primer direction 17-1).  
 
148 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xv 
ABBREVIATIONS 
AHLs N-Acylhomoserine lactones 
AEC Anion Exchange Chromatography 
ang Antimicrobial gene(s)  
Ap Ampicillin 
ApR Ampicillin resistant 
APS Ammonium Persulfate Solution 
BA Blood Agar 
BHI Brain Heart Infusion Agar 
BLAST Basic Local Alignment Search Tool 
CSM Concentrated spin medium 
Da Daltons 
dH2O Distilled water 
DIG Digoxigenin 
DNA Deoxyribonucleic Acid 
EB Elution Buffer 
EDTA Ethylene Diamine Tetra Acetic Acid 
FPLC Fast Protein liquid Chromatography 
h Hour 
hrs Hours 
HCl Hydrochloric Acid 
Km Kanamycin 
KmR Kanamycin resistant 
LB Luria Bertani Agar 
l Litres 
MA Milli Ampere 
Ml Millilitres 
MIC minimal inhibitory concentration 
mins Minutes 
MRD Maximum Recovery Diluent 
MRSA Methicillin-resistant Staphylococcus aureus 
NA Nutrient Agar 
NB Nutrient Broth 
NaCl Sodium Chloride 
 xvi 
NaOH Sodium Hydroxide 
ng Nano Gram 
NRPs Nnonribosomal peptides 
NRPSs Nonribosomal peptide synthetases 
OD Optical Density 
PAGE Polyacrylamide Gel Electrophoresis 
pmol Picomoles 
PM Potential mutant strains 
PKs Polyketides 
PKSs Polyketide synthases 
PCR Polymerase Chain Reaction 
RNA Ribonucleic Acid 
rpm Rotation per minute 
RT Room temperature 
sec Second 
SEC Size Exclusion Chromatography 
sdH2O Sterile distilled water 
SDS Sodium Dodecyle Sulphate 
SM The spent culture medium 
SSC Saline-Sodium Citrate 
spp Species 
St Streptomycin 
StR Streptomycin resistant 
TEA Tris-acetate-EDTA buffer 
TetrR Tetracycline resistant 
TEMED N,N,N,N,-Tetramethyle-Ethylenediamine 
TJP Transposon Junction Plasmid 
TJPs Transposon Junction Plasmids 
TSA Tryptone Soya Agar 
Tris 2-amino-2hydroxymethylpropan-1,3-diol 
TSB Tryptone Soya Broth 
VRE Vancomycin-resistant Enterococcus 
 
  
 
 
 
 
 
 
 
 
 
INTRODUCTION
Chapter. 1                                                                                                                                        Introduction  
 1 
 
1. Introduction 
1.1 Antimicrobial Agents 
 
In nature, organisms need to strive in order to survive in their own environment. This 
kind of bioprocess can be achieved by using competitive mechanisms such as the 
production of extracellular enzymes, toxins and antimicrobial substrates. An 
Antimicrobial agents are defied as a mixture of chemical substrates produced by certain 
species of Eukaryotic and Prokaryotic organisms, and they are able to prevent or inhibit 
the growth of certain predators and competitors such as protozoa, fungi bacteria (Herbert, 
1981; Marwick et al., 1999). More precisely, the synthetic chemical or natural agents that 
can act by preventing or inhibiting the growth of other micro-organisms such as viruses, 
bacteria, fungi or protozoa are antimicrobial agents (Bryskier, 2005). 
 
1.1.1 Antimicrobial agents from Micro-organisms 
  
There are several groups of micro-organisms such as Gram-negative and Gram-positive 
bacteria, and fungi have the ability of producing antimicrobial substances with no obvious 
role in the economy of the organism such as extracellular enzymes (chitinase, proteinase, 
lipase, casinase, gelatinase and DNase); toxins; CO2; alcohols (ethanol isopropanol); 
acids (lactic acid and acetic acid); peroxides (hydrogen peroxide); bacteriocins (nisin and 
natamycin) and antibiotics (Klaenhammer, 1988; Nosova et al., 1996; Frankowski et al., 
2001; Bryskier, 2005). Historically, Bartolomeo Bizio was the first to report antimicrobial 
activity in 1823; this was against Serratia marcescens and involved moulds. In 1876, 
John Tyndall observed the same phenomenon, demonstrating the inhibitory activity of 
Penicillium (Bryskier, 2005). One year later, Louis Pasteur and Jules F. Joubert described 
antimicrobial activity between Bacillus anthracis and other bacteria (Bryskier, 2005). 
Subsequently, in 1886, Louis Gutman and Paul Ehrlich observed antiplasmodia activity 
(inhibiting the growth of the Plasmodium spp that causes malaria) by methylene blue and 
this was the beginning of studies regarding antimicrobial agents. Following on from this, 
in 1889, Paul Vuillemin invented the term “antibiotic” to describe the antagonism effect 
between two micro-organisms (Bryskier, 2005).   
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1.2 Secondary metabolites  
 
Generally, there is a two–stage process for the production of such secondary metabolites 
compounds: the growth phase and the production phase. The understanding of these 
stages is important for any bioreactor producing secondary metabolites, which aims to 
maximise the biomass in a short time with the best conditions for high production 
(Marwick et al., 1999). However, micro-organisms (often fungi and bacteria) are a good 
source of secondary metabolite compounds particularly antibiotics, with many, studies 
having been undertaken to discover natural antimicrobial compounds (secondary 
metabolites) present in micro-organisms.  
 
As a consequence, more than 120 medicines, and the majority of commercially available 
antibiotics were obtained from micro-organisms (Ahmed et al., 2008). According to 
Marwick et al. (1999), several factors need to be taken into account, which can affect the 
production of such useful secondary metabolite compounds from micro-organisms. Some 
of those factors are discussed below: 
 
1.2.1 Control of secondary metabolite compounds by growth media composition 
 
Microbial growth nutrients, for example carbon, nitrogen, phosphate and trace elements 
affect microbial growth and the production of secondary metabolite compounds (Marwick 
et al., 1999). For instance, using different quantities and types of sugars can affect the 
production of the secondary substrates. For example, glucose as a carbon source is often 
used to harvest maximum biomass growth but it dramatically decreases the production of 
many secondary metabolites (Martin and Demain, 1980). Several studies have taken this 
further and demonstrated that the chemical composition of the growth media significantly 
affects antimicrobial activity (Farmer, 1985; Spížek and Tichý, 1995; Marwick et al., 
1999).   
 
1.2.2 Control of secondary metabolite compounds by physical factors 
 
Physical parameters such as temperature, pH, oxygen, pressure and salt concentrations 
can also affect both the micro-organisms and their secondary metabolite production 
(Marwick et al., 1999).  For instance, exposure to external factors such as temperature 
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affects the function of internal pathways. According to Moons et al. (2006), changing the 
environment of an organism may affect the expression of genes and cell signalling 
processes involved in the production of antimicrobial secondary metabolites. For 
example, a newly characterised secondary metabolite compound was induced by 
changing the dissolved O2 concentrations (DOC) in liquid growth cultures of 
Streptomyces paravulus (Kaiser et al., 1994). 
 
 
1.3 Antibiotics  
 
According to Bryskier (2005), ‘An antibiotic’ can be defined as a derivative produced by 
the metabolism of micro-organisms that possesses antibacterial activity at low 
concentrations and is not toxic to the host’; this does not apply to all compounds with 
antibacterial activity, for example, penems and benzyle-pyrimidines, are not considered to 
be antibiotics as these compounds are detrimental to host cells as well (Bryskier, 2005).   
 
1.3.1 The need for new antibiotics 
 
Currently, the increasing prevalence of antibiotic resistant “super-bugs” this and risks 
associated with food safety are global issues. For example, according to the Centers for 
Disease Control and Prevention (http://www.cdc.gov), in the United States of America 
(USA), about 48 million Americans annually become ill from foodborne disease.  Table 
1.1 shows the majority of bacterial pathogens associated with the causation of foodborne 
illnesses.  
 
 
Table 1.1 Numbers of annual estimated cases of bacterial food borne disease in the USA* 
 
Micro-organism No. of annual estimated cases (U.S) 
Salmonella, non-typhoidal 1,027,561 
Clostridium  perfringens 965,958 
Campylobacter spp 845,024 
Staphylococcus aureus 241,148 
 *Cited from http://www.cdc.gov/foodborneburden/2011-foodborne-estimates.html (27-12-2012). 
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1.3.2 Antibiotic resistance   
  
The discovery of antibiotics was a turning point in human history. They have been 
revolutionary in a number of different respects including the ability to save the lives of 
organisms including those of humans and animals. However, after the introduction of the 
first classes of antibiotics (penicillin and sulphonamides), several opportunistic and 
pathogenic bacteria have developed resistance; or are now becoming more resistant to 
these commercially available antibiotics (Dessen et al., 2001; Alanis, 2005). During the 
three decades following awareness of antibiotic resistance, it has increasingly been 
recognised as a problem for hospitalised patients. In the 1930s and 1940s, sulfonamide 
and penicillin resistance occurred via the pathogenic bacterium Staphylococcus aureus. 
Then, in 1944 after the introduction of the streptomycin antibiotic to treat tuberculosis 
infections, mutated strains of Mycobacterium tuberculosis became resistant to this 
medicine during patient treatment (Davies and Davies, 2010).  
 
As other antibiotics have been discovered and used to treat patients in clinical practice, a 
similar course of events has arisen. However, the list of multi-drug resistant bacteria has 
increased. These included β-lactamase-producing Haemophilus influenzae and penicillin-
resistant Neisseria gonorrhoeae (PPNG), during the 1970s (Jaffe et al,. 1981; Jorgensen, 
1992); the recovery of the multi-drug resistant (MDR) Mycobacterium tuberculosis and 
methicillin- resistant Staphylococcus aureus (MRSA) in the late 1970s and 1980s, 
(Espinal and Laszlo, 2001; Lowy, 1998); in addition to some gram-negative resistant 
bacterial strains (common enteric and non-enteric organisms) such as Escherichia coli, 
Vibrio cholera, Shigella sp., Salmonella sp., Klebsiella pneumoniae, Pseudomonas 
aeruginosa, Acinetobacter baumanii, some of which were associated with foodborne 
disease in the 1980s and 1990s (Fey and Safranek, 2000; Waterer and Wunderink, 2001).  
 
More recently, the first record for clinically isolated vancomycin resistant Staphylococcus 
aureus (VRSA) was reported in 2002 from the USA (Tiwari and Sen, 2006). In addition, 
several studies reported certain cases which were related to the spread of resistant bacteria 
outside of the hospital environment and responsible for community-acquired infections 
such as resistance of Streptococcus spp to the erythromycin antibiotic (Seppälä et al., 
1995). Streptococcus pneumonia is becoming resistant to penicillin (Nuorti et al,. 1998); 
and vancomycin resistant to enterococci (VRE) are now relatively common (DeLisle and 
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Perl, 2003). The excessive use of antimicrobial agents has also become a global issue. For 
instance, the numbers of identified β-lactamase enzymes have dramatically increased 
during the introduction of the β-lactam antibiotics (Davies and Davies, 2010) (See  
Figure1.1).  
According to the world Economic Forum (http://forumblog.org/tag/antibiotics), In the 
European Union (EU), about 25,000 patients annually die from bacterial infection that 
associated with antibiotic resistant bacteria. 
 
 
 
Figure 1.1 The rate of discovery of Beta-lactamase enzymes during the age of antibiotics. From 
Davies and Davies (2010). 
 
 
In view of this, new or chemically modified existing antibiotics are needed to prevent the 
potential spread of multi-drug resistant (MDR) pathogenic bacteria; therefore, several 
efforts need to be taken into account to reduce antibiotic resistance. Over the years, a 
number of different solutions have been suggested by international health organisations 
such as the World Health Organisation (WHO), and the United States Centers for Disease 
Control and Prevention (CDC). These suggestions have included eliminating the use of 
antibiotics for the treatment of viral infections and colds; eliminating their use unless 
there has been an accurate prescription made by a doctor, ensuring that patients take the 
prescribed dose and complete their course of treatment and also controlled therapeutic use 
within agriculture and animal husbandry. In addition, there should be an overall 
awareness regarding disease control through the application of good hygiene by different 
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countries. These measures should have a substantial impact on reducing the overall 
spread of disease and eventually the need for antibiotics (Davies and Davies, 2010).  
 
1.3.3 The mechanism of action of antibiotics 
 
Approximately seventeen different classes of antibiotics have been identified for use in 
clinical practice to date, and at least one mechanism of resistance has developed for each 
of these groups of antibiotics. The mechanisms of action and modes of resistance of the 
major antibiotics are summarised in Table 1.2. (Davies and Davies, 2010).  
 
 
 
Table 1.2 Mechanisms of action and resistance of commonly used antibiotics (Taken from Davies 
and Davies, 2010). 
 
Antibiotic 
families. 
Example. Cellular Process 
affected. 
Mode(s) of 
resistance. 
 
β-Lactams. Penicillin 
(Ampicillin) 
Disruption of 
peptidoglycan 
biosynthesis (inhibit the 
transpeptidation by 
Penicillin-binding 
Proteins (PBPs)).   
β-lactamases 
and altered target 
(PBPs). 
Aminoglycosides. Gentamicin 
and 
streptomycin 
Inhibition of translation 
(30S ribosomal site).  
Mutation and 
hydrolysis 
(enzymatic 
modification). 
Glycopeptides. Vancomycin Disruption of 
Peptidoglycan 
biosynthesis. 
Reprogramming 
peptidoglycan 
biosynthesis. 
Tetracyclines. Minocycline Inhibition of translation. 
(Block tRNA binding to 
30S ribosomal site). 
Monooxygenation
, efflux and 
altered target. 
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Table 1.2 continued 
Lincosamides. Clindamycin Inhibition of 
translation. 
Nucleotidylation, 
efflux and altered 
target. 
Macrolides. Erythromycin Inhibition of 
translation 
(50S Ribosome site). 
Erythromycin 
esterase 
(Hydrolysis), active 
efflux and altered 
target. 
Streptogramins. Synercid Inhibition of 
Translation. 
C-O lyase (Type B 
streptogramins), 
acetylation (Type A 
streptogramins), 
efflux and altered 
target. 
Oxazolidinones. Linezolid Inhibition of 
translation.  
Efflux and altered 
target. 
Phenicols. Chloramphenicol Inhibition of 
ribosomal function 
(50S ribosomal 
site)  (blocking 
peptide elongation). 
Altered outer 
membrane 
(chromosomal 
mutations). 
 
Quinolones. Ciprofloxacin. Inhibit DNA 
topoisomerases or 
gyrases (inhibition 
of DNA replication).  
Acetylation, efflux 
and altered target. 
Pyrimidines. Trimethoprim Disruption of C1 
metabolism. 
Efflux and altered 
target. 
Sulfonamides. Sulfamethoxazole Disruption of C1 
metabolism. 
Efflux and altered 
target. 
Rifamycins. Rifampin Inhibition of 
transcription. 
ADP-ribosylation, 
efflux and altered 
target. 
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In summary, there is at present a huge demand for new antimicrobial compounds, with 
lower or no resistance having a wider range of activity and fewer side effects. Two-thirds 
of the naturally occurring antibiotics discovered so far have been isolated from the 
terrestrial environment, particularly from cultured soil micro-organisms (Ahmed et al., 
2008 and Stach, 2010). However, reflecting the increasing importance of seeking out a 
new source of antimicrobial agents, several studies have been conducted with the aim of 
investigating new groups of micro-organisms with both industrial and clinical importance 
form different sources (Wright et al., 2001; Xue et al., 2003).  
 
One of the key sources of this type of interesting micro-organism is the marine 
environment; the seas and oceans are known to be highly biodiverse (Bernan and 
Greenstein, 1997).  
 
1.4  Diversity of natural products from the marine environment  
 
The chances of discovering novel chemical compounds with potential applications for 
both the industrial and clinical sectors from the marine environment compared to the 
terrestrial environment are higher, as the water (seas and oceans) cover 70% of the planet 
(Austin, 1988). The marine environment, often has different organisms to those of found 
in terrestrial ecosystems (Wright and McCarthy, 1994), and it has a rich biodiversity that 
presents the necessary growth conditions. These are abundant nutrients, moderate 
temperatures, light, and pH; in addition, there are a range of conditions such as high salts, 
low temperatures and high pressure, which may prove ideal for inducing the production 
of secondary metabolites. Therefore, the reported discovery of new structural classes of 
compounds from the marine environment is not surprising. 
 
Several studies have indicated that the majority of the antimicrobial compounds, 
produced from marine micro-organisms, result from secondary metabolites. These 
metabolites have evolved within certain micro-organisms, in order to help them to survive 
within the unique conditions of a marine environment (Zheng et al., 2005). Furthermore, 
preliminary studies have suggested that the wealth of microbial diversity within the 
marine environment makes it an excellent source when searching for new groups of 
micro-organisms with potential applications for both the industrial and clinical sectors 
(Xue et al., 2003). 
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1.5  Marine micro-organisms as a source of bioactive compounds  
 
As Jem Stach evoked, “the search for sunken treasure raises images of shiny gold 
discovered once a seeker’s hand wafts away the sand” (Stach, 2010). However, for a 
different type of treasure hunter, the micro-bioprospector, a marine sample brought from 
the sea is in itself the goal, whether it comes from the sea-coast, or the depths of the sea, 
to the laboratory bench. In this case, the micro-bioprospector is interested in marine 
micro-organisms with biotechnologically important properties; such as industrially 
relevant enzymes with potential for producing antimicrobial compounds and generating 
worldwide sales of life-saving products (forecast to be worth around $100 billion USD by 
2015) (Stach, 2010). The value of these micro-organisms is inestimably high and this is 
driving ‘prospectors’ as if to a gold rush. 
 
 
Marine micro-organisms form a particular group of organisms which are able to grow in 
the marine environment, the seas and oceans, and or on, the surface of or inside marine 
plants or animals, most of which are salt-tolerant with a few being salt requiring. Marine 
micro-organisms, especially marine bacteria, have been shown to be good producers of 
bioactive compounds, such as antimicrobial compounds (Davidson, 1995). 
 
 The search for novel antimicrobial compounds from marine micro-organisms has been 
remarkably successful. For instance, in 1947, Rosenfeld and Zobell studied the antibiotic 
production from marine bacteria; the majority belonged to the Bacillus and Micrococcus 
species. Fourteen years later, in 1961 and 1962 further research confirmed the production 
of antibiotics by marine micro-organisms conducted by Krassil'nikova and Buck et al., 
respectively (Austin, 1988).  
 
The initial identification and characterisation of antibiotics from marine bacteria took 
place in 1966 by Burkholder et al, who discovered novel brominated pyrroles from the 
antimicrobial producing bacterium Pseudomonas bromoutilis, which was isolated from 
Thalasia spp. The inhibitory molecule was active against gram-negative pathogenic 
bacteria; Mycobacterium tuberculosis, Staphylococcus aureus, Streptococcus pneumoniae 
and Streptococcus pyogenes. In same year, Lovell confirmed the chemical structure of 
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this antibiotic as 2, 3, 4-tribromo-5 (1'-hydroxy-2', 4’-dibromophenyl) pyrrole (Lovell, 
1966).  
 
In 1974, Anderson et al. isolated an antibiotic producing bacterium from seawater in the 
North Pacific described as purple pigmented Chromobacterium spp., which was named 
Chromobacterium marinum 1-L-33. It produced several inhibitory compounds, extracted 
with ethyl acetate, and were identified as 4-hydroxybenzaldehyde, hexabromo-2, 2'-
bipyrrole, tetrabromopyrrole, and 2-(2'-hydroxy-3' 5'-dibromophenyl)-3, 4, 5-tribromo 
pyrrole against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa 
pathogenic yeast Candida albicans.  
 
Furthermore, in 1976, Gauthier and Flateau (1976) isolated four antibacterial compounds 
(two brominated and two polyanionic polysaccharide compounds) from marine violet-
pigmented bacterium Alteromonas luteoviolaceus with inhibitory activity against 
Staphylococcus human pathogenic bacterium (Staphylococcus aureus) and 
Staphylococcus epidermidis.  
 
In 1977, Wratten et al. isolated antibiotic producing yellow-pigmented marine 
Pseudomonas bacterium which produced two novel antibiotics; 2-n-heptyl-4-quinolinol 
and 2-n-Pentyl-4-quinolinol which inhibited the growth of Staphylococcus aureus, 
Candida albicans, Vibrio anguillarum and V. harveyi (Wratten et al,. 1977). Screening 
for antibiotic producing marine bacteria has continued. In 1985, a study carried out by 
Lemose et al. isolated antimicrobial producer strains from the surface of seaweed. They 
reported that micro-organisms were found to inhibit the growth of Staphylococcus aureus 
ATCC 25923. They identified the inhibitory molecule found as a low molecular weight 
inhibitor (smaller than 2KDa). One year later Okami carried out screening for novel 
antibacterial agents from the marine environment and discovered novel antibiotics. For 
instance, he discovered new antibacterial agents: Aplasmomycin and Istamycin from 
marine actinomycetes Streptomyces griseus and Streptomyces tenjimariensis, 
respectively, from mud sea samples, which were obtained from the Sagami Bay in Japan 
(Okami, 1986).  
 
The inhibitory molecule aplasmomycin was active against wide varieties of gram-
negative bacteria in addition to Mycobacterium spp; whilst the antibiotic Istamycin which 
belonged to the aminoglycoside family was active against wide varieties of gram-negative 
Chapter. 1                                                                                                                                        Introduction  
 11 
and gram-positive bacteria including micro-organisms that had developed resistance to 
aminoglycoside antibiotics (Okami, 1986).  
 
A number of investigations of marine bacteria, associated with marine organisms, have 
also revealed the capability to produce secondary metabolites (the group of metabolites to 
which the majority of discovered antibiotics, also belong. Shiozawa et al. (1993) isolated 
antimicrobial antibiotic Thiomarino from the marine isolated bacterial strain 
Alteromonas rava spp. with strong inhibitory activity against gram-negative and gram-
positive bacteria. (Shiozawa et al., 1993). In 1995, Kunze et al. isolated novel 
chondramides from marine myxobacteriun Chondromyces crocatus, strain Cm c2. The 
compound showed inhibitory activity against micro-organisms such as yeast in addition 
to its cytostatic activity against animal tissue cultures including human cells. 
 
A novel antibacterial agent which belongs to the group phenazin antibiotic methyl ester, 
was isolated from marine actinomycetes Streptomyces spp., and termed 5, 10- 
dihydrophencomycin methyl ester. The compound had antibacterial activity against E.coli 
and Bacillus subtilis (Pusecker et al,. 1997). Furthermore, Imamura et al. (1997) 
discovered a new phenazine antibiotic termed pelagiomicine from a new marine 
bacterium strain Pelagiobacter variabilis Ni-2088, which was isolated from Pocockiella 
variegate (alga). The inhibitory molecule showed good antimicrobial activity against a 
wide range of gram-positive and gram-negative bacteria including E. coli, B. subtilis, P. 
aeruginosa, Enterococcus hirae, Salmonella choleraesuis, Shigella sonnei, Klebsiella 
pneumoniae and S. aureus.  
 
Gerard et al. (1999) also isolated new decapeptide antibiotics termed loloatins A-D from 
an unidentified marine bacterium strain (Designated MK-PNG-276A) from the Great 
Barrier Reef, in Papua, New Guinea. The compound inhibited the growth of multi-drug 
resistant human pathogenic bacteria, such as vancomycin-resistant enterococci (VRE), 
methicillin-resistant Staphyloccoccus aureus (MRSA) and drug-resistant Streptococcus 
pneumoniae.  
 
In summary, the main conclusion to be drawn from the literature is that the marine 
environment represents a significant source for isolating micro-organisms, which have the 
potential to produce novel bioactive metabolites for drug discovery. 
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Contemporary scientists are engaged in a continual search for antimicrobial compounds 
with novel characteristics. To date in the region of two-thirds of the bioactive materials 
present in the environment, that have been taken from bacteria, have been found to have a 
role to play in medical science; this is especially true of genus actinomycetes (Stach, 
2010). The research so far, focusing on identifying marine bacteria, has targeted marine 
variants of actinomycetes, whilst the investigation of other marine antimicrobial 
producing bacterial species is relatively limited. However, it is though that by studying 
isolates from rare marine micro-organisms we will find new producer strains and 
antimicrobial compounds. Of particular interest to this research are marine variants of the 
genus Serratia, more details of which are given below. 
 
1.6  The genus Serratia: taxonomy, distribution and characteristics 
 
Italian physicist Serafino Serrati named the genus Serratia; it is a group of bacteria within 
the Gamma-proteobacteria that relates to both the DNA sequence and phenotypically to 
the family of Enterobacteriaceae. Serratia species are described as gram-negative, rod-
shaped, facultative anaerobes and some species (S. marcescens, S. rubidaea and S. 
plymuthica) produce a non-diffusible red-pigment (prodigiosin, 2-methyl-3-amyl-6 
methoxyprodigiosene). Serratia are widely distributed in nature and have been isolated 
from water (fresh and salt), soil, plants, animals, insects and humans. However, there are 
several species of the Serratia; from those that have a harmful impact on humans such as 
pathogenic Serratia marcescens to those that have a beneficial impact on agriculture in 
the biological control of pathogenic plant fungi and bacteria as a biocontrol tool such as 
Serratia plymuthica. This genus currently consists of sixteen species and four subspecies, 
which are listed in Table 1.3 (Grimont and Grimont, 1978; Vleesschauwer and Hofte, 
2007; Neupane et al., 2012).  
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Table 1.3: List of Serratia species* 
 
  
Species. Type strain. 
 
Source/ Reference  
Serratia entomophila ATCC 43705 Grimont et al. (1988) 
Serratia ficaria  ATCC 33105 Grimont et al. (1981) 
Serratia fonticola ATCC 29844  Gavini et al. (1979) 
Serratia glossinae CCUG 57457  Geiger et al. (2010) 
Serratia grimesii  ATCC 14460  Grimont et al. (1982) 
Serratia liquefaciens 
 
ATCC 27592  
 
Grimes and Hennerty (1931) 
and Bascomb et al. (1971) 
Serratia marcescens ATCC 13880  
 
Bizio (1823) (Type of genus 
species) 
Serratia marcescens subsp. ma
rcescens  
ATCC 13880 
 
Bizio (1823) and Ajithkumar 
(2003) 
Serratia marcescens subsp. sak
uensis  
 CIP 107489 Ajithkumar (2003) 
Serratia marinorubra   ATCC 27593 ZoBell and Upham (1944) 
Serratia nematodiphila   DSMZ0503SBS1 Zhang et al. (2009) 
Serratia odorifera 
 
ATCC 33077 
 
Grimont et al. (1978) 
 
Serratia plymuthica  
 
ATCC 183  
 
Lehmann and Neumann (1896) 
and Breed et al. (1948) 
Serratia proteamaculans  ATCC 19323  Grimont and Grimont (1978) 
Serratia proteamaculans subsp
. proteamaculans 
ATCC 19323 
 
 Grimont and Grimont (1978) 
and Grimont et al. (1982)  
Serratia proteamaculans subsp
. quinovora 
ATCC 33765 
 
Grimont et al. (1982) 
 
Serratia quinivorans corrig  ATCC 33765  Grimont et al. (1982) and 
Ashelford et al. (2002) 
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Table 1.3 continued 
*Cited from (http://www.bacterio.cict.fr/s/serratia.html) (27-12-2012). Culture Collection, 
University of Göteborg, Sweden (CCUG), Deutsche Sammlung von Mikroorganismen und 
Zellkulturen GmbH (DSMZ) and the American Type Culture Collection (ATCC).  
 
S. marcescens species is a well known characterised bacterium belong to the genus of 
Serratia spp. Unlike other Serratia spp. S. marcescens has pathogenic properties. 
(Grimont and Grimont, 1978). S. marcescens is recognised to be an important pathogenic 
bacterium associated with nosocomial infections and has received intensive attention 
because of its properties relevant to pathogenicity in humans and its resistance to wide 
range of antibiotics such as β-lactam antibiotics including ampicillin and aminoglycosides 
(Sleigh, 1983). 
 
S. marcescens produces a range of metabolite compounds including pigments (red 
pigment {prodigiosin} and yellow pigment), toxins (lipopolysaccharide{(LPS}), acids (β-
cis-cis-carboxymuconic acid and an uncolored muconic acid), enzymes (nuclease, 
protease, lipase and chitinase) and antibiotics (carbapenam), bacteriocin and siderophore 
(aerobactin) (Grimont and Grimont, 1978). However, some of these metabolites have 
antimicrobial properties (antifungal and/or antibacterial activities). These properties have 
been investigated by several researchers, including Thomson et al. (2000), who 
investigated the biosynthesis of the antibacterial carbapenam antibiotic (β-lactam 
antibiotic) that is produced by S. marcescens strain ATCC 39006. Also Krausse et al. 
(2005), reported that S. marcescens strain NCTC 10211 has antibacterial activity against 
the opportunistic human pathogen Helicobacter pylori that causes stomach ulcers. This 
study suggested that S. marcescens strain NCTC 10211 has a probiotic activity against H. 
pylori.  
 
1.6.1 Historical aspects of S. plymuthica 
 
S. plymuthica is widely distributed and has been isolated from seawater, insects and soil 
(Grimont and Grimont, 1978), as an opportunistic fish pathogen (Austin and Stobie, 
Serratia rubidaea  ATCC 27593 Stapp, (1940) and Ewing et al. 
(1973) 
Serratia symbiotica  DSMZ 23270  Sabri et al. (2011) 
Serratia ureilytica  CCUG 50595 Bhadra et al. (2005) 
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1992) and also from the air of poultry houses (Vucemilo et al., 2005). Furthermore, some 
species of S. plymuthica have been found to be associated with nosocomial infections. For 
instance it has been isolated from surgical wound exudates, blood cultures, the peritoneal 
fluid, bone marrow infections and central venous catheters (Zbinden and Blass, 1988 and 
Carrero et al., 1995).  
 
According to an internationally approved German directive (TRBA 466), S. plymuthica is 
recognised within risk group 1 by the German Collection of Micro-organisms and Cell 
Cultures (DSMZ), which indicates that the species does not cause a hazard to human 
health in comparison to S. marcescens, which is grouped in risk group 2. However, so far, 
there has been insufficient evidence for pathogenicity in S. plymuthica when compared to 
other nosocomial pathogens such as Stenotrophomonas and Burkholderia (Vleesschauwer 
and Hofte, 2007). Thus, so far, there is no convincing evidence that S. plymuthica is 
responsible for causing infections to humans.  
 
To date the majority of the work performed on S. plymuthica is within the area of soil 
microbiology and biocontrol and many terrestrial isolates have been extensively studied.  
Thus it has been isolated from the green part of lettuce and carrot (Grimont and Grimont, 
1981) and the rhizosphere of different plants. For instance, the rhizosphere of wheat  
( Alström and Gerhardson, 1988); tomato (Frommel et al., 1991); grape (Chernin et al., 
1995); oilseed rape (Kalbe et al., 1996); maize (Lucon and Melo, 2000);  onion (Park and 
Shen, 2002); Brassica spp. (Carlot et al., 2002); Cichorium intybus (Stock et al., 2003) 
and also from the endorhiza of potatoes (Berg et al., 2005). 
 
 1.6.2 Bioactive compounds produced by the terrestrial isolates of S. plymuthica 
 
During the last two decades, several studies have focused on S. plymuthica isolates for 
controlling soil-borne pathogens, particularly fungal plant pathogens.  Alström and  
Gerhardson (1987) isolated the S. plymuthica strain G15 from rhizospheres of various 
plant species. The bacterium showed strong antifungal activity against soil-borne fungal 
pathogens: Gerlachia nivalis and Botrytis cinerea and moderate antifungal activity 
against plant fungal pathogens: Pythium spp, Rhizoctonia solani. solani and Fusarium 
culmorum. One year later they also isolated another strain of S. plymuthica (termed A153) 
from the rhizosphere of wheat ( Alström and Gerhardson, 1988). This bacterium was later 
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used by several researchers in the field of biological control as an antifungal agent 
producer (Berg, 2000; Levenfors et al., 2004).  
 
Chernin et al. (1995) isolated the S. plymuthica strain IC1270 from the rhizosphere of 
grapes. This bacterium inhibited the growth of the soil born fungus Rhizoctonia solani on 
cotton. One year later, the strain of S. plymuthica A21-4 was isolated from onion roots 
and used in vitro as biocontrol against the plant fungal pathogen Phytophthora capsici. 
The isolate (S. plymuthica A21-4) showed a significant inhibition of cystospore 
germination, mycelium growth and zoosporangia formation of the pathogenic fungus 
(McCullagh et al., 1996).  
 
Kalbe et al. (1996) carried out a study on 5000 rhizobacteria isolates from the roots of 
oilseed rape to isolate strains with antifungal properties. The study reported that sixteen 
strains of the 146 antifungal isolates belonged to S. plymuthica strains and showed an 
antifungal activity against R. solani, Verticillium dahliae and Sclerotinia sclerotiorum. 
One of the antifungal isolates was well characterised in this study and was termed as the 
S. plymuthica strain HRO-C48.  This strain of S. plymuthica was also used in another 
study to evaluate antifungal activity against plant pathogenic fungi Phytophtora cactorum 
and Verticillium. The result reported that the S. plymuthica strain HRO-C48 caused a 
significant reduction in fungal disease on strawberry roots, which had resulted from 
Verticillium and P. cactorum (Kurze et al., 2001).  
 
Galland and Paul (2001) isolated the soil bacterium S. plymuthica strain B-781, from the 
Burgundy region in France. This soil isolate showed strong antifungal activity against the 
fungal plant pathogen Pythium perplexum, which causes damping-off disease of 
cucumber. More recently, a study performed on the antifungal-producing S. plymuthica 
strain IC1270 showed a good antifungal activity against Pythium aphaniderma which 
causes Pythium disease on cucumbers grown under greenhouse conditions (Ovadis et al., 
2004).   
 
Berg et al. (2005) isolated an endophyte, S. plymuthica (termed B4) from the endorhiza of 
the potato. This bacterial isolate caused a reduction of up to 25% in the plant disease 
caused by plant fungal pathogen R. solani on potato sprouts. Moreover, the commercial 
antifungal product (RhizoStar1) has been developed by e-nema GmbH, Raisdorf, 
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Germany under European patent 98124694.5, from the S. plymuthica strain (HRO-C48) 
(Vleesschauwer and Hofte, 2007). 
 
Only a few studies have reported in reference to using an antifungal producer S. 
plymuthica against post-harvest diseases. For instance, the S. plymuthica strain 
NCIMB40492S=CL43, was used as a biocontrol agent producer (antifungal) against; 
Alternaria brassicicola and B. cinerea on Dutch white cabbage in cold storage (Leifert et 
al., 1993). Ritte et al. (2002) reported that the S. plymuthica strain IC1270 showed 
antagonistic activity against the plant fungal pathogens Penicillium expansum and 
Monilia fructicola, which cause blue mould on apples and peaches, respectively. Strains 
of S. plymuthica (IC1270 and IC14), have also been used to protect cucumber leaves from 
fungal diseases such as Sclerotinia sclerotiorum (white mould) and Botrytis cinerea (grey 
mould) under greenhouse conditions (Kamensky et al., 2003). 
 
This supports a conclusion that over the last two decades strains of S. plymuthica from 
terrestrial sources have been used as biocontrol agents to attack soil-borne pathogens 
(Fungal pathogens). Although, information regarding S. plymuthica from marine isolates 
is limited. We can also hypothesise in view of current knowledge, that any study of rare 
marine antimicrobial producer micro-organisms has the potential to lead to the discovery 
of new antimicrobial compounds. By conducting studies in this area we can increase 
awareness of the resources in the marine ecosystem, as well as explore the antimicrobial 
activities of marine S. plymuthica strains by testing their effects on foodborne pathogens 
and multi-drug resistant bacteria, such as VRE and MRSA. More information about the 
antimicrobial mechanisms S. plymuthica is given below. 
 
1.6.3 Antimicrobial mechanisms of S. plymuthica 
 
S. plymuthica strains produce a range of antimicrobial metabolites including antibiotics, 
siderophores and Parasitism (lytic enzymes) (Shoji et al., 1989; Chernin et al., 1995; 
Kalbe et al., 1996; Faltin et al,. 2004; Levenfors et al., 2004 and Ovadis et al., 2004). An 
overview of bioactive metabolites produced by strains of S. plymuthica is presented in 
Table 1.4 (Vleesschauwer and Hofte, 2007). 
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Table 1.4: Overview of antimicrobial metabolites produced by S. plymuthica strains (Taken from 
Vleesschauwer and Hofte, 2007) 
 
S. plymuthica strain Metabolite compounds 
HRO-C48 Pyrrolnitrin  Chitinases Proteases  Siderophores 
IC1270 Pyrrolnitrin Chitinases Proteases  Siderophores 
IC14 Pyrrolnitrin Chitinases Proteases  Siderophores 
A153 Pyrrolnitrin  Haterumalides   
R12 Glucanases  Chitinases Proteases  
3Re4-18 Glucanases  Chitinases Proteases Siderophores 
 
1.6.3.1 Antibiotics 
 
Terrestrial S. plymuthica isolates have been shown to produce several useful secondary 
metabolites like antifungal antibiotics. For instance, it is reported that S. plymuthica 
strains may produce antibiotics similar in structure to biosynthesis substrates from type I 
polyketide synthase, which have a wide range of pharmaceutical potential as anti-tumour 
intervention and antibiotics (Levenfors et al., 2004). However, several studies have 
reported that terrestrial S. plymuthica isolates produce antimicrobial compounds such as 
chlorinated macrolides, haterumalide (A, B, NE, and X) and pyrrolnitrin, 1-acetyl-7-
chloro-1-H-indole and the dipeptide antibiotic CB-25-I.    
 
Shoji et al. (1989), isolated a new antifungal antibiotic, from S. plymuthica CB-25, which 
was isolated from soil samples collected from Fukiagecho and Kagoshima Prefecture, in 
Japan. The bioactive compound inhibited the growth of Candida albicans and was named 
as CB-25-I and found to be a water-soluble dipeptide. The chemical structure of the 
compound was identical to the Sch 37137 and A19009 (antifungal antibiotic produced by 
Actinomycetes strains) (Shoji et al., 1989). 
 
 Chernin et al. (1996) isolated antibiotics from the S. plymuthica IC1270 strain identified 
as pyrrolnitrin [3-chloro-4-(28-nitro-38-chlorophenyl) pyrrole]. The compound showed 
inhibitory activity against several phytopathogenic fungi and bacteria. The haterumalides 
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and chlorinated macrolides were the first polyketide compounds found to be produced by 
Serratia plymuthica strains (Vleesschauwer and Hofte, 2007).  
 
Thaning et al. (2001), isolated from soil a strain of S. plymuthica which produced a 
bioactive compound, which inhibited both ascospore germination and apothecial 
formation of the fungal plant pathogen Sclerotinia sclerotiorum. The compound was 
identical in chemical structure to chlorinated macrolides and was identified as 
haterumalide NA.  
 
Recently, Levenfors et al. (2004), isolated several inhibitory compounds from the soil 
bacterium Serratia plymuthica A 153. The compounds showed inhibitory activity against 
the plant pathogenic fungus Sclerotinia sclerotiorum and were identified as chlorinated 
macrolides, haterumalide (NA, B, NE and X), 1-acetyl-7-chloro-1-H- indole and 
pyrrolnitrin.  
 
More recently, Shen et al. (2007), evaluated the potential biocontrol properties of the 
biocontrol producer Serratia plymuthica A21-4 against the Phytophthora capsici which 
causes Phytophthora blight of pepper. The chemical structure of the antifungal compound 
was found to be identical to chlorinated macrolide. The chemical structures of antifungal 
antibiotics produced by terrestrial isolated S. plymuthica strains are shown in Figure 1.2. 
However, further research considering the biosynthetic pathway and genetic origin of 
haterumalide antibiotics produced by S. plymuthica is needed to confirm the involvement 
of a type I polyketide synthase cluster in the biosynthesis of these antibiotics 
(Vleesschauwer and Hofte, 2007).  
 
Some strains of terrestrial S. plymuthica isolates have been reported to produce red 
pigmentation associated with the antibiotic prodigiosin (red-pigmented tripyrrole 
antibiotic).  Alström and Gerhardson (1987), isolated red-pigmented Serratia plymuthica 
G15 from plant rhizospheres, which showed antagonistic activity against the growth of 
fungal pathogens: Gerlachia nivalis, Botrytis cinerea Pythium spp, Fusarium culmorum 
and Rhizoctonia solani. 
 
 Kalbe et al. (1996), suggested that antifungal activity of the rhizosphere isolated Serratia 
plymuthica strains against the tested phytopathogenic fungi might have resulted from the 
production of prodigiosin, pyrrolnitrin and lytic enzymes. Berg (2000), reported that 21 
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terrestrial S. plymuthica isolates produced antifungal antibiotics against the tested plant 
fungal pathogens; six of them were produced red pigmentation associated with the 
antifungal antibiotic prodigiosin. 
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1. Haterumalides. 
  
2. Pyrrolnitrin (pyrrole rings 
highlighted in green). 
3. Chlorinated macrolide (Macrocyclic lactone 
A21-4). 
 
Figure 1.2: The chemical structures of some antimicrobial substrates produced by S. 
plymuthica: Haterumalide, Pyrrolnitrin and Macrocyclic lactone A21-4. From (Levenfors et 
al. 2004; Shen et al. 2007; Kirner et al. 1998).  
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1.6.3.2 Chitinase 
 
Chitinases are the enzymes that hydrolysis chitin which is a universal element of most 
cell walls of fungi. This enzyme can be classified into two major groups: endochitinases 
which randomly cleave the chitin at internal sites, producing low molecular mass 
multimers of chitin, (i.e. chitotriose, chitotetraose, and diacetylchitobiose); and the 
exochitinases which are divided into two subgroups: N-acetyl-β-(1,4)-D-
glucosaminidases and chitobiosidases (Patil et al., 2000). Based on these systems of 
classification, several kinds of chitinases have been identified in antifungal producer S. 
plymuthica strains. Several pieces of research have studied the role of chitinases in 
biocontrol activity (as antifungals). Frankowski et al. (1998), suggested that chitinases 
produced by S. plymuthica strains played an important role in antifungal activity and 
Kamensky et al. (2003), reported that S. plymuthica IC1270 secreted two exochitinases 
(N-acetyl-b-D-glucosaminidases) with a molecular mass of 67 and 89 kDa, and two 
endochitinase (chitobiosidases) with a molecular mass of 50 and 59 kDa.  
Moreover, S. plymuthica strains (HRO-C48 and IC14), have been reported to produce an 
endochitinase N-acetyl-β-1, 4-D- hexosaminidase or chitobiase with a molecular mass of 
100 kDa (Frankowski et al., 2001; Kamensky et al., 2003). 
 
1.6.3.4 Siderophores 
 
Iron is an important element supporting the growth of all organisms. It is essential for 
biological processes such as DNA synthesis and respiration. Despite iron being one of the 
abundant elements on our planet, the bioavailability of this element is limited, because of 
the very low solubility of ferric ions in several habitats, such as the sea, soil and plant 
surfaces (Höfte et al., 1993). Iron found in nature in mineral phases accumulates as iron 
hydroxides and oxide, and cannot directly be used by organisms (Höfte et al., 1993;  
Kraemer, 2004).  
 
Under iron-limitation, bacteria release a range of low-molecular-weight substrates (iron 
chelators or siderophores) to transfer ferric irons from insoluble phases (minerals) to a 
soluble phase that can be utilised by organisms. Several of these siderophores are non-
ribosomal peptides  (NRPs) (Miethke and Marahiel, 2007). As biocontrol and 
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antimicrobial agents, these bacterial iron carriers (siderophores) reduce the iron available 
in the rhizosphere, thus preventing soil-borne pathogens such as plant pathogenic fungi 
from developing and subsequently inhibiting their growth (O’Sullivan and O’Gara, 1992; 
Loper and Henkels, 1999). 
 
Several studies have reported that terrestrial S. plymuthica isolates, including strains such 
as IC14, IC1270, HRO-C48 and 3Re4-18, have been shown to produce potential 
siderophore molecules with antifungal activity when grown on free-iron media (Kalbe et 
al., 1996; Frankowski et al., 1998; Kamensky et al., 2003; Ovadis et al., 2004;  Berg et 
al., 2005). 
 
1.7 Polyketides (PKs) and Non-ribosomal peptides (NRPs) 
 
Non-ribosomal peptides and polyketides are two groups of complex natural products, 
which are found in plants and micro-organisms. These metabolites result from multi-
modular enzyme systems called non-ribosomal peptide synthetases (NRPSs) and 
polyketide synthases (PKSs) and have various structures. For instance, they can be linear 
like ribosomally synthesised peptides, branched, cyclic (totally or partially) or polycyclic 
(Minowa et al., 2007). The various structures of these peptides allows them to engage in a 
wide range of important biological and pharmacological activities; including antibiotics, 
such as vancomycin (a non-ribosomal peptide antibiotic), erythromycin (a polyketide 
antibiotic), amphotericin (a macrolide) and yersiniabactin (a siderophore) (Pfeifer et al., 
2003). The chemical structures of some of these PKs and NRPs compounds are shown in 
Figure 1.3. 
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Figure 1.3: The chemical structures of polyketide and non-ribosomal peptide compounds (a) 
Erythromycin; (b) amphotericin; (c) yersiniabactin; (d) CDA; and (e) fengycin (lipopeptide 
antibiotics). From Minowa et al.(2007). 
 
 
1.7.1 PKs and NRPs produced by the terrestrial isolates of S. plymuthica 
 
The first report of polyketide compounds to be produced from S. plymuthica strains was 
in 2001 by Thaning et al. who isolated S. plymuthica from soil and produced a bioactive 
compound that inhibited the fungal plant pathogen Sclerotinia sclerotiorum. The 
compound was identified as a chlorinated macrolide and termed haterumalide NA. Three 
years later, Levenfors et al. (2004) isolated several inhibitory compounds from different 
soil sourced S. plymuthica (strain A153) including polyketide compounds (chlorinated 
macrolides and haterumalide (NA, B, NE and X). More recently, Shen et al. (2007) 
identified a potential polyketide compound with antifungal activity which was found to be 
a chlorinated macrolide (macrocyclic lactone A21-4). An examination of the Serratia 
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genus in general (e.g. Serratia sp. ATCC 39006 and S. marcescens ATCC 274) 
characterising the prodigiosin gene cluster (pig cluster), and the result showed that the 
sequenced pig gene cluster contains genes with some similarity to non-ribosomal peptide 
synthases (NRPSs), polyketide synthases (PKSs) and the red proteins of Streptomyces 
coelicolor (Harris et al., 2004).  
 
In contrast, some studies have indicated that the similarities of the structure of the 
haterumalide biosynthesis genes in macro-organisms such as seaweed suggests that the 
biosynthetic pathway of the haterumalides involve a type I polyketide synthase gene 
cluster, similar to the haterumalide biosynthesis in bacteria, such as that found in 
Pseudomonas sp. (Rangaswamy et al., 1998; Nowak-Thompson et al., 1999). 
Nevertheless, further research considering the biosynthetic pathway and the genetic origin 
of haterumalide antibiotics produced by S. plymuthica is necessary to confirm the 
involvement of the type I polyketide synthase gene cluster in the biosynthesis of these 
antibiotics (Vleesschauwer and Hofte, 2007). 
 
1.8 Quorum sensing (QS) 
 
Quorum-sensing systems (QS), in bacterial cells, are regulatory mechanisms for 
controlling gene expression, via the production of small diffusible chemical signal 
molecules (autoinducers). The autoinducers express or inhibit certain gene(s) in response 
to bacterial cell population density (Miller, 2001). The increase of the bacterial cell-
population density results in increases in autoinducer concentration, and therefore, 
increasing levels of these signalling molecules to be sensed allowing surrounding bacteria 
to respond correspondingly.  Gram-negative and gram-positive bacteria use quorum-
sensing systems to regulate several physiological activities including virulence, 
competence, symbiosis, conjugation, motility, sporulation, biofilm formation and 
antibiotic production. In general, gram-positive bacteria use oligopeptides as 
autoinducers, whereas gram-negative bacteria use N-acyl-L-homoserine lactones (AHLs), 
which have been very well studied on this group of bacteria (Figure 1.4) (Miller, 2001; 
Waters and Bassler, 2005; Van Houdt et al., 2006; Van Houdt et al., 2007a). Although 
the nature of autoinducers, the target genes controlled and the mechanisms of quorum 
sensing systems differ, in every situation the ability to communicate with one another 
allows bacteria to control the gene expression, and thus the behaviour, of the whole 
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community. This QS mechanism impart upon bacterial communities some of the qualities 
of eukaryotic organisms (Miller, 2001). 
 
Studies have suggested that the quorum-sensing system plays a role in the expression of 
specific genes, including in some instances those for antimicrobial production (Labbate et 
al,. 2004). Antimicrobial production in bacteria has been reported to be controlled 
globally by Quorum sensing and two-component systems. Quorum sensing systems 
release autoinducers such as AHLs, which bind to transcriptional regulators, which in turn 
bind to the promoters of the targeted gene(s) to control gene expression. However, low 
levels of autoinducers (AHL) have an opposite effect. The two component systems allow 
organisms to control the internal environment with regards to exterior factors (Moons et 
al., 2006; Van Houdt et al., 2007a; Van Houdt et al., 2007b). 
  
 
 
 
Figure 1.4: The chemical structure of the most intensively studied autoinducer system in gram-
negative bacteria (a) and gram-positive bacteria (b). From Waters and Bassler (2005).  
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1.8.1 Quorum sensing and antimicrobial production in S. plymuthica 
   
In the terrestrial S. plymuthica isolates, different quorum sensing and target genes have 
been studied. ALH-dependent quorum-sensing signalling has been linked with several 
phenotypes; for instance, the production of chitinase, nuclease, protease, antibacterial 
compounds and biofilm fermentation (Van Houdt et al., 2007a).  
 
The first report of the role of the QS system in regulating the production of an 
antimicrobial in S. plymuthica was a study looking at the production of pyrrolnitrin (Liu 
et al., 2007). The study showed that S. plymuthica HRO-C48 (rhizosphere isolated), 
produced several quorum-sensing signalling molecules (AHLs) which included; N-
hexanoyl-HSL, N-butanoyl-HSL and N-3-oxo-hexanoyl-HSL (OHHL), which are 
required for the production of pyrrolnitrin.  
 
Moreover, a study performed by Pang et al. (2008),  confirmed the involvement of QS in 
the antimicrobial production S. plymuthica HRO-C48 (Pang et al., 2008). Also, Van 
Houdt et al. (2007b), reported that the production of an antimicrobial compound by S. 
plymuthica RVH1 was quorum sensing controlled and indicated that the LuxR and SplR, 
homologs of S. plymuthica RVH1 were repressors of AHL genes.   Some examples of the 
autoinducing molecules (AHLs) identified in S. plymuthica strains are shown in Table 1.5  
 
Table 1.5 Examples of quorum sensing systems identified in S. plymuthica strains. 
 
S. plymuthica strains AHLs. LuxI/LuxR. Reference. 
IC1270 3 3-hydroxy-C6-HSL,  
3-hydroxy-C8-HSL 
SplI/SplR Ovadis et al. 
(2004). 
RVH1 C4-HSLw, 
 C6-HSLw 
3-oxo-C6-HSL 
SplI/SplR Van Houdt et al. 
(2007b) 
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1.9 Aims of this study 
 
The research reported within this study, had five aims: 
 
1) The characterisation of an antimicrobial producer bacterium isolated from the 
surface of seaweed (Ascophyllum nodosum). 
2) The investigation of antimicrobial activity against a wide variety of indicator 
micro- organisms; such as food borne pathogens, food spoilage micro-organisms 
and medically important pathogenic micro-organisms. 
3) The study and modification of cultivation methods, to induce the production of 
antimicrobial compound(s) in a liquid culture. 
4) The characterisation of the antimicrobial compound(s) produced by the marine 
bacterium. 
5) Identification of the gene(s) responsible for antimicrobial production. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS
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2. Materials and Methods 
2.1 General Methods 
 
All chemicals, media, reagents, enzymes, buffers and other materials were supplied by 
Thermo Fisher Scientific (UK) or Sigma-Aldrich (UK). All the materials in this study 
were handled and stored according to the manufacturer’s instructions. Centrifugation was 
carried out using a microfuge for small samples, using 1.5ml microcentrifuge tubes. 
Large volume samples up to 1 litter, however, were centrifuged using a large centrifuge 
(Beckman Avanti J-26 XP). All centrifugations were run at an appropriate speed and at 
either room temperature or 4 oC. In this study, solutions and glassware were autoclaved 
for 15 min at 121 oC.  
 
2.1.1 Microbial strains used in the study  
 
2.1.1.1 Marine microorganisms  
 
From the screening of seaweed associated marine microorganisms, for their ability to 
produce antimicrobial compounds, (samples collected from Aberdour beach, Scotland on 
the 17th of November 2009), the laboratory observed that a red-pigmented micro- 
organism inhibited the growth of a filamentous microorganism (Figure 2.1). This 
particular antimicrobial producer was the subject of this study (termed P) and the 
filamentous micro-organism whose growth was inhibited (sensitive strain) was termed F.  
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Figure 2.1 Initial nutrient agar plate with unknown colony (P), inhibiting the growth of 
filamentous microorganism (F).  
 
2.1.1.2 Test microorganism strains  
 
The sensitive strains used in this study, for antimicrobial screening represent certain 
concerns for the medical sector, such as: multi-drug resistant human pathogenic bacteria, 
pathogenic yeast, food spoilage and food borne pathogenic micro-organisms. Table 2.1 
shows the microorganisms, used for this study. They were obtained from the School of 
Life Sciences Heriot Watt University.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 P 
 F 
Chapter 2.                                                                                                                      Materials and Methods 
 
 32 
 
Table 2.1 Micro-organisms used in this study 
 
Microorganisms / Lab ID Source Category 
 
Serritia plymuthica (P) D. Jamieson1 Antimicrobial producer 
Serratia marcescens (ATCC13880). P. Cyphus2 Antimicrobial producer 
Bacillus cereus var mycoides (F) D. Jamieson1 Test strain 
Serratia plymuthica DSM 4540 DSMZ Reference strain 
Methicillin resistant 
Staphylococcus aureus (MRSA) 
H. Rahman3 Test strain 
Staph. epidermidis H. Rahman3 Test strain 
Vancomycin resistant 
enterococci (VRE) 
H. Rahman3 Test strain 
Listeria monocytogenes scott A W. Mitchell4 Test strain 
L. monocytogenes NCTC7973 W. Mitchell4 Test strain 
Clostridium difficile W. Mitchell4 Test strain 
Candida albicans (NCTC3153) D. Jamieson1 Test strain 
Candida albicans (NCTC5314) D. Jamieson1 Test strain 
Pichia angusta D. Jamieson1 Test strain 
Penicillium expansum P. Cyphus2 Test strain 
Pseudomonas aeruginosa P. Cyphus2 Test strain 
E. coli BW20767 P. Morris5 Test strain 
E. coli D28 S. Dewar6 Test strain 
E. coli P. Cyphus2 Test strain 
 
Legend to Table 
 
1 D. Jamieson, School of Life Sciences, Heriot Watt University, Edinburgh, UK 
2 P. Cyphus, School of Life Sciences, Heriot Watt University, Edinburgh, UK 
3 H. Rahman, School of Life Sciences, Heriot Watt University, Edinburgh, UK 
4 W. Mitchell, School of Life Sciences, Heriot Watt University, Edinburgh, UK 
5 P. Morris, School of Life Sciences, Heriot Watt University, Edinburgh, UK 
6 S. Dewar School of Life Sciences, Heriot Watt University, Edinburgh, UK 
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2.1.1.3 Established bacterial strains used in the study  
 
Table 2.2 Established bacterial strains used in the study 
 
 
 
 
 
 
 
Strains Genotype/Characteristic Source/ 
Reference  
E. coli BW20767  leu-63::IS10 recA1 zbf-5 creB510 hsdR17 
endA1 thi uidA(MluI::pir) chromosome::RP4-2 
Tc::Mu Km::Tn7; Tpr Smr. Transposon donor 
strain. (LB+ Kan [50 µg /ml]) 
Larsen et al. 
(2002) 
E. coli S17-1/λ pir  pro thi hsdR recA chromosome::RP4-2 Tc::Mu 
Km::Tn7/_pir; Tpr Smr. Maintaining 
Transposon junction plasmids. (LB+ Str[20 µg 
/ml]) 
Larsen et al. 
(2002) 
 
E. coli XL1-Blue Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 
supE44 thi-1 recA1 gyrA96 relA1 lac [F  ́proAB 
lacIqZΔM15 Tn10 (Tetr)].  
Stratagene, 
UK 
Chromobacterium 
violaceum (CV0blu) 
Triple mini-Tn5 mutant derived from C. 
violaceum ATCC 31532. N-acylhomoserine 
lactones (AHLs) biosensor HgrcviI::Tn5xylE 
Kmr Cmr, plus spontaneous Smr and another 
uncharacterised mutation allowing a stronger 
response to AHLs 
Swift et al. 
(1997) 
Chromobacterium 
violaceum (CV031) 
Mini-Tn5 mutated derivative of 
Chromobacterium violaceum ATCC 31532 
which was originally selected for 
overproduction of the purple violacein pigment. 
M. K. 
Winson, 
pers. Comm, 
Heriot Watt 
University 
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2.1.1.4 Bacterial strains created during this study  
 
Table 2.3 Bacterial strains created during this study 
 
Strains Description Markers Source 
 
M4 Non antimicrobial producer mutant no 4, 
Tn5-RL27 (KmR-oriR6 K) delivery 
vector: inserted into the chromosomal 
DNA of S. plymuthica ( P)  
KmR, ApR This study 
M5 ,,      ,,  mutant no 5  ,,    ,,    ,,   ,,   ,,    ,,     KmR, ApR This study 
M6 ,,      ,,  mutant no 6  ,,    ,,    ,,   ,,   ,,    ,,     KmR, ApR This study 
M7 ,,      ,,  mutant no 7  ,,    ,,    ,,   ,,   ,,    ,,     KmR, ApR This study 
M8 ,,      ,,  mutant no 8  ,,    ,,    ,,   ,,   ,,    ,,     KmR, ApR This study 
M9 ,,      ,,  mutant no 9  ,,    ,,    ,,   ,,   ,,    ,,     KmR, ApR This study 
M10 ,,      ,,  mutant no 10  ,,    ,,    ,,   ,,   ,,    ,,     KmR, ApR This study 
M11 ,,      ,,  mutant no 11  ,,    ,,    ,,   ,,   ,,    ,,     KmR, ApR This study 
M12 ,,      ,,  mutant no 12  ,,    ,,    ,,   ,,   ,,    ,,     KmR, ApR This study 
M13 ,,      ,,  mutant no 13  ,,    ,,    ,,   ,,   ,,    ,,     KmR, ApR This study 
M14 ,,      ,,  mutant no 14  ,,    ,,    ,,   ,,   ,,    ,,     KmR, ApR This study 
M15 ,,      ,,  mutant no 15  ,,    ,,    ,,   ,,   ,,    ,,     KmR, ApR This study 
M16 ,,      ,,  mutant no 16  ,,    ,,    ,,   ,,   ,,    ,,     KmR, ApR This study 
M19 ,,      ,,  mutant no 19  ,,    ,,    ,,   ,,   ,,    ,,     KmR, ApR This study 
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2.1.1.5 Established plasmids and constructed plasmids used in this study 
 
Table 2.4 Established plasmids and constructed plasmids used in this study 
 
Plasmid Size/bp Description and/or construction Markers Source  
 
pRL27 
 
4080  
 
Tn5-RL27 (KmR-oriR6 K) delivery 
vector: circularised PCR fragment from 
pRL23 (primers tetAp-for and oriT-rev) 
KmR Larsen et 
al. (2002) 
pBluescript 
II KS(-) 
2961 DNA cloning victor ApR Stratagene
, UK 
TJP4 
 
˜8000  Transposon junction plasmid No 4 
carrying Tn5- insertion in P 
chromosomal DNA from strain PM4 on 
a BamH1 fragment self ligated with T4 
DNA ligase, and transformed into E. 
coli S17-1/λ pir strain  
KmR, StR This study 
TJP5 ˜5000  
 
Transposon junction plasmid No 5 
carrying the Tn5- insertion in P 
chromosomal DNA from strain PM5 on 
a BamH1 fragment, self ligated with T4 
DNA ligase and transformed into E. 
coli S17-1/λ pir strain  
KmR, StR This study 
TJP7 ˜8000  
 
Transposon junction plasmid No 7 
carrying Tn5- insertion in P 
chromosomal DNA from strain PM7 on 
a BamH1 fragment, self ligated with T4 
DNA ligase and transformed into E. 
coli S17-1/λ pir strain  
KmR, StR This study 
TJP8 ˜6000  
 
Transposon junction plasmid No 8 
carrying Tn5- insertion in P 
chromosomal DNA from strain PM8 on 
a BamH1 fragment, self ligated with T4 
DNA ligase and transformed into E. 
coli S17-1/λ pir strain  
KmR, StR This study 
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2.1.1.6 Maintenance of microbial cultures  
 
Microbial stock cultures were prepared for all the micro-organism strains within the 
study, using ProTec bacterial preservers (provided by Technical Service Consultancy 
limited). Stock cultures were then stored at –70 oC. Working stocks of microbial cultures 
were maintained on NA plates, stored at 4 oC.  
 
2.1.2 Antibiotics used in the study 
 
Antibiotic Stock concentration* 
(Mg/ml) 
Final concentration in solid and 
liquid media (µg/ml) 
 
Kanamycin (Km) 50 50 
Ampicillin (Ap) 50 50  
Streptomycin (St) 50 20 
Tetracycline (Tet) 50 50 
*Stock solution prepared in distilled water and filter sterilised. 
 
 
2.1.3 Bacterial growth, media and culture conditions  
 
Microbial cultures were regularly grown on nutrient agar (NA) plates or in nutrient broth 
(NB, 5g/L Sodium Chloride) with incubation at 21 oC for 18-24 hrs. Additional media 
was also used such as: Marine broth (MB, 19.45 g/L Sodium Chloride) DNase agar, 
Tryptone soya agar, Tryptone soya broth, Brain heart infusion agar, Brain heart infusion 
broth and Blood agar, Gelatin agar (NA plus 8% Gelatin w/v), Casein agar (NA plus 2% 
Skimmed milk w/v) and Maximum Recovery Diluent (MRD, Peptone Saline Diluent (1.0 
g/L Peptone and 8.5 g/L Sodium Chloride).  E. coli strains, however, were grown on 
Luria-Bertani (LB, 10g/L Sodium Chloride) broth or agar. For cultures, purified single 
colonies of bacterial strains were grown in nutrient broth (NB) or LB broth at 37 oC for 
18-24 hrs. Media component were obtained from Oxoid Ltd. The medium was prepared 
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and autoclaved, once it had cooled enough to be handled (~55 oC) any (filter-sterilised) 
antibiotics required, were then added to the appropriate concentration. 
 
2.1.4 Cultivation conditions 
 
Growth was either on agar plates or in shake flask cultures. Shake flask cultures were 
incubated aerobically at 21 oC with shaking (220 r.p.m.) for up to 24hrs. 
 
2.1.5 Spot test and disc diffusion assays for antimicrobial activity 
 
Antimicrobial activity was performed using two methods; the disc diffusion test (Mearns-
Spragg et al,. 1998) and also the spot test against various of test micro-organisms (Table 
2.1). Briefly, a fresh overnight culture of the appropriate sensitive strain (100 µl) was 
spread onto an NA plate using a metal spreader. Then, the inoculated plates were left to 
dry before spotting a 10 µl volume of a fresh overnight culture of the test microorganism 
directly onto the surface of the inoculated plates (Spot test).  
 
A disc diffusion assay was performed using Whatman 6 mm paper discs, saturated with 
100 µl of test samples. Briefly, a 20 µl volume of liquid samples was dropped directly 
onto the surface of the disc. Then, the saturated discs were left on the bench for up to 1hr 
to dry before addition of another 20 µl volume of the test liquid. Following this, the discs 
were placed onto the inoculated nutrient agar plates with the indicator micro-organisms. 
 
The tests (spot test and disc diffusion) were carried out in triplicate and the plates 
incubated either aerobically or / anaerobically, at appropriate temperatures (typically 21, 
30 and 37 oC) for up to 24 hrs to 5 days, depending on the test strains. The inhibition zone 
was measured edge to edge (spot test) or edge the disc (disc diffusion assay), in mm and 
results recorded according to the presence (or absence) of a clearing zone.  
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2.1.6 Gram reaction, colony morphology and microscopy 
 
An overnight fresh culture of the test micro-organism, was subjected to Gram staining 
using the Hucker and Conn method (Hucker and Conn, 1923), then examined with a light 
microscope at x1000 magnification, using an oil immersion lens. Colony morphology on 
the surface of agar plates was also examined, using the naked eye. 
 
2.1.7 Sensitivity tests 
 
Antibiotic sensitivity testing was performed using antibiotic sensitivity discs (Abtek 
Biological Ltd). The test was conducted on NA plates, and the plates incubated 
aerobically at 21 oC for up to 24 hrs. The result was recorded by measuring the clearing 
zone around each antibiotic test disc.  
 
2.1.8 Total Viable cell count 
 
The total viable count for microbial growth samples was carried out in this study. Briefly, 
one ml of overnight culture was diluted with 9 ml of 0.1% (w/v) sterile maximum 
recovery diluent (MRD, Section 2.1.3) to obtain a 10-1 dilution. Serial dilutions (10-2, 10-
3¸ 10-4, 10-5, and 10-6) from the 10-1 dilution were prepared, and 0.1 ml volumes of the 10-
1 10-4, 10-5and 10-6 of the diluted sample were then surface plated (spread plate method), 
in duplicate, onto NA plates agar, which were aerobically incubated at 21 oC for up to 24 
hrs. The colony forming units (CFU) were counted, following the incubation period and 
the results were recorded as log 10 of colony forming unit CFU /ml in the plates 
containing between 25–250 colonies. 
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2.2 DNA techniques 
 
2.2.1 Extraction of genomic DNA  
 
Pure cultures were obtained from the frozen stock culture by directly plating out on an 
agar plate (NA or LB with / without the appropriate antibiotic). Briefly, a colony was then 
scratched up from frozen stock with a sterile wooden stick and streaked out onto an agar 
plate. Following the incubation period (dependent on the growth conditions of each test 
microorganism) a single colony from the streaked plate was placed into a 10ml flask of 
growth media. Following appropriate incubation conditions, saturated cultures were 
transferred to sterile 1ml centrifuge tubes and the cells pelleted using centrifugation, to 
harvest the microbial cells. Briefly, microbial cultures were spun in 1.5 ml Eppendorf 
tubes at 13.000 rpm for 1 min in a bench top microcentrifuge. The supernatant was then 
discarded and the genomic DNA from the bacterial cells (pellets) was extracted using a 
DNeasy® Tissue kit (Qiagen) and following to the manufacturer’s instructions. All the 
DNA samples in this study were stored at 4 oC. 
 
2.2.2 Extraction of plasmid DNA 
 
In order to prepare bacterial cells for plasmid DNA purification, E. coli cells (Section 
2.1.1.5) were treated as discussed, in the previous Section (2.2.1). Plasmid DNA was 
extracted from E. coli cells by the QIAprep spin miniprep Kit (QIAprep® Miniprep, 
Qiagen) using a microcentrifuge method, according to the manufacturer’s instructions. 
Plasmid DNA samples were stored at 4 oC until required. 
 
2.2.3 Concentration of DNA  
 
The method described below was used to purify and/or concentrate DNA from aqueous 
solutions. One volume of DNA solution was mixed with 0.1 volume of 3 M Sodium 
Acetate, pH 5.2 and two volumes of Ethanol (96%). The DNA was allowed to precipitate 
at -20 oC for 30 minutes, followed by centrifugation at 13000 rpm for 10 minutes. The 
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supernatant was then discarded and the pellet washed by adding 1ml Ethanol (70%). A 
further centrifugation was carried out (13000 rpm for 10 minutes), the supernatant was 
discarded and the pellet dried at 37 oC for 1 hr. The DNA was then suspended in an 
appropriate volume of sterile dH2O and stored at 4 oC.  
 
2.2.4 Restriction enzyme digestion of DNA 
 
Chromosomal DNA or plasmid DNA was cleaved, using restriction endonucleases. The 
digestion sample contained DNA (1-2 µg, plasmid DNA or up to 10 µg, genomic DNA) 
the appropriate restriction enzyme(s), an enzyme specific buffer, and sterile dH2O to 
bring the digestion sample to its final volume. All restriction enzymes and buffers 
utilised in the study were obtained from MBI Fermentas. The digestion samples were 
incubated at 37 oC for up to 24 hrs (plasmid DNA digest or genomic DNA digests). 
Following incubation, the digestion samples were spun for 5 seconds and then placed in 
an incubator at 80 oC for 20 minutes, for enzyme thermal inactivation, (as recommended 
by the manufacturers). The sample was immediately placed on ice for 10 minutes and the 
efficiency of the DNA digestion reaction was evaluated using gel electrophoresis 
(Section 2.2.8). 
 
2.2.5 DNA ligation 
 
Up to 20µl of a digested DNA sample (Section 2.2.4) was subjected to a ligation reaction, 
within a total volume of 40µl. The ligation (40µl) contained 20µl of digested DNA, 1µl of 
T4 DNA ligase (5 units/µl; Fermentas), 5µl of 10x T4 DNA ligase buffer and 14µl 
sdH2O. The ligation mixture was then incubated at room temperature for 24hrs. 
Following the period of incubation, the mixture was incubated at 70 oC for 10 minutes to 
inactivate the ligase (as recommended by the manufacturers). The mixture was then 
immediately placed on ice for 10 minutes. DNA ligation reaction efficiency was 
evaluated using gel electrophoresis (Section 2.2.8).  
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2.2.6 The Polymerase Chain Reaction (PCR) 
 
PCR reagents were stored at -20 oC and mixed in 0.5ml Eppendorf tubes (Sarstedt PLC). 
To ensure careful application, a fresh pipette tip and sdH2O was used for each addition. 
All PCR reactions were conducted in a total volume of 50 µ1. PCR controls were also 
prepared using sdH2O instead of the template DNA. The PCR machine used was a 
Techne progene thermocycler. The standard protocol used in PCR experiments is detailed 
below in Table 2.5 and Table 2.6. Long PCR reactions were also carried out using a Long 
PCR kit (Long PCR Enzyme Mix, Fermentas), according to the manufacturer’s 
instructions (> 30 Kb). All primers used in this study were supplied by MWG Eurofinns, 
and were re-suspended in sdH2O to a final concentration of 100 pmol/µl before storing 
at -20 oC. (they are listed in Table 2.7).  
 
Table 2.5 PCR conditions 
 
Temperature Time Number of cycles Event 
 
95 oC 5 mins 1 Initial denaturation 
95 oC 
56 oC 
72 oC 
1 mins 
1 min 
2 mins 
 
25-35 
Denaturation 
Annealing 
Elongation 
 
Table 2.6 PCR components 
 
PCR recipe Volume of stock solution / (50µl) 
 
DNA template 5µl 
Forward primer  (10 pmol) 1µl 
Reverse primer  (10 pmol) 1µl 
MgCl2 (50mM) 5µl 
TAQ Mix* 10µl 
Milipore (Mili-Q) H2O 27µl 
Taq DNA polymerase 1µl 
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*TAQ Mix for PCR reaction 
Recipes Quantity Per 1000µl 
dATP (100mM) 10 µl 
dTTP (100mM) 10 µl 
dGTP (100mM) 10 µl 
dCTP (100mM) 10 µl 
Milipore (Mili-Q) H2O 460 µl 
10X NH4 buffer 500µl 
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Table 2.7 List of Primers used in this study 
 
Primer name Sequence Target Reference 
 
 27 F AGAGTTTGATCMTGGCTC  16S rRNA gene Lane (1991) 
 1492R TACGGYTACCTTGTTACG
ACTT  
16S rRNA gene Lane (1991) 
AGPT-F  ATTCAACGGGAAACGTCT
TG 
KmR gene Callum Scott 
Thesis, Heriot 
Watt University 
AGPT-R ACTGAATCCGGTGAGAAT
GG 
KmR gene Cullum Scott 
Thesis, Heriot 
Watt University 
tpnRL17–1 AACAAGCCAGGGATGTA
ACG 
Outward-directed 
prime (Anneals to 
the oriR6K of the 
transposon)  
Larsen et al. 
(2002) 
tpnRL13–2 CAGCAACACCTTCTTCAC
GA 
Outward-directed 
prime (Anneals to 
the end of KmR 
gene)  
Larsen et al. 
(2002) 
ox 495 CGAACCTGTGGCTCCAAA
GG 
 
Anneals to a 
segment of the S. 
plymuthica 
genomic DNA 
present in TJP7 
This study 
ox 496 GGTGCTAATGCAGCACTT
GGA 
 
As for ox 495 TJP 
7 
This study 
ox 497 ACTGCCTGTTCGTCCTCTT
TAG 
As for ox 495 TJP 
5 
This study 
ox 498 TCCAGGTGTTCAAGCAAG
CGC 
As for ox 495 TJP 
5 
This study 
ox 501 CAGTCATTGCTGAAGAGC
AGG 
As for ox 495 TJP 
7 
This study 
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Table 2.7 continued 
ox 502 ACACCAAAGGAACGGCTC
GA 
As for ox 495 TJP 
7 
This study 
ox 503 GCTTGGACCGATAACGCT
ACC 
As for ox 495 TJP 
5 
This study 
ox 504 TCCGTATGGGGAAGAGGA
TT 
As for ox 495 TJP 
5 
This study 
ox 505 CCAATTGGACATACACCC
ATGTC 
As for ox 495 TJP 
7 
This study 
ox 506 GACCGGAACTCACGATAG
AGC 
As for ox 495 TJP 
7 
This study 
ox 507 GAAGCGTAGACTGACGCA
ACT 
As for ox 495 TJP 
5 
This study 
ox 508 CTCTGATTGACGGTAGTG
GAGTG 
As for ox 495 TJP 
5 
This study 
ox 511 CATGATCCAGTTCACAGT
GTC 
As for ox 495 TJP 
8 
This study 
ox 512 AATTGCCGTCTTATGAGA
GGCC 
As for ox 495 TJP 
8 
This study 
ox 513 TGTTATCTGGTGCTTGCCT
TG 
As for ox 495 TJP 
7 
This study 
ox 514 CTTGCGGGTCGATACTCC As for ox 495 TJP 
7 
This study 
ox 517 AAAGGATCCATAAACTCA
GCTTCGCG 
Anneals to 
portions of the S. 
plymuthica 
genomic DNA 
present in TJP 7 
BamH1 site in 
red) 
This study 
ox 518 AAAGGATCCTAAAACACC
AAAGGAACGG 
As for ox 517 TJP 
7 
This study 
ox 519 AAAGGATCCATCCACTCA
GCTTCTTG 
As for ox 517 TJP 
5 
This study 
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Table 2.7 continued 
ox 520 AAAGGATCCGCAAGCTCT
GGTATTG 
As for ox 517 TJP 
5  
This study 
ox 521 AAAGGATCCTTATCGTAT
TGGTTTAGTAGTG 
As for ox 517 TJP 
8 
This study 
ox 522 AAAGGATCCCATAAAAA
GGGCGCTG 
As for ox 517 TJP 
8 
This study 
 
2.2.7 Ribotyping  
 
The sequencing of the 16S rRNA gene was performed according to Charrier et al., (2006) 
with the primers as described by Lane (1991) and listed in Table 2.7. Genomic DNA for 
ribotyping was prepared as described in Section 2.2.1 and the 16S rRNA gene was 
amplified by PCR as details in Section 2.2.6. The amplified fragment of the rDNA gene 
was then cleaned using a using a QIA quick PCR Purification Kit (Qiagen) to remove 
residual template DNA nucleotides and primers prior to sending to the University of 
Edinburgh sequencing facility (Genepool). The resulting sequences were used to search 
the nucleotide sequence databases using a nucleotide query and the BLAST program 
(www.blast.ncbi.nlm.gov/blast.cgi). 
 
2.2.8 DNA separation by gel electrophoresis 
 
Agarose gels were prepared by dissolving agarose powder to a final concentration of 0.7 
to 1% (w/v) in 1x TAE buffer (pH 8.0) and then melted using a microwave oven; after 
which the molten gel was left to cool down to about 50 oC and ethidium bromide (final 
concentration 0.15 µg/ml) was added and the gel then was cast and left to set. Before 
loading the DNA samples into the gel wells, 5µl of the DNA sample was added to 2µl of 
5x gel loading buffer (0.25% bromophenol blue, 25% glycerol, 1% SDS, 150 mM EDTA) 
and mixed gently. A 1kb DNA ladder (MBI Fermentas) was used to size the DNA 
fragments and the gels were run in 1x TAE buffer at 95v for 55 minutes. After this, the 
electrophoresed DNA was visualised using ultra-violet light and a photograph was taken.  
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Tris Acetate-EDTA (50 x TAE, PH 8.8) buffer/ Litre: 
 
Recipes Quantity Per 1000ml 
 
Tris base 242.0 g 
Glacial acetic acid 57.1 ml 
0.5 M EDTA pH 8.0 100 ml 
Distilled water Up to 1000 ml 
 
 
2.2.9 DNA Sequencing of plasmid DNA 
 
The DNA samples for sequencing were purified, when required, using a QIA quick PCR 
Purification Kit (Qiagen) with the microcentrifuge method, according to the 
manufacturer’s instructions. All sequence samples were prepared in 8 strip tubes and 
covered with 8 strip caps (PCR.0208 C, AXY GEN® Scientific.USA). Briefly, 1µl of 
purified PCR product or 200-400ng purified plasmid DNA was added to 4µl of sdH2O 
and 1µl of desired primer (3.2 pmol). The sequencing samples were sent to Edinburgh 
University for cycle sequencing. The generated DNA sequences were compared to the 
reference bacterial gene sequences available in nucleotide databases (Genbank), using a 
nucleotide query BLASTN and X. 
 
2.2.10 Gene cloning  
 
Chromosomal DNA was isolated, as discussed in Section 2.2.1, and subjected to long 
PCR reaction (Section 2.2.6) using appropriate primers.  Next, the PCR product was cut 
with the restriction enzyme BamH1 (Section 2.2.4), and then purified using a QIA quick 
PCR Purification Kit (Qiagen) with the microcentrifuge method, according to the 
manufacturer’s instructions. The pBluescript (pBS) plasmid was extracted from the E. 
coli pBluescript II KS (-)(Section 2.2.2) (For plasmid map see Figure 2.2), and cut with 
BamH1 as described in Section 2.2.4, and also purified. Next, the digested purified DNA 
samples (PCR product {insert} and pBS plasmid {vector}) were ligated together using T4 
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DNA ligase (Section 2.2.5) to create a recombinant plasmid cloning reaction, which was 
carried out using the following equation; 
 
3: 1 molar ratio insert: vector used in ligation reaction as follow: Insert	  Mass	  in	  ng	  = 3× !"#$%&  !"#$%!  !"  !"!"#$%&  !"#$!!  !"  !" ×𝑉𝑒𝑐𝑡𝑜𝑟𝑀𝑎𝑠𝑠  𝑖𝑛  𝑛𝑔 
 
Following ligation, a 1-10µl-ligation mixture was transformed chemically into E. coli 
XL1-Blue competent cells, as mentioned in Section 2.2.13. Afterwards, screening for 
successful transformants was completed using blue/white colour screen. Briefly, the 
transformed cells were plated out on LB plates containing 50 µg/ml Ap and 40µl of 0.1 M 
Isopropyl thioglactoside (IPTG) and 2% 5-bromo-4-indolyl-beta –D- galactopyranoside 
(Xgal) that was spread on top of the LB plates and left to dry before plating, plates were 
incubated aerobically at 37 oC for 18-24hrs. Following the period of incubation, the white 
colonies (transformants) were selected randomly and sub-cultured with the selective 
media (LB+AP) and then subjected to mini plasmid preparations as described in Section 
2.2.2. 
 
 
 
Figure 2.2 Graphic map (circular) of the cloning vector pBluescript (pBS) plasmid. From Thermo 
Scientific. 
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2.2.11 Random priming 
 
Generation of digoxigin-labelled probes using random priming was as follows; plasmid 
DNA was extracted (Section 2.2.2), and subjected to a PCR reaction (Section 2.2.6), 
using specific primers (Table 2.7). The PCR product was purified using PCR purification 
Kit (50, Qiagen) according to the manufacturer’s instructions. The purified DNA was 
labelled with digoxigenin-11dUTP (DIG), according to the manufacturer’s instructions, 
using a DNA labelling kit (Boehringer Mammheim). The probe was stored at -20 oC until 
required. 
 
2.2.12 Southern blot hybridisation 
 
Southern blotting was performed in the study, using capillary action, as described by 
Southern (1975). The bacterial genomic DNA and Plasmid DNA were extracted as 
described in Sections 2.2.1 and 2.2.2 respectively. Chromosomal DNA was digested with 
BamHI and separated on a 0.7% agarose gel, along with DNA Molecular Weight Marker 
II Digoxigenin. The DNA was then transferred to a nylon membrane according to the 
method described by Sambrook et al. (1989). Once the DNA was separated on a 0.7% 
agarose gel, the gel slab was placed in a denaturing solution for 45 minutes, and gently 
shaken, using a platform shaker. It was then washed in dH2O for 10 minutes and placed in 
a neutralising solution for 30 minutes. Following this, the gel was then placed on pre-
soaked chromatography paper in 20xSSC on a gel tray (Figure 2.3). Nylon membrane 
(Hybond-N, Amersham) and was then cut to the same size as the gel and placed on top of 
the agarose gel. Two sheets of chromatography paper were cut to size and soaked in 
20xSSC, and then placed on top of the membrane. After removing any bubbles present 
between the gel, the nylon membrane and chromatography papers, many dry 
chromatography papers (two-three inches), were placed on top, with a weight placed 
above the filter paper to hold it in place and allow the DNA transfer onto the membrane 
by capillary action. Following the overnight transfer period, the DNA was fixed to the 
nylon membrane by exposing the membrane to UV light (UV Stratalinker 2400) for 1 
minute. The membrane was then placed in Saran wrap, to dry, and then stored in the dark 
at RT until required. 
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Figure 2.3 A diagram, highlighting the transfer of DNA to a nylon membrane by capillary action. 
 
 
DNA hybridisation was performed in a hybridisation oven (Shaker S1 20H, Stuart 
Scientific). Firstly, the nylon membrane was placed in hybridisation solution for 1hr at 62 
oC with slow shaking. The Dig-labelled probe was denatured; 10µl probe and 90µl sdH2O 
(95 oC / 5 minutes). The denatured probe was then swiftly placed on ice, and then added 
to the hybridisation solution (indirectly onto the nylon membrane). For the next step, the 
nylon membrane was then incubated in the hybridisation solution with the probe, for 24 
hrs at 62ºC, with gentle shaking. Following the hybridisation step, the membrane was 
washed as follows; twice for 5 minutes each at RT with a low stringency wash buffer 
(2xSSC+0.1% (W/V) SDS) slow shaking and then twice with high stringency washes 
(0.1xSSC+0.1% (W/V) SDS) at 62 ºC/15 minutes with shaking. Then the membrane was 
stored in a dark drawer until required for the detection steps. 
 
Subsequent detection of DIG labelled DNA steps was conducted at RT as follows; the 
membrane was washed in DIG buffer 1 (5 minutes with slow shaking), and then 
submerged in Buffer 2 (100 ml) for 30 minutes with gentle shaking. Another brief wash 
with Buffer 1 was completed and followed by incubation in 30ml of buffer 1 and 6 µl 
antibody solution; Anti-DIG conjugated alkaline phosphatase (Roche) for 30 minutes 
with gentle shaking. Next, the membrane was washed twice in 100ml of Buffer 1 (10 
minutes each with slow shaking), and was equilibrated by placing it in 100ml of Buffer 3 
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(2 minutes with slow shaking). Finally, the membrane was placed in a square Petri dish, 
with 90ml of development solution and left in the dark up to for 2- 3hrs, until the colour 
developed. Then, the membrane was washed with H₂O and stored in a dark drawer. 
 
 
Denaturing Solution: 
NaCl 43.83 g 
NaOH 10 g 
Distilled water Up to 500ml 
 
Neutralising Solution: 
NaCl 43.83 g 
EDTA (0.1M soln) 1ml 
Tris/ HCl pH 7.2 (1M soln) 250ml 
Distilled water Up to 500ml 
 
20x SSC: 
Na3Citrate 44.1 g 
Distilled water Up to 500ml 
pH to 7 with 1N NaOH 
 
 
Hybridisation Solutions: 
5x SSC 5ml 20x SSC stock solution 
0.02% SDS 20µl 20% SDS stock solution 
I% blocking reagent 2ml 10% Skimmed milk stock solution 
Distilled water Up to 20ml 
 
Detection DIG labelled DNA Solutions: 
 
10xBuffer 1 
100 mM Tris/ HCl pH 7.5 121.1 g 
150 mM NaCl 87.7 g 
Distilled water Up to 1000ml 
pH to 7.5 with 1N NaOH 
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10xBuffer 2: 
100 mM Tris/ HCl pH 7.5 121.1 g 
150 mM NaCl 87.7 g 
I% blocking reagent 100ml 10% skimmed milk stock solution 
Distilled water Up to 1000ml 
pH to 7.5 with 1N NaOH 
 
Buffer 3: 
100 mM Tris/ HCl pH 9.5 12.11 g 
100 mM NaCl 5.849 g 
50 mM MgCl2.6H2O 10.17 g 
Distilled water Up to 1000ml 
pH to 9.5 with 1N HCl 
 
Development Solution: 
  
NBT Solution: 
75 mg/ml nitroblue tetrazolium in 70% 
(v/v) dimethyl-formamide 
 
115µl 
X-phosphate (BCIP) Solution: 
50 mg/ml 5-bromo-4-cholor-3-indolyl 
phosphate (BCIP) in dimethyl 
formamide 
90µl 
Stored @ -20 oC 
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2.2.13 Preparation and transformation of chemically competent cells 
 
2.2.13.1 Preparation of chemically competent E. coli cells 
 
This was performed using a calcium chloride method of Sambrook et al. (1989), with 
some modification as follows; single colonies of E. coli strains (Section 2.1.1.3) were 
inoculated into 5ml of LB (+ appropriate antibiotic; 20 µg/ml St for λpir and 50µg/ml Tet 
for XL1-Blue, Section 2.1.1.3) and aerobically incubated by shaking (overnight at 37 oC).  
 
The fresh overnight E. coli strains (λpir or XL1-Blue) were sub-cultured in 5ml of 
appropriate LB broth media. Following the period of incubation, 1ml of overnight culture 
was transferred into 100 ml of LB broth media and incubated at 37 oC for 2-3hours 
(OD600~ 0.6, exponential phase). The flask was then placed on ice for 15 minutes, to 
prevent growth. The culture was then divided into four 50ml sterile centrifuge tubes and 
centrifuged at 4000 rpm for 10 mins at 4 oC. The pellet was re-suspended in 10ml of ice-
cold sterile 75mM CaCl2, and left on ice for 20 minutes, the cells were then centrifuged as 
before. The pellet was then re-suspended in 4ml of transformation buffer TFB2 (10 mM 
3-(N-morpholino) propanesulfonic acid (MOPS) [pH 7.0], 75 mM ClCl2, 10 mM RbCl 
and 15% Glycerol) and incubated on ice as before. The competent E. coli cells were then 
dispensed into 1.5ml microcentrifuge tubes (400µl per tube) and stored at -70 oC until 
needed for transformation. 
 
2.2.13.2 Transformation of Competent Cells  
 
Recombinant plasmids (cloned DNA) were transferred to chemically competent E. coli 
strains (λpir or XL1-Blue,) using the heat shock method defined by Sambrook et al. 
(1989). Up to 10µl of plasmid DNA (10-50ng, Section 2.2.2) was mixed with 100µl 
thawed E. coli competent cells (from -70 oC freeze stock above) and 50µl TMC buffer (10 
mM Tris/ HCl [pH 8.0], 10 mM MgCl2 and 10 mM CaCl2), in a 1.5ml microcentrifuge 
tube. The mixtures were then placed in a water bath at 42 oC for 60 seconds and then 
immediately placed on ice (5 minutes). 1ml of sterile LB broth was added to the mixture 
and the cells incubated aerobically at 37 oC for 30 minutes. Cells were harvested with 
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centrifugation (13000 r.p.m. for 5 mins at RT) and re-suspended in the residual media 
(~50µl). Following this, the cells were spread onto LB agar plates with appropriate 
antibiotic selection. Non-transformed competent cells were also plated out as a negative 
control. Plates were incubated overnight at 37 oC. 
 
 
2.2.14 Bacterial mutagenesis (Tn5 mutagenesis) 
 
2.2.14.1 Tn5 mutagenesis 
 
In this study, a transposon mutagenesis technique was used to isolate potential non-
antimicrobial mutant strains (PM) (Larsen et al., (2002). S.	  plymuthica (P), was	  used	  as	  a	  recipient,	   in	  conjunction	  with	  the	  E.	  coli	  donor strain (BW20767 (carrying	  the	  Tn5-
pRL27 ((KmR-oriR6 K)) plasmid (Figure 2.4) (Larsen et al., 2002). 
 
 
 
 
Figure 2.4 Graphic map (circular) of delivery vector (pRL27) plasmid.  
 
 
Chapter 2.                                                                                                                      Materials and Methods 
 
 54 
An overnight culture of the recipient strain was grown in nutrient broth medium at 21 oC, 
while an overnight culture of the donor strain (E.	   coli) was grown in a selective broth 
medium (LB 50µg/ml Kan) at 37 oC. Both cultures were aerobically incubated by shaking 
(170 rpm). Following this, fresh cultures of both the recipient (P) and the E. coli donor, 
were prepared by inoculating 5ml of fresh broth media with 0.1ml of each overnight 
culture and incubating aerobically, at the appropriate temperature, until reaching an 
OD600 of ~ 0.8 to achieve the same cell density (end –log phase). 1ml of the donor strain 
was transferred to a microcentrifuge tube and the cells pelleted by centrifugation. 
Following this, the cells were washed three times in 1ml sterile dH2O. After which, the 
recipient cells and donor strain were mixed at a ratio of 1:1 (100µl of recipient (P) and 
100µl of E. coli donor), in a 1.5ml microcentrifuge tube. For the next stage, the cells were 
mixed by vortexing for 10-20 seconds (Conjugation step starts). A 20µl volume of the 
mixed strains was then spotted directly onto the surface of the nutrient agar plates and 
incubated at 37 oC for 24hrs. Following this period of incubation, the colonies were then 
scraped off using a plastic inoculating loop, and resuspended in 10ml of sterile maximum 
recovery diluent (MRD, Section 2.1.3) and stored at 4 oC until required for further 
investigation. Figure 2.5 highlights the procedures used in the conjugation experiments.  
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Figure 2.5 Random transposon mutagenesis protocol. 
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2.2.14.2 Screening for potential mutants 
 
Nutrient agar plates containing two antibiotics (20µg/ml Ap, and 50µg/ml Kan) were 
used to screen for potential mutants after a mating experiment. Briefly, 100µl of each 
strain was plated out onto to the Nutrient agar, containing two antibiotics (20µg/ml Ap, 
and 50µg/ml Kan). The colonies growing on the selective plates were isolated using a 
sterile inoculating loop, and transferred to 96 well microtiter plates under microbiological 
conditions. Each well, contained 200µl of selective Nutrient broth medium (50µg/ml Kan 
and 20µg/ml Amp). The inoculated microtiter plates were then incubated under aerobic 
conditions, at 21 oC for 24hrs. Following the period of incubation, the kanamycin resistant 
trans-conjugants were then screened to identify those that failed to produce a clearing 
zone on a lawn of sensitive bacterial strain, using a spot-test (Section 2.1.5) with certain 
modifications. Square NA plates were used instead of standard Petri dishes, and were 
inoculated with 300µl of an overnight culture of the sensitive strain. A 96 pin sterile 
replicator was used to sample the microbial cells grown on the microtiter plates, onto 
these NA plates containing the sensitive strain. The plates were incubated aerobically at 
21 oC for 24hrs. Potential mutants were then retested, to confirm the phenotype. A viable 
cell plate count was also performed, using the spread plate method (Section 2.1.8). Figure 
2.6 shows the procedures used to screen for the potential mutant strains (PM) in this 
study. 
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Figure 2.6 Screening for the potential mutant strains (PM). 
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2.2.14.3 Cloning and recovery of transposon insertion mutants 
 
Figures 2.7 and 2.8 provide a diagram to summarise the process for cloning the 
transposon along with flanking genomic DNA. Genomic DNA of potential mutants was 
extracted (Section 2.2.1), and then digested (Section 2.2.4) (Larsen et al., 2002). 
Subsequently, the digested chromosomal DNA was ligated (Section 2.2.5) and introduced 
into chemically competent E. coli strains (Section 2.2.13). The transformation mixes were 
then plated onto selective agar LB plates (+ Kan [50µg/ml]) and Str [30µg/ml]) and 
incubated overnight at 37 oC. The Graphic map of Tn5 Transposon is shown Figure 2.9 
and the digesting map with unique enzyme is in Figure 2.10.  
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Figure 2.7 Diagram summarising the cloning, recovery and sequencing of the transposon 
junction plasmids (TJP). 
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Figure 2.8 Diagram showing of primer sites (tpn RL17-1 and tpn RL13-2) to identify pag. 
 
 
 
 
 
 
Figure 2.9 Graphic map (circular) of transposon.  
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Figure 2.10 Graphic map (linear) of Transposons digesting map with unique enzyme. 
 
 
2.3 Protein methods  
 
2.3.1 Ultra filtration  
 
The liquid samples (spin culture medium), was fractionated using a centrifugal 
concentrator technique; Vivaspin Ultra filtration spin columns (15ml, Biotech, Germany), 
with different molecular weight cut-off membranes (100,000; 50,000; 30,000; 10,000 and 
5000 Da) according to the manufacturer’s instructions.  
 
2.3.2 Concentration of spent culture media  
 
The spent culture medium (SM) was concentrated using a centrifugal vacuum 
concentrator (Savant AES 2010 Speed Vac® System). Briefly, 20ml of SM was 
distributed by pipette, into sterile 1.5ml microcentrifuge tubes. All the tubes were then 
placed into the vacuum concentrator and run for 3 hrs at RT. The dried materials in each 
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tube were then re-suspended in 50µl of sterile distilled water and labelled concentrated 
spent media (CSM) samples, and stored in the refrigerator until used. 
 
 
2.3.3 Size exclusion chromatography (SEC) 
 
A fast Protein Liquid Chromatography (FPLC) system was used in this study by 
employing a Superose®-12 column (GE Healthcare Life Sciences). The column was 
initially calibrated using the following molecular weight (MW) markers; 
 
Compound MW/ Da 
 
Blue Dextran 2000000 
Bovine serum albumin (BSA) 67000 
Cytochrome C 12700 
Vitamin B12 135537 
Subsequently, 1ml of test sample such as concentrated spent media (CSM) of test strains 
resuspended in the following buffer; 50mM Tris (pH7.5), 150 mM NaCl and 1mM EDTA 
was injected and the Colum run at a flow rate of 0.8ml/min. The fractions were monitored 
with UV light, at 280nm, and collected in 1.5ml microcentrifuge tubes.  
 
2.3.4 Anion exchange chromatography (AEC) 
 
This was performed using the same methods, involved in size exclusion chromatography 
with modifications as follows; Mono Q column (GE Healthcare Life Sciences) 
(negatively charged) instead of a Superose®-12 column, and different buffers; Low salt 
(50mM Na acetate [pH 5] +100mM NaCl and high salt (50mM Na acetate [pH 5] +1M 
NaCl.  
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2.3.5 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
 
2.3.5.1 Sample preparation for SDS-PAGE 
 
1ml overnight cultures were spun in a microfuge tube at 13,000 rpm for 1 minute. Then, 
the supernatant was discarded and pellets re suspended in 120µl 2X SDS PAGE loading 
buffer (sample buffer). For the next stage, protein denaturation was completed, by placing 
the sample on a heating block, at 95 oC for 5 minutes, with a further centrifugation 
applied, to pellet the cell debris. For the analysis of the cell free spent media, (SM), a 
100µl of 2X SDS PAGE loading buffer was added to 100µl of test samples, followed by 
heating to denature the proteins (95 oC/5 minutes) in a heating block. Further 
centrifugation was carried out to remove any precipitate. 
 
2.3.5.2 SDS PAGE 
 
The SDS equipment was cleaned with water, then 95% ethanol. Next, a gel sandwich was 
assembled and placed in an alignment slot, with an alignment card, between glass plates. 
Following this, two 10% mini-gels were prepared. The resolving gel mixture was poured 
into the space between the glass plates (about 75% of the space) and covered with 50µl of 
water-saturated butanol (5ml butanol + 5ml H2O). When the gel was set (about 20 
minutes), the butanol was discarded and a 10-well comb inserted. The stacking gel was 
gently added using a pipette and left to polymerise for 10 minutes. Then, the comb was 
removed from the gel and placed in the SDS-PAGE chamber, and run in 1X running 
buffer after loading 15µl of SDS-PAGE prepared samples, (Section2.6.4.1) and 10µl of a 
molecular weight marker (26,600-1,060Da) solution (Sigma). 
 
2.3.5.3 Staining of SDS page gels 
 
Coomassie brilliant blue (CBB) was used to stain the SDS gel according to the method of 
Garfin, 1990. The gels were then removed from the SDS-PAGE chamber and placed in a 
plastic container containing staining solution, and left to stain for 2hrs by gently shaking 
them. Next, the gels were removed from the stain solution and placed on a plastic 
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container for destaining, using a destaining solution and left overnight at RT, after slowly 
shaking. The gel was then placed on clear background to detect blue-stained bands 
(proteins) and photographs were taken.  
 
Resolving gel 20ml(10%): 
4xResolving Buffer 5ml 
40% Acrylamide/Bis’* 5ml 
H2O 9.28ml 
APS (10%) 100µl 
TEMED 20µl 
*Sigma 40% Acrylamide/Bisacrylamide mix (Cat. No. A7802-100ML, Store @ 4 oC) 
 
Stacking gel 10ml (3%): 
4 x Stacking buffer 2.5ml 
40% Acrylamide/Bis 0.75ml 
H2O 6.37ml 
APS (10%) 50µl 
TEMED  20µl 
 
4x Resolving gel buffer: 
Tris base 18.17g 
10% SDS 1ml 
H2O To 100ml 
PH to 8.8 with HCl  
 
4x Stacking gel buffer: 
Tris base 6.06g 
10% SDS 1ml 
H2O To 100ml 
pH to 6.8 with HCl  
 
10x Running Buffer:  
Tris base 30.28g 
Glycine 144.25g 
SDS 10g 
H2O To 1 L (pH will be ~8.6) 
Dilute it to 1X for running use 
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Sample buffer (2X LSB OR SDS loading buffer): 
Tris (HCl) 0.5M pH6.8 6.25ml 
SDS 2 g 
Glycerol 9ml 
2-mercaptoethanol 5ml 
Bromophenol blue (0.1% soln’) 10ml 
H2O To 50ml 
 
Stain: 
Coomassie blue (R250) 0.5 g 
Methanol 250ml 
Glacial Acetic acid  50ml 
H2O  200ml 
 
Destain: 
Methanol 100ml 
Glacial Acetic acid 100ml 
 
2.4 Quorum sensing assay  
 
The production of N-acylhomoserine lactones (AHLs) was evaluated using a cross-
streaking bioassay as described by Swift et al. (1997). Briefly, fresh culture bacteria were 
cross-streaked against a biosensor strain Chromobacterium violaceum (CV0blu {Section 
2.1.1.3.}) onto an NA plate using a sterile toothpick. The assay was conducted in 
triplicate and the plates incubated at (21 oC and 30 oC for between 1 and 2 days). A 
positive result was recorded by the production of a purple pigment in the test bacterial 
strain. Chromobacterium violaceum (CV031 {Section 2.1.1.3.}) was used as a positive 
control. 
  
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
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3. Identification of the marine bacterium ‘P’ 
 
3.1 Introduction 
 
At the present time, the increasing prevalence of antibiotic resistant “super-bugs” and 
risks associated with food safety are global issues. Of particular concern is the risk of 
food borne illnesses, which are in part due to the transportation of high water content 
foods that are easily spoiled as result of undesired microbial growth (food spoilage) 
(http://www.cdc.gov). Consequently, excessive use of antimicrobial agents has become 
an additional global issue, because many bacteria have developed resistance or have 
become increasingly resistant to commercially available antibiotics. Thus, there is a need 
for a continuous search to identify new and effective antimicrobial substances (Dessen et 
al., 2001; Alanis, 2005). Traditionally most antimicrobials were isolated from organisms 
in the terrestrial environment, with little attention given to marine based organisms, until 
relatively recent times. Marine based micro-organisms still represent a relatively 
untapped source of new antimicrobials (Stach, 2010). In view of this, seaweed was 
screened for associated marine microorganisms with the ability to produce antimicrobial 
compounds. An organism producing antibacterial metabolite(s) was found to be strongly 
active against several microorganisms, particularly the microorganisms associated with 
food borne spoilage, food borne pathogens and multi-resistant human pathogenic bacteria, 
such as VRE and MRSA.  
Morphological, phenotyping and ribotyping experiments were carried out to identify the 
isolated marine bacterium (P), using classic microbiology and molecular microbiological 
techniques, as follows: 
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3.2 Results 
 
3.2.1 Screening for Antimicrobial Compound Production 
 
During a screening of seaweed associated marine micro-organisms, for their ability to 
produce antimicrobial compounds, an organism was isolated, as producing antimicrobial 
metabolite(s) and was termed P. This marine isolated micro-organism was screened for its 
ability to produce antimicrobial compounds and kill or prevent the growth of a variety of 
different bacterial and fungal strains. Antimicrobial activity was performed in this study 
using two methods; the disc diffusion test (Mearns-Spragg et al,. 1998) and also the spot 
test (Material and Methods, Section 2.1.5) ,against various of test micro-organisms (Table 
2.1). The results from these experiments demonstrated that this marine bacterium strongly 
inhibited the growth of the test micro-organisms particularly, multi-drug resistant 
Staphylococcus aureus (MRSA), Clostridium difficile strain 630, Vancomycin resistant 
enterococci VRE, Bacillus cereus var mycoides, Listeria monocytogenes scottA, 
Staphylococcus epidermidis and the food spoilage fungus, Penicillium expansum. The 
data is shown in Table 3.1 with selected images of the zones of growth inhibition shown 
in Figure 3.1. Based upon these results, it was decided to investigate this antimicrobial 
producer strain (P) in greater depth to increase our knowledge about this strain.  
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Cl. difficile Bacillus cereus var mycoides MRSA 
   
P. expansum Bacillus cereus var mycoides Staph. epidermidis 
 
Figure 3.1 Disc test (top panels, 100 µl CSM was added to a sterile paper disc in the center 
of an NA plate spread with a lawn of Cl. Difficile, Bacillus cereus var mycoides and 
MRSA (as the sensitive strain)) and a spot test (bottom, 10µl volume of a fresh overnight 
culture of the test microorganism (P) was spotted directly onto the surface of an NA plate 
spread with a lawn of P. expansum, Bacillus cereus var mycoides and Staph. epidermidis 
(as the sensitive strain)), showing the antimicrobial effect of marine isolate P. 
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Table 3.1 Summary of antimicrobial activities of the marine isolate P, filter-sterilised spent 
culture medium (SM), and concentrated spent media (CSM), against wide varieties of indicator 
micro-organisms. For the tests/various spent media were prepared, see Material and Methods, 
Section 2.1.5 and Results, chapter 5, Section 5.2.1.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Micro-organism  
 
Antimicrobial activity  Growth conditions 
 
Spot test  
(10µl) 
SM 
 
Spot 
test  
(20µl) 
SM 
Disc test  
(100µl) 
 CSM  
 
L. monocytogenes 
scottA 
+++ +++ +++ 30 oC /24h - NA -
aerobic 
L. monocytogenes 
NCTC7973 
++ +++ +++ 
30 oC /24 h - NA -
aerobic 
B. cereus  var 
mycoides  (F) 
+++ ++ ++ 
21 oC /24 h - NA - 
aerobic 
S. epidermidis 
+++ +++ +++ 30 oC /24 h - NA -
aerobic 
MRSA 
+++ +++ +++ 30 oC /24 - NA -
aerobically 
VRE 
++ ++ ++ 30 oC /24 h - NA -
aerobic 
Clostridium difficile +++ +++ +++ 25 oC /48 h - NA - 
anaerobic 
Penicillium 
expansum 
+++ ++ ++ 25 oC /4 days – NA 
and YPD-aerobic 
Escherichia coli - - - 
35 oC /24 h- NA - 
aerobic 
E. coli (D28) - - - 
35 oC /24 h- NA -
aerobic 
E.	  coli	  BW20767 ++ ++ ++ 
 
Pseudomonas 
aeruginosa	  
- - - 
30 oC /24 h- NA –
aerobic 
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Table 3.1 continued 
 
 
 
 
 
 
 
 
 
(+++)=(3mm) Very strong antimicrobial activity, (++)=(2mm) strong antimicrobial activity, 
partial antimicrobial activity (+)=(1mm) and (-)=(0mm) no antimicrobial activity.  
 
 
3.2.2 Bacterial identification 
 
Based on the findings presented in the previous Section (3.2.1), it was decided to identify 
marine isolate P. The use of phenotypic profiling should provide useful information about 
the group and species that the strain (P) belongs to. Potentially this will help identify the 
inhibitory molecule(s) produced by this strain. The tests performed to identify P are 
detailed below: 
 
 
3.2.2.1 Colony morphology 
On agar plates the bacterium formed circular, convex, brick red pigmented and smooth 
surface colonies (Figure 3.2). Gram staining revealed that its cells were short rod shaped, 
gram-negative, and non-spore forming. 
 
 
 
 
 
 
Candida albicans 
(NCTC3153) 
- - - 
30 oC /24 h- NA and 
YPD-aerobic 
Candida albicans 
NCTC SC5314) 
- - 
- 30 oC /24 h- NA and 
YPD-aerobic 
Pichia angusta - - - 
30 oC /24 h – NA 
and YPD-aerobic 
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Figure 3.2 Pure culture of marine isolate P (antimicrobial producer) on a NA plate, grown at 21 
oC for 24hrs. 
 
3.2.2.2 Salt Tolerance  
 
To obtain more detailed information about the properties of the antimicrobial producer 
strain (P), a salt tolerance assay was carried out. P was isolated from the marine 
environment and as a result I decided to determine how salt tolerant it was? 10 ml of NB 
was inoculated with a single colony of strain P, and aerobically incubated by shaking 
(overnight at 21 oC). Following the period of incubation, 100µl the overnight culture was 
transferred into 10ml of nutrient broth, supplemented with increasing amounts of NaCl 
(5g/l, 10g/l, 15g/l, 20g/l, 25g/l and 30g/l) and incubated at 21 oC for 8hrs (OD600nm= 
0.830, late exponential phase).  The colony forming units (CFU) were counted per ml for 
each concentration, following the incubation period (21 oC for 18hrs) (Material and 
Methods, chapter 2, Section 2.1.8). The results were recorded as survival curve (% 
CFU/ml), against NaCl concentrations. The result showed that marine isolate P is a salt-
tolerant bacterium (Figure 3.3). 
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Figure 3.3 Cell survival of marine isolate P cells on exposure to increasing concentrations of 
sodium chloride (g/l). Bacterial cultures were grown aerobically in nutrient broth, supplemented 
with increasing amounts of NaCl (5g/l, 10g/l, 15g/l, 20g/l, 25g/l and 30g/l) and incubated at 21 oC 
for 8hrs (OD600nm= 0.830, late exponential phase). Total viable cell count was then carried out 
on NA plates and these were incubated overnight at 21 oC. The result represents a survival curve 
(% CFU/ml) against increasing concentrations of NaCl. N= 2 times.  
 
3.2.2.3 Production of extracellular enzymes  
 
Many micro-organisms, including fungi, actinomycetes, as well as bacterial species, have 
the ability to secrete cell-wall hydrolase enzymes such as chitinase and proteases 
(Frankowski et al., 2001). As a result this bacterium (P) may produce extracellular 
enzymes which could possibly explain the antimicrobial activity. Therefore, production of 
extracellular enzymes was examined. Strain (P) was investigated for its ability, to produce 
several enzymes, such as chitinase, proteinase, lipase, casinase, gelatinase and DNase. An 
overnight fresh culture of the bacterium P was spotted onto fresh agar plates; Gelatin 
agar, Casine agar, DNA agar, Colidal-chitin agar, Tributyrin agar and blood agar, and 
incubated for up to 24 hrs/21 oC.  The results shown in Figure 3.4 show that the marine 
bacterium P was chitinase positive, proteinase positive, lipase positive, gelatinase 
positive, DNase positive and haemolysis positive.  
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A)   
 
B) 
 
C) 
 
D) 
 
E) 
 
 
 
Figure 3.4 Enzymatic producing assays. 10µl of a fresh broth culture of marine isolate P was 
placed on agar plates to assay for the presence of key enzymes; A (DNase activity, DNA agar), B 
(gelatinase activity, Gelatin agar), C (chitinase activity, colloidal chitin agar), D (haemolytic 
activity, blood agar) and E (casinase activity, casein agar), grown at 21 oC for 24hrs. 
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3.2.2.4 The effect of growth medium on the production of antimicrobial activity 
 
It has been reported that the chemical composition of growth media can significantly 
affect the antimicrobial activity of some bacteria (Martin and Demain, 1980; Farmer, 
1985; Spížek and Tichý, 1995; Marwick et al., 1999). Therefore, it was decided to study 
the effects of different growth media (NA, LB, TSA and BHI) on the antimicrobial 
activity of the marine isolate P. The experiments were performed using a spot test as 
described in Section 2.1.5 with B. cereus var mycoides as the sensitive microorganism, 
and incubated for 18- 24 hrs/21 oC. It was observed that the inhibition zone around the 
culture drop was much wider on the nutrient agar plates when compared with the other 
media tested (LB and TSA and BHI). Thus, NA plates are a good test plate for 
demonstrating the zone of inhibition against micro-organisms, whereas the other test 
plates negatively affected the production of the active compound(s). On the other hand, 
the red pigmentation was more prominent on the BHI agar plates, compared with NA, LB 
and TSA media, with LB and TSA plates resulting in an intermediate level of red pigment 
(Figure 3.5).  
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A)   
 
B) 
 
C)  
 
D)  
 
 
Figure 3.5 Effect of growth media on antimicrobial activity; 10µl of a fresh broth culture of 
marine isolate P was spotted onto different growth media seeded with a lawn of B. cereus var 
mycoides; A (LB), B (NA), C (TSA) and D (BHI agar).  
 
3.2.2.5 The effect of growth temperature on the production of antimicrobial activity 
 
Exposure to external factors such as temperature can affect the functions of internal 
pathways, by controlling the expression of genes involved in the production of 
antimicrobial compounds (Moons et al., 2006). Therefore, the effect of various growth 
temperatures (9, 21, 30, 37 and 50oC) on the growth, antimicrobial activity and red 
pigment production was tested in reference to the marine isolate P. The assay was 
performed using NA and NB media. Briefly, 10 ml of NB was inoculated with a single 
colony of strain P, and aerobically incubated at different temperatures (9, 21, 30, 37 and 
50oC) for up to 24hrs. Optical density (OD at 600nm) was measured at 0h and 24hrs, 
respectively. Spot test NA plates were also prepared and incubated aerobically, at 
different temperatures (9, 21, 30, 37 and 50 oC) for up to 24 hrs and antimicrobial 
production and red pigmentation were recorded (Material and Methods, Section 2.1.5). 
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The results demonstrated that 30 oC was a better temperature for the growth of bacterium 
P, whereas 9 and 21 oC resulted in greater antimicrobial production (as demonstrated by 
larger zones of clearing). The results also highlighted that the level of red pigmentation 
reduced as the incubation temperature was increased (Table 3.2 and Figure 3.6). 
 
Table 3.2 The effect of various temperatures on the growth, antimicrobial activity and red 
pigment production of marine bacterium P. 
 
Growth 
temperature 
Antimicrobial 
activity 
Red pigment 
production 
 
OD 600nm 
0h 24h 
9 oC +++ +++ 0.032 0.073 
21oC +++ +++ 0.092 0.620 
30 oC ++ ++ 0.084 0.688 
37 oC - + 0.075 0.326 
50 oC - - 0.105 0.097 
 
(+++) Very strong antimicrobial activity / red pigmentation , (++) strong antimicrobial activity / 
red pigmentation, (+) partial antimicrobial activity / red pigmentation and (-) no antimicrobial 
activity /no red pigmentation.  
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A)  
 
B)  
 
C)  
 
D)  
 
Figure 3.6 Effect of growth temperature on antimicrobial production and red pigment production; 
10µl of a fresh overnight broth culture of marine isolate P was spotted onto NA agar plates, 
previously seeded with a lawn of B. cereus var mycoides, plates were incubated at the following 
temperatures; A (9 oC), B (21 oC), C (30 oC), and (37 oC) for 24hrs. 
 
 
3.2.2.6 Antibiotic sensitivity tests 
 
The spectrum of sensitivity towards a variety of antibiotics was also determined as this 
would help with further molecular microbiological techniques. Antibiotic sensitivity 
testing was performed using disc diffusion testing on NA plates, and the plates were 
incubated aerobically at 21 oC for 18-24hrs. The marine isolate demonstrated sensitivity 
to the following antibiotics; colistin sulphate, gentamicin, streptomycin, sulphatrid, 
tetracycline, cotrimoxazole, chloamphenicol, but was resistant to ampicillin, cephalothin 
and penicillin (Figure 3.7). In separate experiments I showed that P was also sensitive to 
kanamycin (data not shown). 
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Figure 3.7 Antibiotic sensitivity disc tests for the marine isolate P; Strain P was sensitive to: 
Colistinsulphate (1), Gentamicin (2, 12), Streptomycin (3,13), Sulphatrid (4), Tetracycline (5), 
Cotrimoxazole (10), chloramphenicol (14); but was resistant to Ampicillin (6), Cephalothin (7) 
and penicillin (8,11). Growth condition, 21 oC /24 -NA. 
 
 
3.2.3 Ribotyping 
 
In order to study the gene(s) responsible for the production of antimicrobial compounds 
and to identify the inhibitory molecules, it was important to identify bacterial strain P. 
This was achieved by ribotyping, at the same time the identity of the sensitive strain (F) 
was also determined (Figure 2.1, Materials and Methods).  Ribotyping analysis was done 
by sequencing the 16S rRNA encoding gene, according to Charrier et al., (2006), using 
specific primers (27F and 1492R, Table 2.7). These primers were initially used in a PCR 
reaction using genomic DNA from P and F, as templates, to amplify the 16S rRNA gene. 
The PCR reaction was carried out as described in Section 2.2.6. The PCR products were 
then cleaned using a Purification Kit and prepared for sequencing as described in Section 
2.2.13 and sent to the University of Edinburgh sequencing facility (Genepool). The 
resulting sequences were used to search the nucleotide sequence databases with the 
BLAST program (www.blast.ncbi.nlm.gov/blast.cgi). The results showed that the marine 
isolate P has a high sequence identity (99%) to Serratia plymuthica, whereas the sensitive 
strain F showed a high sequence identity (99%) to Bacillus cereus var mycoides (Table 
3.3 and Figure 3.8). 
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Table 3.3 Summary of the ribotyping results for the marine isolates P, and F. 
 
Sequenced 
organism 
 
Blast match 
 
% of nucleotide sequence 
identity 
 
P Serratia plymuthica 99 (777/781 bp) 
F Bacillus cereus var 
mycoides 
99 (734/738 bp) 
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Figure 3.8 Phylogenetic tree based on the 16S rRNA gene sequences, highlighting that the marine 
antimicrobial producer is a variant of Serratia plymuthica.  
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In general, Serratia plymuthica species have received limited attention with respect to 
their antimicrobial producing properties, compared to S. marcescens (Stock et al., 
2003;Harris et al., 2004). Studies performed on S. plymuthica strains have focused on the 
area of its potential pathogenicity in humans and animals (Nieto et al., 1990). However, a 
number of reports suggest that S. plymuthica have potential in the biocontrol of fungal 
pathogens (Compant et al., 2005; Meziane et al., 2006;  Vleesschauwer and Hofte, 2007). 
How similar, with respect to antimicrobial production, is strain (P) to the type strains of S. 
plymuthica? I investigated the similarity of the antimicrobial production of our strain (S. 
plymuthica (P)), and that of two type strains of S. plymuthica and the most common 
Serratia spp, in regards to human health (S. marcescens). This investigation was carried 
out to determine whether this marine strain (P) produces inhibitory molecules with 
different inhibitory activities from the antimicrobial compounds produced by the other 
Serratia spp. Antimicrobial testing (spot test) was carried out as described in Material and 
Methods (Section 2.1.5), with a type strain of S. plymuthica, DSM 4540 and S. 
marcescens (ATCC13880). These experiments revealed that this marine isolate (P) did 
not produce a similar spectrum of antimicrobial activity to these characterised strains 
(Table 3.4 and Figure 3.9). However, based on the spot test results (Figure 3.9), the 
environmental isolate of S. plymuthica produced a more uniform antimicrobial clearing 
zone against the Bacillus cereus var mycoides test strain (F) compared with S. 
marcescens (ATCC13880), although both inhibited the growth of this organism, 
suggesting that the antimicrobial compound(s) produced by P are different. Furthermore, 
antimicrobial production can be seen when S. plymuthica (P) was tested against other 
bacteria (MRSA and VRE), while S. marcescens (ATCC13880) was unable to retard their 
growth (Table 3.4). Thus, it appears that the antimicrobial compound(s) produced by my 
environmental isolate of S. plymuthica are/ is potentially different than those produced by 
the S. plymuthica DSM 4540 and S. marcescens (ATCC13880). These results showed 
significant phenotypic differences between the marine strain (P) and the other tested 
Serratia spp. Importantly, this supports the likelihood that P is a new strain, or at least is a 
strain that produces different antimicrobial compound(s).  
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Table 3.4 Antimicrobial activity of the marine S. plymuthica (P), S. marcescens ATCC13880 and 
type strain of S. plymuthica DSM 4540 against a variety of microorganisms.  
 
 
Micro organisms Antimicrobial activity 
P S. marcescens 
(ATCC13880) 
S. plymuthica 
DSM 4540 
Bacillus cereus 
 var mycoides (F)  
++ +++ - 
VRE ++ - - 
MRSA +++ - - 
E.	  coli	  BW20767 ++ - - 
 
(+++) Very strong antimicrobial activity, (++) strong antimicrobial activity and (-) no 
antimicrobial activity. Growth condition, 30 oC /24-NA.  
 
 
 
 
 
Figure 3.9 Antimicrobial activity of marine bacterium S. plymuthica P (A) and S. marcescens 
(ATCC13880) (B), on nutrient agar plates with confluent growth of test microorganism Bacillus 
cereus var mycoides test strain (F), grown at 21 oC for 24hrs. 
 
 
 
 
 
 
A) 
 
B) 
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3.2.4 Quorum sensing bioassay 
 
Studies have suggested that the quorum-sensing system plays a role in the expression of 
specific genes, including in some instances those for antimicrobial production (Labbate et 
al,. 2004). Several researchers have recently studied the quorum-sensing systems present 
in S. plymuthica. (Labbate et al,. 2004; Van Houdt et al,. 2007 and Pang et al,. 2008). 
More recently studies performed by Liu et al. (2011), have indicated that two QS systems 
from S. plymuthica strain G3 have been characterized and their AHL profiles determined. 
In contrast, a study was carried out by Van et al. (2006) on the S. plymuthica strain RVH1 
examining the effect of AHLs deletion gene (luxS gene knockout) on the production of 
chitinase, nuclease, extracellular protease, and antibacterial compound and biofilm 
formation.  None of these phenotypes was affected by luxS knockout. As a result an 
experiment was performed to indirectly determine N-acylhomoserine lactone (AHLs) 
production using a cross-streaking bioassay as described by Swift et al. (1997). In this 
assay diffusible AHLs production induces the biosensor strain to produce a purple 
pigment. It was carried out using the antimicrobial producer S. plymuthica (P), S. 
marcescens (ATCC13880), S. plymuthica strain DSM 4540 and a terrestrial isolate of S. 
plymuthica at 21 and 30 oC, against the bio-sensory strain Chromobacterium violaceum 
(CV0blu) (Section 2.1.1.3) on an NA plates. The plates were incubated at (21 oC and 30 
oC for between 1 and 2 days). A positive result was recorded by the production of a 
purple pigment in the test bacterial strain Chromobacterium violaceum (CV031). The 
results shown in Figure 3.10 show that both the antimicrobial producer S. plymuthica (P) 
and the other Serratia species did not appear to produce diffusible N-acylhomoserine 
lactones (AHLs). 
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CV0blu 
 
 
 
Terrestrial isolate 
S. plymuthica 
 
S. mercecens 
(ATCC13880) 
CV031 
   
 
 
 
S. plymuthica 
DSM (4540) 
S. plymuthica (P) 
   
 Figure 3.10 AHL production bioassay. Cross streaking of S. plymuthica (P), S. marcescens 
(ATCC13880), S. plymuthica strain DSM 4540 and a terrestrial isolate of S. plymuthica (right), 
against biosensor strain C. violaceum (CV0blu) (centre) and Chromobacterium violaceum 
(CV031) (Positive control), grown at 30 oC for 24-48hrs.
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4. Isolation and preliminary characterisation of mutants unable to 
produce the antimicrobial (s) 
 
4.1 Introduction 
 
In order to gain an insight into the type of antimicrobial compound(s) produced by strain 
P a genetic approach was used in an attempt to identify the gene(s) involved in 
antimicrobial production. In this study, fourteen mutants, unable to produce antimicrobial 
compound(s) have now been obtained using transposon mutagenesis. The isolation, 
preliminary identification and characterisation of the gene(s) involving the antimicrobial 
production are presented here. 
 
4.2 Results 
 
4.2.1 Tn5 mutagenesis  
 
It has been recently reported that transposon delivery vector pRL27 is efficient, useful 
and functional for the genetic analysis of  Gamma-Proteobacteria such as E. coli, 
Salmonella enterica serovar typhi, Vibrio cholerae El Tor C6706 (Larsen et al., 2002). 
Therefore, it was decided to use Tn5 mutagenesis in an attempt to obtain non-
antimicrobial mutant strains, from the marine isolate strains (P). To achieve this a 
transposon mutagenesis technique was performed, using the system designed by Larsen et 
al., (2002). S.	  plymuthica (P), was	  used	  as	  a	  recipient,	  in	  conjugation	  experiments	  with	  the	  E.	   coli	  donor strain (BW20767 carrying	   the	  Tn5-pRL27 ((KmR-oriR6 K)) plasmid 
(Materials and Methods, Figure 2.4).	   	   A flow chart of the procedures used in the 
conjugation experiments is shown in Figure 2.5 (Materials and methods). Screening for 
potential mutants was carried out using nutrient agar plates containing two antibiotics 
(20µg/ml Ap, and 50µg/ml Kan).  Figure 2.6 (Materials and Methods) describes the 
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method used in this study to screen for potential mutant strains (PM). Following 
screening for S. plymuthica carrying an integrated Tn5, it became evident that the 
transposon mutagenesis was successful; with frequency for recipient cells (about 
9.1±0.2×10–4 CFU ml-1). Approximately 5000 transposon insertion mutants were 
screened in this study (Figure 4.1). Those mutants that were unable to produce a growth 
inhibition zone against sensitive strain B. cereus var mycodies (F); were considered as 
potential mutants and colony purified (Figure 4.2). Following re-testing, 14 non-
antimicrobial producing mutant strains were obtained (Figures 4.3) numbered as follows: 
4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 and 19 
 
One of these mutants was non-pigmented (4) whereas the other thirteen are pigmented 
(Figures 4.4) 
 
 
 
 
 
Figure 4.1 A plate showing antibiotic-resistant transconjugants of marine isolate 
S. plymuthica (P) colonies growing on Nutrient agar + 50µg/ml Kanamycin (Kan) 
+20µg/ml Ampicillin (Amp). 
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Figure 4.2 Screening for potential non-antimicrobial mutant strains, 
indicator micoorganism; B. cereus var mycodies (NA plate after 24hour  
incubation at 21ºC). 
 
 
 
 
 
Figure 4.3 A plate showing the lack of antimicrobial production phenotype 
of the transposon mutants, with test microorganism B. cereus var mycodies 
 (N-A plate after 24hour incubation  at 21ºC). 
 
B.cereus var 
mycodies (test strain) 
 
Potential mutant  
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Figure 4.4 A plate showing the non-antimicrobial producing mutants growing on  
Nutrient agar + 50µg/ml Kan + 20µg/ml Amp to confirm they were all resistant to  
Kanamycin as well as Ampicillin (24hrs incubation at 21ºC). One of these mutants 
is non- pigmented (No 4). 
 
 
4.2.2 Ensuring that mutants result from the insertion of the transposon into the 
genome of strain P 
 
Since the KmR gene is within the transposon element, a PCR reaction was carried out to 
ensure that the KmR phenotype of the mutants resulted from the insertion of the 
transposon into the S. plymuthica genome. A PCR reaction was performed (Section 2.2.6) 
using specific primers (AGPT-F and AGPT-R, {Table 2.7, Materials and Methods}) 
using genomic DNA as a template in the reaction. 
Amplified DNA from the PCR reaction was then subjected to gel electrophoresis and the 
results show a band in each of the potential mutants, corresponding in size (600 bp) to the 
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positive control (amplified from the pRL27 plasmid) (Figure 4.5). Therefore, these strains 
carry the transposon (the Kanamycin resistant (KmR) gene) within their genomic DNA. 
 
 
 
Figure 4.5 Agarose gel electrophoresis of the PCR amplified Kanamycin resistance gene (KmR) 
from the non-antimicrobial producing mutants. Aliquots, 5µl, of each PCR reaction were run on 
an 0.7% agarose gel and DNA was detected using ethidium bromide staining. Lane Marker: 1 kb 
ladder, lane 4-19: PCR products from non-antimicrobial producing mutants 4, 5, 6, 7, 8, 9, 10, 11, 
12, 13, 14, 15, 16 and 19 respectively, lane P: Negative control PCR reaction using wild type 
S.plymuthica, P genomic DNA as template and lane pRL27: Positive control (PCR reaction using 
pRL27 as a template). 
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4.2.3 Characterisation of the transposon mutants 
 
It was important to initially determine whether or not the isolated mutants were the result 
of single or multiple transposon insertions. Furthermore, determination of the size of the 
BamHI genomic DNA fragment that the transposon had been inserted into should help to 
provide an insight how many different genes may be involved. Therefore, southern blot 
analysis was used to obtain physical evidence of the number of transposon insertion sites 
in these mutants. The chromosomal DNA of the mutants (4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 
14, 15, 16 and 19), was digested with BamHI, which does not cut within the transposon. 
(Section 2.2.4, Materials and Methods) (See Figure 4.6 for BamHI digested genomic 
DNA), and then hybridised with the Km-DNA probe (labelled with DIG), as described in 
Sections 2.2.11 and 2.2.12 (Materials and Methods). The results shown in Figure 4.7 
demonstrate that single transposons are independently integrated within the chromosomal 
DNAs of the selected mutant (one band only in each lane). Therefore, the southern blot 
results indicate that the fourteen insertions of each of the test-selected mutants were 
present in the genomic DNA, and in the single copy. Furthermore, the size of the BamHI 
genomic DNA fragment that the transposon had been inserted into differs depending on 
each mutant. Fragment sizes were determined as shown in Table 4.1. 
 
Chapter 4.     Isolation and preliminary characterisation of mutants unable to produce the antimicrobial (s) 
 92 
 
 
Figure 4.6 The agarose gel electrophoresis of BamHI digested genomic DNA. M:  DIG labelled 
marker (λ HindIII), 4-19:  BamH1cut genomic DNA from mutant No. 4-19, respectively. +Ve: 
Unlabelled purified PCR KmR gene from PRL27 plasmid (positive control, 1/30 fold dilution). 
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Figure 4.7 Southern blot hybridisation with BamHI, digested DNA prepared from mutants (Nos. 
4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 and 19). The 0.6- kb DIG labelled purified PCR KmR 
gene from pRL27 plasmid was used as a DNA probe.  M:  DIG labelled marker (Hind111) 
digested DNA marker, +Ve: Unlabelled purified PCR KmR gene from the pRL27 plasmid 
(positive control), 4-19:  BamH1 cut genomic DNA from mutant Nos. 4-19, respectively. 
 
 
Chapter 4.     Isolation and preliminary characterisation of mutants unable to produce the antimicrobial (s) 
 94 
 
Table 4.1 The size of the transposon containing BamHI fragments in the mutants, as determined 
by Southern blot analysis.  
 
Mutants No. Fragment sizes  (Kb) Fragment sizes  (Kb) without the 
transposon (1.8 Kb) 
4 6.5 4.7 
5 5.7 3.9 
6 3.1 1.3 
7 9 7.2 
8 5.7 3.9 
9 6.5 4.7 
10 5.7 3.9 
11 22 18.2 
12 6.5 4.7 
13 3.5 1.7 
14 6.9 5.1 
15 12.8 11 
16 15 13.2 
19 12.8 11 
 
 
4.2.4 Cloning and recovery of the transposon insertion and flanking genomic DNA 
 
Having isolated transposon insertion mutants no longer producing antimicrobial activity, 
the next stage was to identify the gene(s) defined by these insertions. This would involve 
the cloning and recovery of the transposon insertion and flanking genomic DNA from 
each mutant. Genomic DNA from the mutants was extracted (Section 2.2.1), and then 
digested with BamHI, which does not cut within the transposon (Section 2.2.4). The 
digested chromosomal DNA was then ligated (Section 2.2.5) and introduced into 
chemically competent E. coli, strain S17-1 λpir (Section 2.2.13). The transformation 
mixes were then plated onto selective LB agar plates containing Kan (50µg/ml) and Str 
(30µg/ml) and incubated overnight at 37ºC. Figure 2.7 (Materials and Methods) shows a 
diagram summarising the cloning, recovery and sequencing of the resulting transposon 
junction plasmids (TJP). The plasmids were purified as described in Section 2.2.2 and 
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subjected to sequencing as described in Section 2.2.9 (Materials and Methods) with two 
primers tpnRL17–1 and tpnRL13–2 (Table 2.7), which anneal to the ends of the 
transposon (oriR6K and KmR, respectively) (For primer sites, see Materials and Methods; 
Figures 2.8). This approach was successful for mutants 4, 5, 7 and 8 respectively. The 
analysis of these plasmids by agarose gel electrophoresis (Figure 4.8) shows that the sizes 
of these particular TJP were varied; TJP from mutant No. 4 was (8.0 Kb), TJP from 
mutant No. 5 (5.0 Kb), TJP from mutant No. 7 (8.0 Kb), and TJP from mutant No. 8 (6.0 
Kb). All of these TJP (4, 5, 7 and 8) were cut with unique restriction enzyme with BamH1 
to form linearised DNA. However, attempts to clone the transposon insertion mutants 
from the following mutants (6, 9, 10, 11, 12, 13, 14, 15, 16 and 19) were not successful 
despite repeated attempts. It is unknown why the other 10 mutants failed to clone during 
the cloning stage. A potential explanation for this could be that result from issues with 
chemically competent E.coli cells. For example, they weren’t competent enough in order 
to receive the recombinant DNA or that they were damaged during the treatment for 
making them competent or that the transposon junction plasmid (TJP) DNA, transferred 
into the competent E.coli cells, then integrated with competent chromosomal DNA.  
 
The genomic DNA flanking on the transposon insertions for the mutants (4, 5, 7 and 8) 
were partially sequenced, as described in the material and methods, chapter 2 (Figure 
2.7). Then the DNA sequence obtained was compared with the sequences in GenBank 
using the BLAST program. Comparison of the resulting sequences against the genomes 
for S. marcescens and S. plymuthica (BLASTN), revealed that is no homology at the 
DNA level. Moreover, none of the four-transposon junction plasmid sequences obtained 
(4, 5, 7 and 8) were found to be related to the delivery vector. Nevertheless, comparison 
of the resulting sequences (BLASTX) revealed that the four mutants (4, 5, 7 and 8) had 
insertions into gene(s) that were similar to those found in the other Serratia spp. when 
encoding non-ribosomal peptide polyketide synthases  (Figure 4.9). This result indicates 
that the levels of matching, are not significantly high; for instance, they were (31%) 
according to the partial sequencing of the flanking genomic DNA from mutant No 5 
(Figure 4.10). (More blast results are shown in Appendix 2).  
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Figure 4.8 Gel electrophoresis of BamHI digested transposon junction plasmids 
(minipreps). Briefly, 5µl of BamHI digested mini-prep was run on a 0.7% 
Agarose gel and stained with ethidium bromide.   Lane M: 1 kb ladder, lane 1: 
TJP from mutant No 4, lane 2: TJP from mutant No 5, lane 3: TJP from mutant 
No 7, and lane 4: TJP from mutant No 8. 
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Figure 4.9 The blastx search result obtained from the partial sequencing the flanking genomic 
DNA from mutant No 5, showing that transposon had inserted into a gene, with similarity to a 
gene encoding a Polyketide synthesis. 
 
 
 
Figure 4.10 Amino acid sequence line-ups (Blastx) between Serratia plymutica (P) flanking end 
of transposon insertion site, mutant 5, sequence from primer 13-2(Query) and Polyketide 
synthesis, from Serratia plymuthica (Sbjct). The E-value for this match is 1e-12, and the sequence 
shows 31% identities and 52% similarities. 
 
4.2.5 Sequencing the flanking regions 
 
An attempt to sequences the flanking regions was carried out in this study to help 
understand is the structure of the genes involved e.g. size of the open reading frame 
(ORF), is it a single transcription unit or part of an operon, are there any readily 
identifiable transcription control sequences that could give an insight to the control of 
antimicrobial production? In order to sequence the whole flanking regions of the 
transposon junction plasmids (TJPs), the sequences obtained using the outward directed 
sequencing primers (Previous Section {4.2.4}), was used to design primers to extend the 
sequence coverage, in an attempt to extend the sequence (Table 2.7). In this study I 
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have partially sequenced the genomic DNA flanking the inserted transposon in mutants 
5, 7 and 8 (See Appendix 1 for sequence data). Based on the sequencing data obtained 
from this part of study, it was decided that it would be worthwhile to attempt to clone the 
genomic DNA region containing the antimicrobial gene(s) (ang). 
 
4.2.6 Attempt to clone the genomic DNA region containing the antimicrobial gene(s) 
(ang) 
 
Further genetic approaches were conducted to gain an insight into the gene(s) required for 
the synthesis of the antimicrobials such as cloning into a plasmid vector. I attempted to 
clone the ang with the aim of establishing a first step for further study, to allow the ang to 
be studied in greater detail for purposes such as gene characterisation (regulation and 
mapping). A gene cloning method was carried out using primers designed for a Long 
PCR reaction, as shown below: 
 
4.2.6.1 PCR amplification of genomic DNA defining the antimicrobial gene(s) 
 
The flanking region sequencing results (Section 4.2.5 and Appendix 1), from the non-
antimicrobial mutant strains (M 5, 7 and 8), were used to design specific primers for the 
amplification of the gene(s) (bold line in Table 2.7, Materials and Methods). These 
primers would result in products containing BamHI sites at each end, enabling easy 
cloning. After designing the primers, genomic DNA from strain P, was isolated (Section 
2.2.1, Materials and Methods) and used as a template, in a long PCR reaction as described 
in Section 2.2.6 (Materials and Methods). The products from the PCR were subjected to 
gel electrophoresis (Section 2.2.8, Materials and Methods) and the results obtained 
showed that the product of mutant’s No. 5 and No. 8 yielded a DNA fragment of ~5 to 6 
kbp; whereas, mutant No. 7 produced a fragment of around 9 kbp (Figures 4.11). In 
comparison, this result is in agreement with the results obtained from the southern 
blotting and gel electrophoresis of cloned insertion mutants (TJPs) mini-prep experiments 
(Table 4.1 and Figure 4.7). Afterwards, the long PCR products were then subjected to 
gene cloning as described in the next Section. 
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4.2.6.2 Cloning of the ang  
 
After checking that the target DNA fragment was successfully amplified, using gel 
electrophoresis (Section 2.2.8), attempts were made to clone the PCR products (from 
mutant’s No. 5, No. 7 and No.  8) into a DNA cloning vector, pBluescript II KS (-)(Figure 
2.2; Materials and Methods). Amplified PCR products were cleaned using a PCR 
Purification Kit (Qiagen), then digested with BamHI (Section 2.2.4, Materials and 
Methods), and ligated into BamHI cut pBSII KS (-) (Section 2.2.5, Materials and 
Methods) and introduced into chemically competent E. coli XL1-Blue cells (Sections 
2.2.13, Materials and Methods). Afterwards, screening for successful transformants was 
completed using a blue/white colour screen. Briefly, the transformed cells were plated out 
on LB plates containing 50 µg/ml Ap and 40µl of 0.1 M Isopropyl thioglactoside (IPTG) 
and 2% 5-bromo-4-indolyl-beta –D- galactopyranoside (Xgal) that was spread on top of 
the LB plates and left to dry before plating, plates were incubated aerobically at 37 oC for 
18-24hrs. Following the period of incubation, the white colonies should be successful 
transformants (recombinant DNA; plasmids with inserts), whilst blue colonies will be 
plasmids without inserts. Despite multiple repeats of the experiment, using different 
competent cells, no plasmids containing the desired insert were isolated.  The precise 
reason why my cloning experiments were unsuccessful is unknown; the reason, why I 
could not get constructed plasmid DNA is unknown, it is possible that the cloned gene 
was transcribed and translated, and the yielded a protein that was toxic to E. coli. In 
general, cloning genes involving antimicrobial production is usually more challenging 
than cloning other genes (Martín and Gil, 1984). 
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Figures 4.11 Analysis of the long PCR products from mutants 4, 5 and 8. Lane 
M: 1 kb ladder, lane 1: amplified DNA using designed primers from mutant No. 
7, lane 2: amplified DNA cut with BamH1. Lane 3: amplified DNA using 
designed primers from mutant No. 5, lane 4 amplified DNA cut with BamH1, 
lane 5: amplified DNA using designed primers from mutant No. 8, lane 6: 
amplified DNA cut with BamH1. (0.7% Agarose gel). 
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5. Characterisation of the antimicrobial agent(s) 
 
5.1 Introduction 
 
Several studies have indicated that antimicrobial compounds produced by terrestrial S. 
plymuthica strains can be associated with chitinolytic enzymes or 1,3- glucanases (cell 
wall degradation enzymes) (Berg et al., 2002; Frankowski et al., 1998; Kamensky et al., 
2003; Kurze et al., 2001); or antibiotics such as antibiotic delivery (siderophores) and 
pyrrolnitrin (Kamensky et al., 2003; Meziane et al., 2006; Calvente et al., 2001). 
However, most work conducted on S. plymuthica strains is in the area of soil 
microbiology and biocontrol (Compant et al., 2005; Meziane et al., 2006). In this study, 
the producer strain (P) was obtained from the marine environment; consequently, 
different strains of Serratia might produce different types of inhibitory molecules. This 
was clearly observed from comparisons between the isolated strain P and both the type 
strain (S. plymuthica DSM 4540) and the most common Serratia spp in regards to human 
health (S. marcescens ATCC13880). The results showed that the molecule(s) produced by 
P had a different antimicrobial spectrum. Therefore, these results showed significant 
phenotyping differences between the marine isolate strain (P), and the other tested 
species, Serratia. Importantly, this finding supports the hypothesis that the marine 
environment isolate S. plymuthica (P) is potentially a new strain, or at least is a strain that 
produces different antimicrobial compound(s). In view of this, it was worthwhile to 
attempt identification of the inhibitory molecule (s) produced by strain P.  
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5.2 Results 
 
5.2.1 The effect of different cultivation conditions on the production of the 
antimicrobial compound(s) 
 
A range of different cultivation conditions were employed in an attempt to produce higher 
levels of antimicrobial compound from the marine isolate P. In these experiments, 
bacterial cultures were incubated at 21oC while shaking at 220 r.p.m for 24hrs, in a 
variety of growth conditions. These included different surface attachment materials, 
different growth media, and use of roller bottle (rb) culture. In addition the effect of 
cross-species interaction, following exposure to a sensitive strain Bacillus cereus var 
mycoides (F) was also examined. The antimicrobial activity was tested using disc and 
spot tests (Materials and Methods, Section 2.1.5) against Bacillus cereus var mycoides on 
NA plates.  
 
5.2.1.1 The effect of growth media on antimicrobial production   
 
Several studies have demonstrated that the chemical composition of growth media 
significantly affects antimicrobial activity (Martin and Demain, 1980) (Farmer, 1985) 
(Spížek and Tichý, 1995) (Marwick et al., 1999). Therefore, it was decided that it was 
worthwhile to cultivate the producer strain P in different growth media to study its effects 
on the antimicrobial compound production. 250ml conical flasks containing 100 ml broth 
media; Nutrient broth (NB), Brain heart infusion broth (BHI), Luria Bertani broth (LB), 
Tryptone soya broth (TSB) or Marine broth (MB), were inoculated with 100µl of an 
overnight culture of strain P. The flasks were then incubated aerobically at 21oC with 
shaking (220 r.p.m.) for 24hrs. After the period of incubation, bacterial cultures (100 ml) 
were spun at 13000 rpm for 10 minutes using a large centrifuge (Beckman Avanti J-26 
XP). The cell pellet was then discarded and the spent culture medium (termed as SM) was 
filter sterilised using a 0.2µm filter (Millipore) and stored in the refrigerator (9 oC) until 
used. The antimicrobial activity of the spent culture medium (SM) was then assessed 
using a spot test (Materials and Methods, Section 2.1.5) using Bacillus cereus var 
mycoides (F) as the sensitive strain. The results showed that there was a decrease in the  
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antimicrobial activity of the SM from LB and MB media in comparison with the SM from 
TSB, BHI and NB grown cultures (Figure 5.1). An explanation for this could be that the 
presence of the salt (sodium chloride) in the LB and MB media seems to suppress 
inhibitory activity. However, this result is in agreement with the results obtained by 
evaluating an inhibitory activity of the live cultures of strain P grown on different agar 
media which showed that the inhibition zone around the culture drop was much wider on 
the nutrient agar plates when compared with the other media tested (LB and TSA and 
BHI) (Section 3.2.2.4, Figure 3.5). In conclusion, it is evident that the chemical 
composition of growth media significantly affects antimicrobial activity and 
unfortunately the use of different growth media failed to enhance the antimicrobial 
production from strain P. 
 
 
 
Figure 5.1 Effect of different growth media on antimicrobial production. 20µl of spent media 
(SM) from cultures of P grown in different broth media was spotted onto a lawn of Bacillus 
cereus var mycoides (F) on NA plates, 21 oC /24hrs. The spent culture media were obtained from 
cultures grown in following media: Nutrient broth (NB), Brain Heart Infusion broth (BHI), Luria 
Bertani broth (LB), Tryptone Soya broth (TSB) and Marine broth (MB). Sterile H2O were used as 
negative control.  
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5.2.1.2 The effect of different surface attachment substrates on antimicrobial 
production 
 
A variety of surface attachment materials and modified roller bottle (rb) cultures were 
used with the aim of stimulating the physical condition of the marine bacteria when 
grown in the marine environment, on the surface of a marine plant (seaweed). Several 
studies have reported that using different surface attachment substrates enhances the 
antimicrobial activity. For instance, Yan et al, reported that using these culture conditions 
leads to the induction of antibacterial production isolated from marine environment (Yan 
et al., 2003). Therefore, an attempt was made to produce higher levels of antimicrobial 
compound(s) from strain P in liquid cultures by using different surface attachment 
substrates. Strain P, was inoculated in 100 ml flasks containing sterile 50 ml NB media, 
which contained different materials; wood (tooth picks), glass (cover-slips), plastic 
washing-up sponges (approximately 1 cm3 foam bungs) and small beads with holes. The 
growth media (6 flasks including a control (NB without material) was prepared separately 
for each of the materials that were tested. The flasks were then incubated aerobically at 
21oC with shaking (220 r.p.m.) for 24hrs. After the period of incubation, the spent media 
from each flask was treated as highlighted previously to determine the antimicrobial 
activity present (Section 5.2.1.1). The results showed no enhancement on the production 
of the inhibitory molecules under the experimental conditions in comparison to the 
control (NB without material) (Figure 5.2). 
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A) 
 
B) 
 
Figure 5.2 The effect of growth on a solid substrate on antimicrobial production. 20µl of spent 
media (SM) from cultures of P with different surface attachment materials was spotted onto a 
lawn of Bacillus cereus var mycoides (F) as sensitive strains on NA plates, incubated at 21 oC 
for 24hrs. A: Foam bung and cubed agar. B: Cover slips, small beads and toothpicks. Sterile 
Nutrient broth (-VE control) and spent media from cultures of P in NB without material (+Ve 
control). 
 
 
5.2.1.3 The effect of modified roller bottle (rb) cultures on antimicrobial production 
 
 Further attempts were also performed at this stage of the study to enhance the production 
of the antimicrobials using modified roller bottle (rb) cultures. Briefly, a 500 ml Duran 
bottle-containing freshly poured hot 100 ml sterile NA was rolled in ice (3-5 mins) to 
create a thin layer of NA agar around the inner bottle surface (to simulate the physical 
condition of the strain P growing in the marine environment, on the surface of a seaweed. 
Following this, 50 ml of sterile NB was added in addition to 100 µl of an overnight 
culture of strain P. The bottle culture was then incubated on a roller at high speed (220 
r.p.m, 21oC for 24hrs). The antimicrobial activity was then assessed as previously 
described (Section 5.2.1.1). Kanamycin (50µg/ml) was used as a positive control in spot 
and disc tests.  The antimicrobial spot results showed that the use of modified roller bottle 
(rb) cultures failed to enhance the antimicrobial production from the marine isolate P in 
comparison to the control an NB shake flask culture (Figure 5.3). 
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Figure 5.3 Effect of growth on an agar surface on antimicrobial production. 20µl of spent media 
(SM) from modified roller bottle (rb) cultures were spotted onto a lawn of Bacillus cereus var 
mycoides (F) on NA plates, incubated at 21 oC for 24hrs. Modified roller bottle (rb), Kan= 
Kanamycin (20µl of a 50µg/ml solution) and spent media from cultures of P in NB (+Ve control). 
 
 
5.2.1.4 Does the presence of a sensitive strain enhance antimicrobial production? 
 
One possibility was that the production of antimicrobial activity could possibly be 
induced by the presence of a potential sensitive bacterial strain. As a result a further 
attempt was made to produce higher levels of antimicrobial compounds from the marine 
isolate P in a shake flask culture to which a sensitive bacterial strain was also grown. Two 
separate experiments were performed; one using heat-killed cells and another using live  
 
cells of the sensitive bacterial strain. A culture of the marine isolated sensitive strain 
Bacillus cereus var mycoides (F) was used, both as heat-killed cells (90oC for 10minutes) 
and live cells. Briefly, either a live culture (2 ml), a heat-killed culture of Bacillus cereus 
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var mycoides (F) (2 ml), SM from a culture of F (2 ml) or NB media (2 ml) was placed 
into a 5 cm length of sterile dialysis tubing, to prevent the direct interaction between the 
sensitive strain and the antimicrobial producer, but allow the free diffusion of any key 
small molecules. The tubing was then sealed using sterile clips, and each piece of tubing 
placed into separate 500 ml flasks containing 100ml of sterile NB media. Following this, 
an overnight culture of strain P was used to inoculate the flasks. They were then 
incubated and the spent medium treated as discussed in Section 5.2.1.1), to evaluate 
antimicrobial production activity. The results (data not shown) showed that using cross-
species interaction did not appear to enhance the production of inhibitory molecules. 
 
In conclusion, the shake flask cultures and different growth conditions employed in this 
stage of the study in an attempt to produce higher levels of antimicrobial compound(s) 
were shown to have no enhancing effects on the production of the inhibitory molecules. 
 
5.2.2 Effect of physiochemical factors on the inhibitory molecule(s)  
 
The presence of the antimicrobial compound in solution enabled a variety of experiments 
designed to probe its composition and physical properties. These included testing for the 
effects of physiochemical factors such as thermo-sensitivity, the antimicrobial molecules’ 
stability at 9oC, pH changes and enzyme tests were studied with the aim of discovering an 
interesting properties for this inhibitory compound, which may support our hypothesis 
that the marine isolate P, is potentially a new strain or at least is a strain that produces 
different antimicrobial compound(s). The SM of the antimicrobial producer S. plymuthica 
(P) was prepared as described in Section 5.2.1.1. The spent culture medium (SM) was 
initially concentrated using a centrifugal vacuum concentrator (Savant AES 2010 Speed 
Vac® System). Briefly, 20 ml of the SM was distributed by pipette, into a series of sterile 
1.5ml microcentrifuge tubes. All the tubes were then placed into the vacuum concentrator 
and run for 3hrs at RT. The dried material in each tube was then re-suspended in 50µl of 
sterile distilled water, termed as concentrated spent media (CSM) samples, and stored 
with the SM in the refrigerator (9 oC), until used for assessing the influence of 
physiochemical factors (pH, enzymes and heat treatment), on antimicrobial activity as 
described below. 
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5.2.2.1 Effect of temperature on antimicrobial activity 
 
I initially asked how does the inhibitory molecule(s) produced by strain P resist heat 
treatment? A series of 200µl aliquots of CSM in sterile 0.5ml microcentrifuge tubes were 
incubated at different temperatures (20, 50, 70 and 100 oC) for 15, 30, 60 and 120 
minutes, respectively, in a dri-block heater. The tolerance of the antimicrobial compound 
to autoclaving was tested at 121 oC for 15 minutes, in an autoclave. The activity for the 
heat-treated CSM was tested by spot testing on NA plates, using MRSA, S. epidermidis, 
Bacillus cereus var mycoides (F), Cl. difficile strain 630 and L. monocytogenes Scott A as 
sensitive strains (Material and Methods, Section 2.1.5). The control used was CSM 
without any heat treatment.  
 
5.2.2.2. Effect of proteinase K, amylase and lysozyme on antimicrobial activity 
 
Studying such enzymatic effects on antimicrobial activity could provide us with 
preliminary characteristics with which to assess the nature of the antimicrobial 
compound(s). This was done by preparing solutions consisting of a combination of 95% 
(v/v) of CSM and 5% (w/v) of one of the following enzymes. Three different enzymes 
were used (proteinase K, β-amylase and lysozyme) and the samples were all tested and 
prepared as follows: (1) (70% proteinase K; 70µl of a 25 mg/ml proteinase K stock 
solution plus 30µl of distilled water and 95µl of the CSM). (2) (70% β-amylase; 70µl of a 
25mg/ml β-amylase stock solution plus 30µl of distilled water and 95µl of the CSM). (3) 
(70% lysozyme; 70µl of a 25mg/ml lysozyme stock solution plus 30µl of distilled water 
and 95µl of the CSM). Afterwards, the tested samples were incubated at 37 oC for 5hrs. 
Subsequently, the antimicrobial activity was evaluated using the spot test as before. The 
controls were CSM without any treatment along with untreated enzyme solutions.  
 
5.2.2.3 Effect of pH on antimicrobial activity 
 
A further assay was performed to investigate how inhibitory molecule(s) was affected by 
pH changes. A series of 50 ml aliquots of SM in sterile 100 ml flasks were adjusted to pH 
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2, 4, 6, 8, 10, 12 and 14 using 1M NaOH or 1M HCl. Afterwards, the SM was 
concentrated and inhibitory activity was evaluated using a spot test as described 
previously.  
 
The results of the effect of physiochemical factors on the inhibitory molecule(s) produced 
by strain P, revealed that the inhibitory molecule(s) was not affected by pH (pH 2 to 14) 
or by temperatures of up to 121 oC (data not shown). Furthermore, proteinase K, β-
amylase and lysozyme did not affect the antimicrobial activity of the secreted inhibitory 
molecule(s) (Figure 5.4). The results of these physiochemical tests make it unlikely that 
the secreted inhibitory molecule is a protein.  
 
 
       
 
Figure 5.4 The effect of proteinase K on antimicrobial activity. Zones of inhibition on nutrient 
agar plates with test micro-organisms (B. cereus var mycoides (F) left panel and MRSA right 
panel). 20µl of concentrated spent media which had been exposed to 25 mg/ ml proteinase K for 5 
hrs at 37 oC (A). (B) concentrated spent media (CSM) and (C) sterile distilled water (Negative 
control). 
 
 
5.2.2.4 Effect of storage at 9oC on the antimicrobial molecules’ stability 
 
The effect of storage at 9 oC on the stability of unknown inhibitory molecule(s), is an 
important factor, in that the more stable it is the easier it will be to work with. Therefore, 
the stability and inhibitory activity of the bioactive molecule in spent media (SM) was 
assessed at various points during storage at 9 oC (1, 3, 5, 10, 15, 20, 25, 30, 40, 70 and 
120 days), using the spot test (Materials and Methods, Section 2.1.5) on NA plates against 
Bacillus cereus var mycoides (F) and MRSA. CSM was used as positive control and H2O 
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as a negative control. The results showed that the inhibitory molecule was stable for 25 
days under these storage conditions, thereafter, the activity decreased as the storage time 
increased (Table 5.1 and Figure 5.5). Thus, the results suggest that an inhibitory molecule 
produced by this bacterium is relatively stable. 
 
Table 5.1 The effect of shelf-life on the inhibitory molecule(s)’ stability in the spent media (SM) 
as measured by its antimicrobial effects on Bacillus cereus var mycoides (F).  
 
No.  days stored Presence of antimicrobial activity  
 
1 +++ 
3 +++ 
5 +++ 
10 +++ 
15 +++ 
20 +++ 
25 +++ 
30 ++ 
40 ++ 
70 ++ 
120 + 
 
(+++) Very strong antimicrobial activity, (++) strong antimicrobial activity, (+) partial 
antimicrobial activity  
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A)  
 
B) 
 
C)  
Figure 5.5 The effect of shelf-life on the antimicrobial molecule stability. A 10µl spot of spent 
growth media (SM) and concentrated spent growth media (CSM, positive control) and sterile 
distilled water (H2O, negative control), was spotted onto a lawn of Bacillus cereus var mycoides 
(F) on NA plates incubated at 21 oC for 24hrs; A. 3 day storage; B. 30 day storage; C, 70 day 
storage. 
 
5.2.3 Preliminary characterisation and purification of inhibitory molecule(s) 
  
In order to gain an insight into the nature of antimicrobial compounds produced by strain 
(P), the purification of such compounds is essential. However, as biological samples 
usually contain mixtures comprised of several components, the use of size exclusion 
chromatography (SEC/ Gel filtration) and ion exchange chromatography (IEC), or a 
combination of several techniques based on different purification principles is needed for 
isolation, identification and characterization of inhibitory molecules. 
 
5.2.3.1 Ultra filtration of the spent culture medium 
 
As an initial step towards to identifying the inhibitory molecule (s) produced by S. 
plymuthica (P), I decided to use an ultra filtration technique in an attempt to give 
preliminary information about the molecular size of the antimicrobial compound. 
Molecular weight cut-off membrane filtration can be used to separate dissolved 
compounds in aqueous solutions on the basis of size: basically, small molecules will pass 
through the membrane pores while larger molecules will be retained at the membrane 
surface. The spent culture medium (SM) of the antimicrobial producer S. plymuthica (P), 
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was prepared as mentioned in Section 5.2.1.1. Then, it was passed through several 
molecular weight cut-off membranes (with the following molecular weight cut-off limits; 
100,000, 50,000, 30,000, 10,000 and 5000 Daltons) (Materials and Methods Section 
2.3.1). Antimicrobial activity of the spent media after passing through these membranes 
was then tested using the spot test method (Materials and Methods, Section 2.1.5) against 
the test micro-organisms (Bacillus cereus var mycoides (F), S. epidermidis, Clostridium 
difficile strain 630 and MRSA. The ultra filtration of the SM appeared to show that the 
inhibitory molecule size is greater than, or equal to 5,000 Daltons (Table 5.2 and Figure 
5.6).  
 
 
Table 5.2 Preliminary sizing of the antimicrobial molecule in spent medium by ultrafiltration.  
 
Membrane size molecular 
weight cut off (MWCO) in 
Daltons 
The presence of antimicrobial activity 
 
 
 MRSA S. epidermidis B. cereus  Cl. difficile 
<5,000 - - - - 
≥5,000 +++ +++ +++ +++ 
≥10,000 +++ +++ +++ +++ 
≥30,000 +++ +++ +++ +++ 
≥50,000 +++ +++ +++ +++ 
≥100,000 +++ +++ +++ +++ 
+Ve control (SM) +++ +++ +++ +++ 
-Ve control (H2O) - - - - 
 
(+++) Very strong antimicrobial activity, (-) no antimicrobial activity, and spent culture medium 
(SM, +Ve control) and sterile distilled water (-Ve control). N= 3 times. 
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Figure 5.6 Zones of growth inhibition produced by spent medium after ultrafiltration.  
20µl of the spent media that had passed through the various molecular weight cut-off membranes 
was spotted on to lawns of the test organisms (Left panel B. cereus var mycoides (F) and MRSA 
right panel) and the NA plates incubated overnight at 21oC. A (<5000 Da), B (≥ 5000 Da), C 
(≥10, 000 Da), D (≥30, 000 Da), E (≥50, 000 Da), F (≥100, 000Da), G (+Ve control, spent culture 
medium (SM)) and H (Sterile distilled water (-Ve control)). N= 3 times. 
 
5.2.3.2 Purification of the antimicrobial molecule by size exclusion chromatography 
(SEC) 
 
The molecular weight cut-off membrane experiments gave a relatively rapid and rough 
estimation of the size of the antimicrobial molecule. In order to provide more reliable 
information about the molecular size of the active compounds, the concentrated spent 
culture media (CSM, Section 5.2.2) from the antimicrobial producer was subjected to gel 
filtration (GF). 1ml of CSM was resuspended in the following buffer; 50mM Tris 
(pH7.5), 150 mM NaCl and 1mM EDTA and was injected onto a Superose®-12 column 
and run at a flow rate of 0.8ml/min. The fractions were monitored with UV light, at 
280nm, and collected in 1.5ml microcentrifuge tubes. Fractions were then tested for 
antimicrobial activity test using a spot test (Materials and Methods, Section 2.1.5) against 
Bacillus cereus var mycoides on NA plates. The results shown in Figure 5.7; a, b and c 
show that nine fractions present in the HPLC analysis showed inhibitory activity against 
the indicator strain B. cereus var mycoides (F). Eight of the fractions (16, 17, 18, 19, 20, 
21, 22 and 23), suggest an approximate molecular weight of ~1,000 Daltons while the 
remaining fraction (fraction No.5) appears to be a significantly higher molecular weight 
Chapter 5.                                                                                 Characterisation of the antimicrobial agent(s)  
 114 
compound (~2,000000 Daltons). These results suggest that the inhibitory compound(s) 
has a molecular weight of ~1,000 Daltons with evidence that the molecule may, under 
certain conditions, aggregate to produce a higher molecular weight complex. It is off 
course still possible that the high molecular weight peak represents a different compound. 
In contrast, this result is not in agreement with results obtained by molecular weight cut-
off membranes (Section 5.2.3.1) that showed that bioactive molecules size is greater than, 
or equal to 5000 Daltons (Table 5.2 and Figure 5.6). An explanation for this could be that 
lots of larger molecules (≥5, 000 dalton) were retained at the surface of the cut-off 
membrane (≥ 5000 Da), consequently, blocking membrane pores and preventing small 
molecules to pass through membrane pores. However, the ultra filtration method alone 
cannot be used to characterize the active compounds.  
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Sample Fractions 
(a) A280nm profile of the concentrated spent culture media (CSM)(blue line). 
 
 
 
(b) Inhibition profile of gel filtration fractions 1-30. 
 
 
 
(c) Zones of clearing (10µl Spot test) resulting from the gel filtration fractions no (5, 16, 17, 18, 
19, 20, 21, 22 and 23), on agar plates with confluent growth of B. cereus var mycoides  
(21 oC for 24hrs). 
 
 
Figure 5.7 Gel filtration (GF). (a) A280nm profile of the concentrated spent culture media (CSM) 
subjected to gel filtration. (b) Inhibition profile of gel filtration fractions 1-30. (C) Zones of 
clearing produced by the active antimicrobial fractions.  
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5.2.3.3 Anion exchange chromatography (AEC) 
 
Further purification was conducted to gain an insight into the nature of the antimicrobial 
compound(s) produced by strain (P). Anion Exchange Chromatography (AEC) was used 
in this study to purify the inhibitory molecule(s), depending on their electrical charge 
(negative / positive) using a specific Anion exchange column. The bioactive fractions 
from the gel-filtration experiment above (5.2.3.2) were pooled (9ml in total), and 
concentrated as described in Section 2.3.2 (Materials and Methods), and then 1ml was 
subjected to the AEC, using a Mono-Q column the initial column running buffer was 
50mM Na acetate pH5 plus 100mM NaCl and followed by a high salt elution buffer 
(50mM Na acetate pH5 plus 1M NaCl). The fractions eluting from the column were then 
tested for antimicrobial activity using the spot test (Materials and Methods, Section 2.1.5) 
against Bacillus cereus var mycoides on NA plates.  The results showed that no inhibitory 
activity was found in the eluted fractions (1-20) (Figure 5.8; a and b) and only a small 
amount of activity was recovered in the column flow-through. This could mean that the 
inhibitory molecule(s) is either negatively charged or uncharged. Given the qualitative 
nature of the assay for the compound it is difficult to be sure that all the available 
bioactive material was recovered. 
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Sample Fractions 
a) A280nm profile of anion exchange fractions (1-20).  
 
 
 
 
 
b) Antimicrobial activity results (spot test) from anion exchange chromatography fractions (1-20), 
on agar plates with confluent growth of B. cereus var mycoides. Concentrated spent media (CSM) 
as a positive control. (plate incubated at 21 oC for 24hrs). 
 
 
Figure 5.8 Anion Exchange Chromatography (AEC). (a) A280nm profile of anion exchange 
fractions (1-20) (b) Antimicrobial activity results from anion exchange fractions (1-20), on agar 
plates with confluent growth of B. cereus var mycoides. The results showed that no inhibitory 
activity was found in the eluted fractions (1-20). 
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5.2.4 SDS-PAGE analysis 
 
Based on the inhibitory molecule size data, obtained from ultra filtration and size 
exclusion chromatography (Gel filtration), it was determined that it would be beneficial to 
attempt to discover whether any proteins were present and to estimate their molecular 
weight. The inhibitory molecule within the spent media (SM), concentrated spent media 
(CSM) and the pooled active fractions from the gel filtration experiment were analysed 
using SDS-PAGE electrophoresis. The gel was run as described in Section 2.3.5 
(Materials and Methods). The results shown in Figure 5.9 show that there was a low 
molecular weight band in lanes 4 and 5 (SM and CSM, respectively); however, the 
estimated size of the molecule will taken near the bottom of the gel, may be at too low a 
concentration to detect, and may not bind to Coomassie blue. No protein band was 
present at detectable levels in the pooled gel filtration fractions (lane 6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
ç 
 
 
Figure 5.9 SDS-PAGE gel analysis. Lane M; the molecular mass marker, Lane 1, 2 and 3; crude 
extract protein of the marine isolate P, Lane 4; the spent media sample (SM), lane 5; concentrated 
spent media sample (CSM), and lane 6; Pooled bioactive fractions (fraction Nos. 5, 16, 17, 18, 19, 
20, 21, 22 and 23) from the gel filtration experiment.  
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5.2.5 Is the inhibitory molecule bacteriostatic or bactericidal?  
 
To establish whether the antimicrobial compound is either bacteriostatic or bactericidal, 
further experiments were carried out using the concentrated spent media (CSM, Section 
5.2.2). The assay was done using a viable count plating method (Materials and Methods, 
Section 2.1.8), after the exposure of MRSA (as the sensitive strain) to different 
concentrations of the CSM. The tested samples were prepared as follows; a single colony 
of MRSA was inoculated into 10 ml of NB, and aerobically incubated with shaking 
(overnight at 37ºC). Following the period of incubation, 100µl of the overnight culture 
was transferred into 10ml of NB media and incubated at 37 oC for 5 hours (OD600nm= 
0.7, late exponential phase). The cell culture was then divided into ten sterile 1.5ml 
microcentrifuge tubes, and centrifuged (13000 r.p.m for 5 min at RT) to obtain cell 
pellets. Different concentrations of CSM (0, 5, 10, 20, 30, 50,70,100 and 200%) (v/v) 
were then added to the pellets. The tubes (9 microcentrifuge tubes including the control 
(0% CSM = cell pellets without adding CSM) were then incubated aerobically at 37 oC 
for 4-hrs and total viable cell count was carried out as described in Section 2.1.8 (Material 
and Methods). The numbers of colonies was counted, following the incubation period (37 
oC for 18-24hrs) and the results were recorded as a survival curve (% CFU/ml relative to 
the control), against CSM concentrations. The results shown in Figure 5.10 illustrate that 
the number of viable cells is decreasing. Thus, the inhibitory compound is bactericidal.  
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Figure 5.10 Cell survival of sensitive strain MRSA cells on exposure to increasing concentrations 
of CSM. Bacterial cultures were grown aerobically for 5 hours to a late exponential phase 
(OD600nm= 0.7) at 37 oC and cell pellets were treated with different concentrations of 0, 5, 10, 
20, 30, 50, 70 100 and 200% (v/v) of CSM for 4 hours. 0% CSM = cell pellets without adding 
CSM. Total viable cell count was then carried out on NA plates and these were incubated 
overnight at 37 oC. The result represents a survival curve (% CFU/ml) against increasing 
concentrations of CSM. N= 2 times. 
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6. Discussion 
 
Historically, the majority of current antimicrobials have been isolated from terrestrial 
organisms and only relatively recently have marine based organisms been the subject of 
research (Stach, 2010). The investigation of marine based micro-organisms has been 
largely successful, with researchers finding that they offer an abundant fresh source from 
which to collect new antimicrobials (Stach, 2010). This is significant because to date, 
roughly two-thirds of naturally occurring antibiotics have been isolated from bacterial 
sources, in particular from the genus actinomycetes. Many of these are of value for 
medical use in humans (Dharmaraj, 2010; Stach, 2010).  It is therefore anticipated that by 
identifying new antimicrobials from marine micro-organisms it will be possible to find a 
new arsenal with which to overcome the increasing levels of resistance to current 
antibiotics. 
 
Several of the currently available studies have focused on identifying novel antimicrobial 
compounds from specific marine bacterial species, primarily marine actinomycetes 
(Stach, 2010). However, so far research into other marine bacteria leading to the isolation 
of antimicrobials is limited; this is a motivation for further scientific research, as it is 
likely to be the study of rare marine micro-organisms that will lead to the emergence of 
new antimicrobial compounds. In recognition of the value of such research, this study has 
aimed to characterise antimicrobial producing micro-organism isolated from the surface 
of seaweed. 
 
My results, as given in Chapters; 3, 4 and 5 have indicated that a micro-organism found 
on the surface of seaweed produces antibacterial metabolite(s) which react strongly 
against the Gram-positive foodborne pathogens: Bacillus cereus var mycoides, Listeria 
monocytogenes, Staphylococcus epidermidis, multi-drug resistant human pathogenic 
bacteria Clostridium difficile strain 630, Vancomycin Resistant Enterococci (VRE), 
Methicillin-resistant Staphylococcus aureus (MRSA), and the foodborne spoilage 
organism Penicillium expansum. The work described utilised molecular microbiological 
techniques and classic microbiology as the basis for an initial characterisation of the 
marine bacterium and the inhibitory molecule(s). This work has extended our knowledge 
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about this natural antimicrobial producing bacterium, as well as providing further insights 
into its properties and potential applications in both industrial and clinical settings. 
 
6.1 Screening for Antimicrobial Compound Production and Identification of the 
Antimicrobial Producing Marine Isolate (P) 
 
When screening seaweed associated marine micro-organisms, for their ability to produce 
antimicrobial compounds, an organism was isolated as it was found to be producing 
antimicrobial metabolite(s); and was termed P. This marine micro-organism was screened 
for its ability to produce antimicrobial compounds and to kill or prevent the growth of a 
variety of different bacterial and fungal strains.  
 
On the basis of the antimicrobial activity screening results (Results, chapter 3; Table 3.1 
and Figure 3.1), the antimicrobial producing marine isolate, P, was shown to exhibit 
strong antimicrobial qualities against several micro-organisms, particularly those 
associated with foodborne spoilage such as Penicillium expansum, foodborne pathogens 
and multi-drug resistant human pathogenic bacteria such as (VRE) and (MRSA). Thus, 
this research has established that this strain produces a water-soluble inhibitory 
molecule(s). I would suggest that there is the presence of more than one molecule because 
of its activity against both Gram- positive bacteria, and fungal cells, due to the various 
differences between bacterial and eukaryotic micro-organisms, e.g., the differences 
between the cell wall structure. The antimicrobial activity screening results also showed 
that this strain (P) was particularly effective at inhibiting the growth of Gram-positive 
microorganisms, although it was inactive against Gram-negative pathogens. This finding 
is consistent with results from Austin et al, who also reported that antibiotics isolated 
from marine producing bacteria are typically more active against Gram-positive bacteria, 
with limited or no activity against Gram-negative bacteria (Austin, 1989). As the 
organism isolated in this study produced compound(s) that were active against pathogenic 
bacterial strains, including multi-drug resistant human bacterial pathogens (i.e. MRSA 
and VRE) and Cl. difficile strain 630, it is hypothesised that it may contain new 
antimicrobial agent(s). 
  
In order to identify the marine micro-organisms (both P and F), a ribotyping analysis was 
applied. The 16S rRNA analysis results showed that the antimicrobial producer isolate, P, 
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has a high sequence identity (99%) to Serratia plymuthica, whereas the sensitive strain, F, 
showed high sequence identity (99%) to Bacillus cereus var mycoides (Results, chapter 3, 
Table 3.3 and Figure 3.8).  
Strain P was further characterised by the use of phenotypic profiling and displayed the 
following phenotypic characteristics: it produced circular, convex, brick red pigmented, 
smooth surfaced round colonies, was Gram-negative, short rod shaped and non-spore 
forming (Results, chapter 3, Figure 3.2). This data corresponds with the characteristics 
that define the genus Serratia (Grimont and Grimont, 1978; Vivas et al., 2000). The 
organism was also positive for chitinase, proteinase, casinase, gelatinase lipase, DNase 
and haemolysis (Results, chapter 3, Figure 3.4). Serratia strains are generally known to 
produce extracellular components such as gelatinase, DNase and lipases (Farmer, 1985).  
The organisms was also salt tolerant which is in agreement with the characteristics 
defining the genus Serratia (they are generally salt tolerant) (Grimont and Grimont, 
1978). 
 
In general, Serratia plymuthica has received limited attention with respect to its 
antibacterial producing properties, in contrast to S. marcescens, (Stock et al., 2003; Harris 
et al., 2004). S. plymuthica strains have been shown to be potential pathogenic in humans 
and animals (Nieto et al., 1990).  More recent studies have focussed on S. plymuthica 
strains isolated from soil with a potential application as bio-control agents against fungal 
pathogens (Compant et al., 2005; Meziane et al., 2006;  Vleesschauwer and Hofte, 2007). 
To the best of my knowledge, this study is the first to attempt to investigate a marine 
isolate of Serratia plymuthica, in relation to its antibacterial properties.  
 
To investigate the characteristics of the antimicrobial molecule(s) from marine S. 
plymuthica I asked: How similar, with respect to antimicrobial production, is strain (P) to 
the type strains of S. plymuthica? The similarity of this strain (S. plymuthica (P)) to other 
S. plymuthica strains (including the most common: Serratia spp, and the strain most 
frequently identified with human health: S. marcescens) was investigated. This 
investigation led to the conclusion that the marine strain is a new strain, as the spectrum 
of antimicrobial activity it generated was significantly different (Results, chapter 3, Table 
3.4 and Figure 3.9). Further, the antimicrobials from strain S. plymuthica (P) are markedly 
different to those produced from S. plymuthica DSM 4540 and S. marcescens 
(ATCC13880). In this study, no antimicrobial activity was seen when using S. plymuthica 
DSM 4540 (reference strain) against strains that were sensitive to P. Crucially, I observed 
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that strain (P) resulted in an antimicrobial clearing zone against the Bacillus cereus var 
mycoides test strain (F) that was more uniform than that obtained when using S. 
marcescens (ATCC13880), although both inhibited the growth of this organism (Table 
3.4 and Figure 3.9). Therefore, I can conclude that the marine environment isolated S. 
plymuthica (P) can be classified as a new strain that produces antimicrobial compound(s) 
that are different from similar strains derived from the terrestrial environment.  
 
To obtain more detailed information about the properties of the antimicrobial producer 
strain (P), I carried out further investigations into the growth kinetics of the strain with 
regards to extrinsic factors. The tests performed to identify P are discussed below: 
 
Growth conditions (media and temperature) were found to have some effect on the 
production of antimicrobial activity. The results showed that there was a decrease in the 
antimicrobial activity of the spent culture medium (SM) from cells grown in LB and MB 
media in comparison to the SM from TSB, BHI and NB grown cultures (Results, Chapter 
5, Figure 5.1). This result is in agreement with the results obtained when evaluating the 
inhibitory activity of the live cultures of strain P that were grown on different agar media, 
which showed that the inhibition zone around the culture drop was much larger on the 
nutrient agar plates when compared with the other media tested (LB and TSA and BHI) 
(Results, Chapter 3, Figure 3.5). A possible explanation for this could be that the higher 
concentration of salt in the LB and MB media may suppresses inhibitory activity. Several 
other studies with different bacteria have also found a demonstrable influence of the 
chemical composition of growth media on antimicrobial activity (Martin and Demain, 
1980; Farmer, 1985; Spížek and Tichý, 1995; Marwick et al., 1999).  
 
Exposure to external factors such as temperature can also affect the functions of internal 
pathways, by controlling the expression of the genes involved in the production of 
antimicrobial compounds (Moons et al., 2006). To establish the effects of growth 
conditions on antibacterial production, the effect of various temperatures (9 oC, 21 oC, 30 
oC, 37 oC and 50 oC) was examined. These results showed that antimicrobial production 
was better at lower growth temperatures (i.e. below 30oC), while the growth of strain P 
was better at 30oC or above. In general, the production of the red pigment prodigiosin 
defines the genus Serratia (Farmer, 1985). As prodigiosin has been shown to have some 
antibacterial activity it was also important to determine if there was any link between 
antibacterial activity and production of the red pigment prodigiosin in strain P. The red 
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pigmentation was more prominent when grown on BHI agar plates, compared with the 
NA, LB and TSA media, with LB and TSA plates resulting in an intermediate level of red 
pigment (Results, chapter 3, Figure 3.6). Despite this, from my work there appeared to be 
no obvious link between prodigiosin production and antimicrobial activity.  
 
A variety of different culture methods were utilised in an attempt to enhance the 
production of the antimicrobial agents. The effect of surface attachment on antimicrobial 
production was also examined, with the aim of stimulating the physical condition of the 
marine bacterium when it was growing on the surface of the plant (seaweed). For 
instance, Yan et al. (2003), reported that using such culture conditions led to the 
induction of antibacterial production when isolated from the marine environment (Yan et 
al., 2003). Moreover, following exposure to the sensitive strain, antibiotic production 
from some marine epiphytic bacteria has also been reported (Burgess et al., 1999). 
Unfortunately the use of different kinds of liquid culture conditions failed to enhance 
antimicrobial production from the marine S. plymuthica in this study, as did co-culturing 
strain P with a sensitive microorganism. 
 
Some recent studies have explored the quorum-sensing abilities of S. plymuthica. Reports 
include the assertion that N-acylhomoserine lactones (AHLs) perform the role of 
signalling molecules in Serratia species, to regulate gene expression. This also includes a 
role in producing antimicrobial compounds and exoenzymes, butanediol fermentation and 
forming biofilms (Labbate et al,. 2004; Van Houdt et al., 2007a; Van Houdt et al., 2007b; 
and Pang et al,. 2008). Liu et al. (2011) characterises two QS systems for S. plymuthica 
strain G3 and determined their AHL profiles. They also asserted that QS molecules play a 
role in the regulation of antifungal activity. My results suggest that my strain of S. 
plymuthica (P) did not produce diffusible AHL molecules (Results, chapter 3, Figure 
3.10). Again this result supports the hypothesis that strain P has unique and novel 
qualities. 
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6.2 Isolation and preliminary characterisation of mutants unable to produce the 
antimicrobial(s) 
 
I decided to employ a Tn5 mutagenesis method to isolate mutants of strain P, which failed 
to produce the antibacterial compound (Materials and Methods, Section 2.2.14). In this 
study, I identified, mutants deficient in antibacterial activity and subsequently cloned the 
transposons plus flanking genomic DNA from four of these mutants (M4, 5, 7 and 8). 
During the study, 14 mutants were obtained, one of these mutants was non-pigmented 
(M4), whereas the other thirteen were pigmented (Results, chapter 4, Figures; 4.3 and 
4.4). There is no explanation for the lack of pigment in the mutant without pigmentation; 
experiments to prove or disprove whether the non-pigmented phenotype was due to the 
presence of the Tn5 insertion were not done. These mutants were all shown to be the 
result of single Tn5 insertions into the genome of strain P using a combination of PCR 
and Southern blotting techniques (Results, chapter 4, Figures; 4.5 and 4.7). The 
transposon insertion mutants should define some or all of the gene(s) responsible for the 
antimicrobial activity, although no attempt was made to determine the number of 
complementation groups. However, given the variation in the sizes of the genomic DNA 
regions flanking each Tn5 and my data, it seems likely that the fourteen mutants define a 
more than one gene (Results, chapter 4, Figure 4.7 and Table 4.1). 
 
One of the key features of the transposon mutagenesis system used is the ease with which 
it is possible to clone the insertion mutant and the adjacent genomic DNA. Genomic 
DNA is first cleaved with a restriction endonuclease, which does not cleave within the 
transposon, and the fragments are ligated; circular molecules containing the transposon 
then replicate as a plasmid (termed a transposon junction plasmid, TJP), in E. coli strains 
carrying the λ pir gene. Insertion mutants; 4, 5, 7 and 8 respectively were cloned 
(Results, chapter 4, Figure 4.8). However, attempts to clone the transposon insertion 
mutants from the following mutants (6, 9, 10, 11, 12, 13, 14, 15, 16 and 19) were 
unsuccessful; the reason for this is unknown.  
 
The genomic region containing the transposon insertions for non-antibacterial producing 
mutants (4, 5, 7 and 8) (TJP 4, 5, 7 and 8) were partially sequenced as described 
previously in the material and methods chapter (Chapter 2, Figure 2.7). The data obtained 
from the transposon junction plasmid DNA sequencing was then compared to that found 
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in the Gen Bank using the BLAST-N and X programmes. Comparison of the resulting 
sequences against other sequenced S. plymuthica strains, such as S. plymuthica AS9, and 
the genome for S. marcescens strains (BLASTN), revealed no homology at the DNA 
level. Also, none of the four-transposon junction plasmid sequences obtained (4, 5, 7 and 
8) were found to be related to the delivery vector (Results, chapter 4, Figure 4.9), 
although comparison of the resulting sequences (BLASTX) revealed that the four mutants 
(4, 5, 7 and 8) had insertions into gene(s) similar to those encoding non-ribosomal peptide 
polyketide synthases (Results, chapter 4, Figure 4.10). The results also revealed that these 
mutants (4, 5, 7 and 8) had insertions into gene(s) similar to those present in the other 
Serratia spp, although the level of homology is low, they were approximately 31% 
identical at the amino acid level and not at all at the nucleic acid level (Figure 4.10).  
 
Non Ribosomal Peptides (NRPs) and Polyketides (PKs) are two classes of complex 
natural compounds produced by micro-organisms. They are metabolites with 
pharmacological properties that are considered to be important; e.g. Vancomycin - a non-
ribosomal peptide antibiotic; Erythromycin - a polyketide antibiotic; and Epothilone - a 
mixture of both a polyketide and a non-ribosomal peptide that acts as an antitumor agent 
(Khosla et al., 1999; Schwarzer et al., 2003; Minowa et al., 2007). In general genes 
encoding non-ribosomal peptide synthases (NRPSs) and polyketide synthases (PKSs) 
have been reported for the genus Serratia spp.  A study performed on Serratia sp. ATCC 
39006 and S. marcescens ATCC 274 to characterise the prodigiosin gene cluster (pig 
cluster), showed that several pig cluster gene products were similar to NRPSs, polyketide 
synthases and the red proteins of Streptomyces coelicolor (Harris et al., 2004). In 
addition, several studies have reported that (NRPs) and (PKs) can be produced by 
terrestrial isolates of S. plymuthica. For example, the first report of polyketide compounds 
produced by Serratia plymuthica strains was in 2001 by Thaning et al. who isolated a 
strain of S. plymuthica from soil. This strain produced a bioactive compound that 
inhibited the fungal plant pathogen Sclerotinia sclerotiorum. The compound was 
identified as a chlorinated macrolide and termed haterumalide NA. Subsequent to this, in 
2004, Levenfors et al. isolated several inhibitory compounds from another soil derived S. 
plymuthica (A 153) including polyketide compounds (chlorinated macrolides and 
haterumalide (NA, B, NE and X). Another polyketide compound with antifungal activity 
was later identified by Shen et al. (2007); this had a chemical structure belonging to the 
chlorinated macrolide family and was termed macrocyclic lactone A21-4. In this study as 
there was essentially no homology between the transposon junction plasmid genomic 
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DNA sequences and related Serratia spp. at the nucleotide level (Results, chapter 4, 
Figures; 4.9 and 4.10), this supports my hypothesis that the marine isolate of S. 
plymuthica (P) is different to the other characterised strains.   
 
Using the partial sequence data (Appendix 1), primers were designed in an attempt to 
clone the wild type genomic DNA for the antimicrobial gene(s), using long-PCR and 
cloning into pBluescript. I was able to amplify the wild type genomic DNA region 
corresponding to mutants 5, 7 and 8 but unfortunately I was unable to clone these 
fragments, even though the experiment was repeated carefully several times. The reason, 
why I could not get these constructs is unknown. For instance, it may be that there’s been 
some form of recombination event between the insert DNA and the E.coli genome, 
probably unlikely as there is not significant homology between the sequenced portion of 
the inserts and E. coli. Or, it may be that the desired cloned gene was transcribed and 
translated, and the protein may then be toxic to the E. coli. In general, cloning genes 
involved antimicrobial production is usually more challenging than cloning many other 
types of genes (Martín and Gil, 1984).  
 
In summary, the experiments have shown that Tn5 mutagenesis was successful in 
disrupting and identifying at least some of the gene(s) associated with antimicrobial 
production in the marine S. plymuthica strain (P).   
 
6.3 Preliminary characterisation of the antimicrobial agent(s) 
 
To successfully characterise and gain insight into the antimicrobial compounds derived 
from strain P it is essential to determine its physical properties and to obtain a pure 
sample of the compound. Thermo-sensitivity, pH changes and the effect of enzymes on 
inhibitory compounds, are important features contributing to a preliminary understanding 
of the characteristics of the active molecule. While to obtain a pure compound several 
different purification steps are usually required, due to the many components present in 
biological samples.  
 
 
The inhibitory activity produced by S. plymuthica (P) was found to be heat stable and the 
did not change after exposure to heat treatments of up to 121 oC. The inhibitory 
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compounds activity was also resistant to proteinase K (Results, chapter 5, Figure 5.1), β-
amylase and lysozyme. In addition, the results also showed that altering the pH, from 2 to 
14, did not affect the antibacterial activity. These results suggest that the secreted 
inhibitory molecule is unlikely to be a protein. This appears to contradict the sequencing 
results from my mutants, these suggested that the compound could be a non-ribosomaly 
encoded polypeptide (Results, chapter 4, Figure 4.10). However in my view, it is more 
likely that the proteins produced by these genes are responsible for the synthesis and 
modification of the antibacterial molecule, as opposed to being parts of the antibacterial 
compound, more work is required to determine if this is indeed the case.  
 
The bioactive molecules produced by the isolated S. plymuthica strain in the spent culture 
media (SM) were found to be fairly stable at a storage temperatures of 9 oC for 25 days.  
This stability may be of interest and of significant value in both industrial and clinical 
applications. For instance, the more stable a compound is, the easier it will be to work 
with. 
 
The effect of the compound on the survival and growth of MRSA was examined with a 
view to determining whether or not the compound was bactericidal or bacteriostatic. 
MRSA was used as the sensitive strain as the B. cereus var mycoides strain grows as 
filaments and consequently does not produce countable colonies. The results showed that 
the inhibitory compound is bactericidal (Results, Chapter 5, Figure 5.10). Following 
purification of the inhibitory molecules, further experiments should be performed to 
determine the minimum inhibitory concentration (MIC).  
 
The spent culture media (SM), concentrated spent media (CSM) and the pooled active 
fractions from the gel filtration experiment, were analysed using SDS-PAGE 
electrophoresis to discover whether any proteins were present and to estimate their 
molecular weight. Figure 5.9 showed that there was a low molecular weight band in lanes 
4 and 5 (SM and CSM, respectively); No protein bands were present at detectable levels 
in the pooled fractions. Indeed, a band on an SDS gel does not denote responsibility for 
antibacterial activity. However, any proteins present may be at too low a concentration to 
detect, and it seems very likely that the inhibitory compound may not bind to Coomassie 
blue. 
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As an initial step towards to identifying the inhibitory molecule(s) produced by S. 
plymuthica (P), I decided to use an ultra-filtration technique in an attempt to provide 
preliminary information about the molecular size of the antimicrobial compound. The 
data showed that the inhibitory compound was present in the SM and its size is greater 
than, or equal to 5,000 Daltons (Results, chapter 5, Table 5.2 and Figure 5.6). While this 
experiment gave a relatively rapid and rough estimation of the size of the antimicrobial 
molecule, to obtain better purification of the inhibitory molecule and confirm its 
molecular weight, a gel filtration fractionation was performed. This experiment split the 
antimicrobial activity into two distinct populations; one of a molecular weight of around 
~1,000 Daltons (over eight fractions) and another much higher molecular weight fraction 
of ~2,000000 Daltons (Results, Chapter 5, Figure 5.7). All the previous studies have 
shown that the antibiotics produced by other strains of S. plymuthica are low molecular 
weight compounds. For instance, Shen et al., reported that terrestrial isolates S. 
plymuthica A21-4 produce antibiotic macrocyclic lactone A21-4 of a low molecular 
weight, 470 Daltons (Shen et al,. 2007). In this study, it is not clear if my result represents 
two separate inhibitory molecules or whether this is evidence that under certain 
conditions the molecule is aggregating to produce a higher molecular weight complex. It 
is also possible that compound aggregation is behind the results obtained from the 
molecular weight cut-off membranes experiments. An alternative explanation would be 
that lots of larger molecules (≥5, 000 Daltons) were retained at the surface of the cut-off 
membrane (≥ 5000 Daltons), consequently, blocking the membrane pores and preventing 
smaller molecules from passing through the membrane pores. Therefore, I find that the 
ultra-filtration method alone is not reliable in characterising the active compounds. As at 
least one of the molecules appears to be small and relatively stable, as a result HPLC 
might be a more useful method for purification.  
 
Anion Exchange Chromatography (AEC) was also used in this study to purify the 
inhibitory molecule(s); based on their electrical charge using a specific anion exchange 
column. The bioactive fractions from the GF assay was subjected to AEC using an anion 
exchanger column (Mono-Q, negatively charged). Unfortunately this was not successful, 
perhaps suggesting that either the inhibitory molecule(s) are negatively charged or 
uncharged.  
 
In conclusion, I found that the active compound is heat resistant and has a low molecular 
mass ~1,000 Daltons and therefore is unlikely to be a protein. Most of the work 
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conducted on S. plymuthica strains is in the area of soil microbiology and biocontrol 
(Compant et al., 2005; Meziane et al., 2006; Matilla et al., 2012). However, as strain (P) 
was obtained from the marine environment and different strains of Serratia could be 
expected to yield multiple types of inhibitory molecules. This supports the notion that the 
marine environment isolate of S. plymuthica (P) is a new strain, one that produces novel 
antibacterial compound(s).   
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7. Conclusion 
 
A microorganism, isolated from the surface of marine plants (seaweed; Ascophyllum 
nodosum), was found to produce antimicrobial metabolite(s) that were strongly active 
against several micro-organisms, particularly those micro-organisms associated with food 
borne spoilage, food borne pathogens and multi-resistant human pathogenic bacteria, such 
as VRE and MRSA. A combination of phenotyping and ribotyping of this marine 
bacterium indicated that it is very similar to Serratia plymuthica, a gram-negative micro-
organism frequently associated with the surface of terrestrial plants. Our results showed 
significant phenotypic differences between the marine isolate and the other tested 
members of the Serratia genus of. The, preliminary characterisation of the inhibitory 
molecule(s) produced by this marine isolate demonstrated it was heat stable and of a low 
molecular weight (~1,000 Daltons), with the potential to be negatively charged or 
uncharged. It was found to be bactericidal towards at least MRSA. Preliminary 
identification and characterisation of the gene(s) involved antimicrobial production 
revealed that the four mutants (4, 5, 7 and 8) were inserted into gene(s) similar to those 
encoding non-ribosomal peptide/polyketide synthases. 
 
To date, much of the work performed on S. plymuthica is within the field of soil 
microbiology and bio control. However, the present study, as far as I am aware, is unique 
in being the first study on a marine S. plymuthica isolated from the surface of seaweed. 
This study proposes that the marine S. plymuthica is a potentially a new strain, or at the 
very least that it is a strain that produces different antimicrobial compound(s). 
Consequently, it is an unexplored potential source of natural antimicrobial compound(s). 
Further investigations will be required to adequately characterise this marine bacterium. 
For example, it is still necessary to identify the all gene(s) responsible for the production 
of the antimicrobial agent(s) by cloning all the transposon insertions. Future research 
should aim to increase our knowledge of this natural antimicrobial producer bacterium, 
and to discover its properties and potential applications in an industrial setting. 
 
 
 
  
 
 
 
 
 
 
 
 
 
APPENDICES 
 
 
 
 
 
 
 
 
Chapter 8.                                                                                                                                         Appendices 
 136 
 
8. Appendices 
8.1 Appendix (1)  
 
8.1.1 Partial DNA sequence of mutant 5 (17-1direcion) 
 
            |       10        20        30        40        50        60        70 
            CGATAGCTTAAGCATTTTGAGTGACACAGGACACTTAACGGCTGACATGGGGGGGTACCGAGCTCGAATT 
            GCTATCGAATTCGTAAAACTCACTGTGTCCTGTGAATTGCCGACTGTACCCCCCCATGGCTCGAGCTTAA 
 
                    80        90       100       110       120       130       140 
            CAGCGATGATGGTTGAGATGTGTATAAGAGACAGGGGTGGGTTTATTGATGATGCATATTGTTTCGATCC 
            GTCGCTACTACCAACTCTACACATATTCTCTGTCCCCACCCAAATAACTACTACGTATAACAAAGCTAGG 
 
                   150       160       170       180       190       200       210 
            CAAATTTTTTAGAATTTCCCCGCAAGAAGCTGAGTGGATGGATCCGCAAGCTCTGGTATTGTTGGAAGAG 
            GTTTAAAAAATCTTAAAGGGGCGTTCTTCGACTCACCTACCTAGGCGTTCGAGACCATAACAACCTTCTC 
 
                   220       230       240       250       260       270       280 
            AGCCTGAATGTTATCTACCATGCCGGTTATACTCATCATGAGCTTGCTGGTATGAATGTAGGTGTTTACA 
            TCGGACTTACAATAGATGGTACGGCCAATATGAGTAGTACTCGAACGACCATACTTACATCCACAAATGT 
 
                   290       300       310       320       330       340       350 
            TTGGAGCGCGTGGTCAACAAGTCAATCTTTCCAAAATCGAACATTGCCGTAATCCTATTATGGCGGTGGG 
            AACCTCGCGCACCAGTTGTTCAGTTAGAAAGGTTTTAGCTTGTAACGGCATTAGGATAATACCGCCACCC 
 
                   360       370       380       390       400       410       420 
            GCAAAACTATCTAGCCGCTAATATTTCGCAATTCTTCAATCTCAGAGGTCCCTCTTTGGTGATTGACACT 
            CGTTTTGATAGATCGGCGATTATAAAGCGTTAAGAAGTTAGAGTCTCCAGGGAGAAACCACTAACTGTGA 
 
                   430       440       450       460       470       480       490 
            GCCTGTTCGTCCTCTTTAGTTGGTATGAATATGGCAGTGGAAGCAATGTGCGCAGGTACTATTGACTCCG 
            CGGACAAGCAGGAGAAATCAACCATACTTATACCGTCACCTTCGTTACACGCGTCCATGATAACTGAGGC 
 
                   500       510       520       530       540       550       560 
            CGTTGGTTGGGGGGGTGAGTTTGCTGGCAAATTCGAGCGCCCATGAAATCTTTGCGCAACGTAATTTATT 
            GCAACCAACCCCCCCACTCAAACGACCGTTTAAGCTCGCGGGTACTTTAGAAACGCGTTGCATTAAATAA 
 
                   570       580       590       600       610       620       630 
            ACAAGCTAACGGAGAGTTTCATATCCTCGATCAGAGAGCATCTGGTGTCGTTCTTGGTGAAGGGTGTGGA 
            TGTTCGATTGCCTCTCAAAGTATAGGAGCTAGTCTCTCGTAGACCACAGCAAGAACCACTTCCCACACCT 
 
                   640       650       660       670       680       690       700 
            ATGGTTTATCTGAAGCCGCTTGAAAAGGCAAAGCAAGATGGTGATTGCATTTATGCTGTTATTGAAGGTA 
            TACCAAATAGACTTCGGCGAACTTTTCCGTTTCGTTCTACCACTAACGTAAATACGACAATAACTTCCAT 
 
                   710       720       730       740       750       760       770 
            TCGGAGTCAATAATGATGGCAGAACTGCAGGGCCCGCTACGCCTAACATGGCGGCTCAGGCCGATGTGAT 
            AGCCTCAGTTATTACTACCGTCTTGACGTCCCGGGCGATGCGGATTGTACCGCCGAGTCCGGCTACACTA 
 
                   780       790       800       810       820       830       840 
            GCAATCTGTGTTAAAGCAAAGCCAGTGTGCAAGCCATGACATAAGTTATCTGGATGTGAACGGATCTGGC 
            CGTTAGACACAATTTCGTTTCGGTCACACGTTCGGTACTGTATTCAATAGACCTACACTTGCCTAGACCG 
 
                   850       860       870       880       890       900       910 
            TCAGAAGTAACAGACTTGCTCGAGATAAAAGCAGTTGCGTCAGTCTACGCTTCAAAAGAAAGAAAGCCTC 
            AGTCTTCATTGTCTGAACGAGCTCTATTTTCGTCAACGCAGTCAGATGCGAAGTTTTCTTTCTTTCGGAG 
 
                   920       930       940       950       960       970       980 
            TGTATTTAGGATCTATGAAGCCAAATATTGGCCATCCTTTATGTGCAGAAGGTATTGCTAGCTTTATAAA 
            ACATAAATCCTAGATACTTCGGTTTATAACCGGTAGGAAATACACGTCTTCCATAACGATCGAAATATTT 
 
 
                   990      1000      1010      1020      1030      1040      1050 
            AGTTGCTTTGATGTTGCAGCACCAGCAGCTAGTTCCCTTTCTCTCTGGTCAAGAACCTCTTGCGCATTAT 
            TCAACGAAACTACAACGTCGTGGTCGTCGATCAAGGGAAAGAGAGACCAGTTCTTGGAGAACGCGTAATA 
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…Sequence continued M5 
 
                  1060      1070      1080      1090      1100      1110      1120 
            TCGATTGAGCGTTCGGGGTTTGCATTCCCAAGACAAGCACAAGCTTTTGAGATGGAATACGCTGCCTTGA 
            AGCTAACTCGCAAGCCCCAAACGTAAGGGTTCTGTTCGTGTTCGAAAACTCTACCTTATGCGACGGAACT 
 
                  1130      1140      1150      1160      1170      1180      1190 
            ATTGCTTCGCTGATGGTGGCACTAATGCTCATGTGATTTTGAGCAAATCATATCAAAACTAATTTTATCC 
            TAACGAAGCGACTACCACCGTGATTACGAGTACACTAAAACTCGTTTAGTATAGTTTTGATTAAAATAGG 
 
                  1200      1210      1220      1230      1240      1250      1260 
            TTTCACATTATCCTATTTAAATTTAGCTTCTTTCTCATTTTTGGAATATATATTCCGTATGGGGAAGAGG 
            AAAGTGTAATAGGATAAATTTAAATCGAAGAAAGAGTAAAAACCTTATATATAAGGCATACCCCTTCTCC 
 
                  1270     |1280      1290      1300      1310      1320      1330 
            ATTTTAATTAGCTTGATATATCATTTCATGAACTTAGCTAGCGGTATATCATTACTAGGCTTAAAGGAAT 
            TAAAATTAATCGAACTATATAGTAAAGTACTTGAATCGATCGCCATATAGTAATGATCCGAATTTCCTTA 
 
                  1340      1350      1360      1370      1380      1390      1400 
            ATGGACATGAATAATCTCAATTCAAATGCAAGAAAGAACAATGTTTCTGATGATCATTCAGTGAGCAAGC 
            TACCTGTACTTATTAGAGTTAAGTTTACGTTCTTTCTTGTTACAAAGACTACTAGTAAGTCACTCGTTCG 
 
                  1410      1420      1430      1440      1450      1460      1470 
            GGTCACCTCTGTCTCTGCCAACTATGCGTCGAGTGGATGTCCGGACACTTCAACTTACAGACAAGAAGAG 
            CCAGTGGAGACAGAGACGGTTGATACGCAGCTCACCTACAGGCCTGTGAAGTTGAATGTCTGTTCTTCTC 
 
                  1480      1490      1500      1510      1520      1530      1540 
            TGAAATTCATCAAGGAAGTGATAGCCTGGGTTATAGAACGCTAAGTCATTCATTTAAACCTTCAGGATGC 
            ACTTTAAGTAGTTCCTTCACTATCGGACCCAATATCTTGCGATTCAGTAAGTAAATTTGGAAGTCCTACG 
 
                  1550      1560      1570      1580      1590      1600      1610 
            TGGGATCTGATTCTCAGTAGCGAGCATCCGATCCTATCTGGTCACCAAGTGTATGGCCAGGAGTTATTGC 
            ACCCTAGACTAAGAGTCATCGCTCGTAGGCTAGGATAGACCAGTGGTTCACATACCGGTCCTCAATAACG 
 
                  1620      1630      1640      1650      1660      1670      1680 
            CAGGCCTTGCTTGGGTTGATTTCTTGTACCAGTGGTTCGCAGAGGCCGGATATTCATACGAGACGTTAGA 
            GTCCGGAACGAACCCAACTAAAGAACATGGTCACCAAGCGTCTCCGGCCTATAAGTATGCTCTGCAATCT 
 
                  1690      1700      1710      1720      1730      1740      1750 
            ATTAAAAAACTTATCCATTTATAGGCCTTTGATTATTTCAGAAAAAGAACAGGTAGCGTTATCGGTACAA 
            TAATTTTTTGAATAGGTAAATATCCGGAAACTAATAAAGTCTTTTTCTTGTCCATCGCAATAGCCATGTT 
 
                  1760      1770      1780      1790      1800      1810      1820 
            GCGATAGAGAGCAAAGAAGGATTTTGGACTGTTCAAGTTTCCAACGCTTCTATTGCCGCTACTGAGTCAG 
            CGCTATCTCTCGTTTCTTCCTAAAACCTGACAAGTTCAAAGGTTGCGAAGATAACGGCGATGACTCAGTC 
 
                  1830      1840      1850      1860      1870      1880      1890 
            CGCCATTGGCACTCTATATGTCGGCACAAATGCATCCGGTATCTGCGGTTTCATTTAAAGAGTCAGTTAA 
            GCGGTAACCGTGAGATATACAGCCGTGTTTACGTAGGCCATAGACGCCAAAGTAAATTTCTCAGTCAATT 
 
                  1900      1910      1920      1930      1940      1950      1960 
            TATTGACGAGGTTCTTGGCGGAAATGAGCCCCAGGTCGATTTCCTTCAACTTTATCAGAAATGCCAATCG 
            ATAACTGCTCCAAGAACCGCCTTTACTCGGGGTCCAGCTAAAGGAAGTTGAAATAGTCTTTACGGTTAGC 
 
                  1970      1980      1990      2000      2010      2020      2030 
            CGAGAGCTACTGCATACAGGAGTAATGAAAGCAAAAGGTGTGGTTTCTTCTAAAAATGGCACAACCTGGA 
            GCTCTCGATGACGTATGTCCTCATTACTTTCGTTTTCCACACCAAAGAAGATTTTTACCGTGTTGGACCT 
 
                  2040      2050      2060      2070      2080      2090      2100 
            TGCATGTTAAAGTGGATGAGGAGGTTCAAGTTGATACGCAAGACTTCTTGTTCCATCCCGCTCTGATTGA 
            ACGTACAATTTCACCTACTCCTCCAAGTTCAACTATGCGTTCTGAAGAACAAGGTAGGGCGAGACTAACT 
 
                  2110      2120      2130      2140      2150      2160      2170 
            CGGTAGTGGAGTGGGCGCTGGCACTTTACTGAGCAAGTTTGTGCCTGAAGAAACAAAGTTGTTTTACCCC 
            GCCATCACCTCACCCGCGACCGTGAAATGACTCGTTCAAACACGGACTTCTTTGTTTCAACAAAATGGGG 
 
                  2180      2190      2200      2210      2220      2230      2240 
            TATTNATCGAATCCTTNAATGCTCAGAGATGTTTGGTAGTGAATGCTATGTACGGATAAAAGAAGGGCTC 
            ATAANTAGCTTAGGAANTTACGAGTCTCTACAAACCATCACTTACGATACATGCCTATTTTCTTCCCGAG 
 
                  2250      2260      2270      2280      2290      2300      2310 
            ATAGAGATAAAAGAGGAGCTAATCAGTCTTACCATGGAGTTTTTAATTCTGAAGTAATAAAATGGGCGAG 
            TATCTCTATTTTCTCCTCGATTAGTCAGAATGGTACCTCAAAAATTAAGACTTCATTATTTTACCCGCTC 
 
 
                  2320      2330      2340      2350      2360      2370      2380 
            TAAGATTNCAAAATAATTGGTCGTCATGACGTTTAGTAAAAAGCAGAGCAAAAGTGCTCACTATGAAAGA 
            ATTCTAANGTTTTATTAACCAGCAGTACTGCAAATCATTTTTCGTCTCGTTTTCACGAGTGATACTTTCT 
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                  2390      2400      2410      2420      2430      2440      2450 
            GATGATTAAAGAAAAGTCGTAGGGCCGGAACTACTTTGACCNGACTCCTATGCACCATTTACGCTATTGG 
            CTACTAATTTCTTTTCAGCATCCCGGCCTTGATGAAACTGGNCTGAGGATACGTGGTAAATGCGATAACC 
 
                  2460      2470      2480      2490      2500      2510      2520 
            ATGTGAACGAGATTGCTAAATGGTTTTGGATGGATGTTCCCCTTTTGAGCCAAAAATAACGGCCTCACTT 
            TACACTTGCTCTAACGATTTACCAAAACCTACCTACAAGGGGAAAACTCGGTTTTTATTGCCGGAGTGAA 
 
                  2530      2540      2550      2560      2570      2580      2590 
            CCCCCGGTTAAAAAAAAACTGGGACCGAAATTTTTTATTATCAACCAACGTTTTAAAAAATTTTTTTAAA 
            GGGGGCCAATTTTTTTTTGACCCTGGCTTTAAAAAATAATAGTTGGTTGCAAAATTTTTTAAAAAAATTT 
 
                  2600      2610      2620      2630      2640      2650      2660 
            AAAAAAAAAAAAAAAAAGTGGTCTTTTTTTAGAAAAAGGGAANNNNNAAAAAAAAAANANNNANNTTGTG 
            TTTTTTTTTTTTTTTTTCACCAGAAAAAAATCTTTTTCCCTTNNNNNTTTTTTTTTTNTNNNTNNAACAC 
 
                  2670        
            AGTGGGGTATAAAAAAA 
            TCACCCCATATTTTTTT 
 
 
 
Figure 8.1 Graphic map of sequence contig obtained from Mutant No.5, primer tpnRL17–1 
direction. BamH1site identified on the base pair No. 180. Each green arrow represents the length 
of sequence coverage and the figure shows the level of sequence overlap between each sequence 
run.   
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8.1.2 Partial DNA sequence of mutant 7 (17-1direcion) 
 
| 
            |       10        20        30        40        50        60        70 
            CCACTAACCTAAGCATTTTGAGTGCACAGGAACACTTAACGGCTGACATGGGGGGGTACCGAGCTCGCAT 
            GGTGATTGGATTCGTAAAACTCACGTGTCCTTGTGAATTGCCGACTGTACCCCCCCATGGCTCGAGCGTA 
                    80        90       100       110       120       130       140 
            TTAAAGATGATGGTTGAGATGTGTATAAGAGACAGGCTTTCCATGACAGGCTGTCAAGCGAGAAGCTGAA 
            AATTTCTACTACCAACTCTACACATATTCTCTGTCCGAAAGGTACTGTCCGACAGTTCGCTCTTCGACTT 
                   150       160       170       180       190       200       210 
            CATGCCTCGCACGCATCGAATTTGCTAACAGTTGCAGAGAAATGGGTAAATGGAACAAGGTTCTCGTGGG 
            GTACGGAGCGTGCGTAGCTTAAACGATTGTCAACGTCTCTTTACCCATTTACCTTGTTCCAAGAGCACCC 
                   220       230       240       250       260       270       280 
            ATGATTTCAATAAAGGAAATGAGCAAAAAGTTCCTTTACCTACCTATCCTTTTGCAAAAGAGAGGCATTG 
            TACTAAAGTTATTTCCTTTACTCGTTTTTCAAGGAAATGGATGGATAGGAAAACGTTTTCTCTCCGTAAC 
                   290       300       310       320       330  |    340       350 
            GGTCAGGGCTGATGGCGTACCGGAAGCCTTTGACCAAAATGATCAAGTAGGTGCTAATGCAGCACTTGGA 
            CCAGTCCCGACTACCGCATGGCCTTCGGAAACTGGTTTTACTAGTTCATCCACGATTACGTCGTGAACCT 
                   360       370       380       390       400       410       420 
            AACGAACAAGATAGCTCTACTGAGGATACTTTACGCATAAAAGTAGAAGACTACCTTAAAGCTATTTTCT 
            TTGCTTGTTCTATCGAGATGACTCCTATGAAATGCGTATTTTCATCTTCTGATGGAATTTCGATAAAAGA 
                   430       440       450       460       470       480       490 
            CTGAAGTGTCTGAGATCGCCATTTCACGCATTGGCTCAGAAGCCACATTTGATGAGTATGGAATTAACTC 
            GACTTCACAGACTCTAGCGGTAAAGTGCGTAACCGAGTCTTCGGTGTAAACTACTCATACCTTAATTGAG 
                   500       510       520       530       540       550       560 
            GCTAATGATAACGAAACTTAACTCACTTCTTGAAAAAGATTTTGGCGAGTTATCAAAAACGTTATTTTTC 
            CGATTACTATTGCTTTGAATTGAGTGAAGAACTTTTTCTAAAACCGCTCAATAGTTTTTGCAATAAAAAG 
                   570       580       590       600       610       620       630 
            GAGTATCAATCTATCCGCGGGTTAGCTAATTACTTTTTAATCAACCATTTAGGAAAACTAAACACACGAT 
            CTCATAGTTAGATAGGCGCCCAATCGATTAATGAAAAATTAGTTGGTAAATCCTTTTGATTTGTGTGCTA 
                   640       650       660       670       680       690       700 
            TCAATCATACTGATTCATCAGCAGTTAAAAAGGCCAGTAGCAGTAATGACGTCATTAAAGAATCTGGAAG 
            AGTTAGTATGACTAAGTAGTCGTCAATTTTTCCGGTCATCGTCATTACTGCAGTAATTTCTTAGACCTTC 
                   710       720       730       740       750       760       770 
            GAAAGGCATTGTTTTATCCACTTCTGATTCGCAAACGGAAAAGGCATGTGATGTTGCTATTATTGGCTTA 
            CTTTCCGTAACAAAATAGGTGAAGACTAAGCGTTTGCCTTTTCCGTACACTACAACGATAATAACCGAAT 
                   780       790       800       810       820       830       840 
            AGTGGTAAGTACCCTCGGTCTGATACTGTTGAAGAGTATTGGGACAATCTACAGAATGCGGTTGATTGTA 
            TCACCATTCATGGGAGCCAGACTATGACAACTTCTCATAACCCTGTTAGATGTCTTACGCCAACTAACAT 
                   850       860       870       880       890       900       910 
            TTTCTGAAATACCTAAATCGAGATGGGATTATCACGATTATTATGATCCGGATAGAACTTCACAAGGAAC 
            AAAGACTTTATGGATTTAGCTCTACCCTAATAGTGCTAATAATACTAGGCCTATCTTGAAGTGTTCCTTG 
                   920       930       940       950       960       970       980 
            GATCCGTTCTAAATGGGGGGGGTTCATAAATGGTGTTGATGAATTTGATCCTCTGTTTTTCAATATATCT 
            CTAGGCAAGATTTACCCCCCCCAAGTATTTACCACAACTACTTAAACTAGGAGACAAAAAGTTATATAGA                                                    
                   990      1000      1010      1020      1030      1040     |1050 
            CCTCGCGAAGCTGAGTTTATGGATCCTAAAACACCAAAGGAACGGCTCGAATTTATTTTGCAAGATGCAA 
            GGAGCGCTTCGACTCAAATACCTAGGATTTTGTGGTTTCCTTGCCGAGCTTAAATAAAACGTTCTACGTT 
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                  1060      1070      1080      1090      1100      1110      1120 
            ATGTATCTGTGATTTTACGCAGGGAAATGGGTTTCTTTGGTAGATGGTTATCAGGGAAGAGTGATTGCTT 
            TACATAGACACTAAAATGCGTCCCTTTACCCAAAGAAACCATCTACCAATAGTCCCTTCTCACTAACGAA 
                  1130      1140      1150      1160      1170      1180      1190 
            TAGATCGGAACAACTTTTCAGAGCAAAGAACAACAAATCTAACCAGTGTTAACCAGCCAGATGACTTGGC 
            ATCTAGCCTTGTTGAAAAGTCTCGTTTCTTGTTGTTTAGATTGGTCACAATTGGTCGGTCTACTGAACCG 
                  1200      1210      1220      1230      1240      1250      1260 
            GTACATAATCTATACTTCAGGTTCTACGGGTAAACCTAAGGGTTGTATGTTGCCTCATGAAGCTATTTGT 
            CATGTATTAGATATGAAGTCCAAGATGCCCATTTGGATTCCCAACATACAACGGAGTACTTCGATAAACA 
                  1270      1280      1290      1300      1310      1320      1330 
            AATCGCTTACTTTGGATGAAAGATCAGTATCAAGTGAGTAACAGTGACCGTATATTACAAAAGACCCCCT 
            TTAGCGAATGAAACCTACTTTCTAGTCATAGTTCACTCATTGTCACTGGCATATAATGTTTTCTGGGGGA 
                  1340      1350      1360      1370      1380      1390      1400 
            ATACATTCGATGTGTCGGTATGGGAGCTGTTTCTTCCTTTGTTATCTGGTGCTTGCCTTGTTTTTGCTAA 
            TATGTAAGCTACACAGCCATACCCTCGACAAAGAAGGAAACAATAGACCACGAACGGAACAAAAACGATT 
                  1410      1420      1430      1440      1450      1460      1470 
            ACCTACAGGGCATAGAGATAATGCATATTTAATCAACCTTATCCAACAAGAGAAAGTCACCATTTGTCAT 
            TGGATGTCCCGTATCTCTATTACGTATAAATTAGTTGGAATAGGTTGTTCTCTTTCAGTGGTAAACAGTA 
                  1480      1490      1500      1510      1520      1530      1540 
            TTTGTTCCTTCAATGTTGCGATTCTTTTTGAACCAAAATGCGGCCTCACACTGCACGTCATTGAAGCACG 
            AAACAAGGAAGTTACAACGCTAAGAAAAACTTGGTTTTACGCCGGAGTGTGACGTGCAGTAACTTCGTGC 
                  1550      1560      1570      1580      1590      1600      1610 
            TATTTGCTAGTGGTGAAGCGCTGCCTTATGAATTGGTTGACAAATTTATAAGTACGATGCCCGCTAAATT 
            ATAAACGATCACCACTTCGCGACGGAATACTTAACCAACTGTTTAAATATTCATGCTACGGGCGATTTAA 
                  1620      1630      1640      1650      1660      1670      1680 
            GCATAACCTATATGGCCCTACAGAAGCAGCTGTCGATGTAAGCTATTGGCAGTGTGAATTACGCCAAGAT 
            CGTATTGGATATACCGGGATGTCTTCGTCGACAGCTACATTCGATAACCGTCACACTTAATGCGGTTCTA 
                  1690      1700      1710      1720      1730      1740      1750 
            AAAAAGGTGCCTATTGGTCGGGAAATTAGCAACGTGCAGCTTCATGTACTGAATGAGCAGTTGGTTCCAG 
            TTTTTCCACGGATAACCAGCCCTTTAATCGTTGCACGTCGAAGTACATGACTTACTCGTCAACCAAGGTC 
                  1760      1770      1780      1790      1800      1810      1820 
            TCGAGCAGGGAGATAGTGGCGAACTGTATATCGGCGGAATTTGTTTGGCCAAAGGTTATTTAAATAGACC 
            AGCTCGTCCCTCTATCACCGCTTGACATATAGCCGCCTTAAACAAACCGGTTTCCAATAAATTTATCTGG 
                  1830      1840      1850      1860      1870      1880      1890 
            GGAACTCACGATAGAGCGATTTATTGATAATCCACTGGTTAGCGCTGCTGAAAAAAGTCAGAAATATATA 
            CCTTGAGTGCTATCTCGCTAAATAACTATTAGGTGACCAATCGCGACGACTTTTTTCAGTCTTTATATAT 
                  1900      1910      1920      1930      1940      1950      1960 
            GGACTGGTGATAAAGCGCGCTGCTTGTCTGACGGAATATTGAATATTAAGCCCGCCTGGACTCTCAGGTT 
            CCTGACCACTATTTCGCGCGACGAACAGACTGCCTTATAACTTATAATTCGGGCGGACCTGAGAGTCCAA 
                  1970      1980      1990      2000      2010      2020      2030 
            AATTACCAGGTTTCGCATAGATTAAGTGATTTGAAAGTAAGCTTAATAACTAAACTATTGATCCCTCGGG 
            TTAATGGTCCAAAGCGTATCTAATTCACTAAACTTTCATTCGAATTATTGATTTGATAACTAGGGAGCCC 
                  2040      2050      2060      2070      2080      2090      2100 
            TATTGGAAAGGAGAGGCTCGTTCACCCAGTTATTGCTTATGTGTACAAAACCGTATAATTTAAGAAGTAG 
            ATAACCTTTCCTCTCCGAGCAAGTGGGTCAATAACGAATACACATGTTTTGGCATATTAAATTCTTCATC 
                  2110      2120      2130      2140      2150      2160      2170 
            AATTTCTTAAACAGCCGCGGATAATCTGCAAAGTGTGGTGCTTAAGAACCCGTAAGAAAGAAAAATGCCA 
            TTAAAGAATTTGTCGGCGCCTATTAGACGTTTCACACCACGAATTCTTGGGCATTCTTTCTTTTTACGGT 
                  2180      2190      2200      2210      2220      2230      2240 
            AGCTTTTTTTTCCAATAACAGAAATCGGGGAAATCCTCAAAAACTTAACTGATTCAGAATAATCGAAGGG 
            TCGAAAAAAAAGGTTATTGTCTTTAGCCCCTTTAGGAGTTTTTGAATTGACTAAGTCTTATTAGCTTCCC 
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                  2250      2260      2270      2280      2290      2300      2310 
            AAAAACGTGCATTTGCAATGATGCTTCCCTTAACGAAGGAGGAAAATTTCGGGACCTTCTGCGGTGAAAC 
            TTTTTGCACGTAAACGTTACTACGAAGGGAATTGCTTCCTCCTTTTAAAGCCCTGGAAGACGCCACTTTG 
                  2320      2330      2340      2350      2360      2370      2380 
            AAATGTCGGGGGGTTATCCAAAATCTTTGGGTACCCACACATTCCCCTCCTGGGTGGCTTTTTTCCGTAT 
            TTTACAGCCCCCCAATAGGTTTTAGAAACCCATGGGTGTGTAAGGGGAGGACCCACCGAAAAAAGGCATA 
                  2390      2400      2410      2420   
            CTTTACTCTTGTACGAATACAGTTTGAAACACTTATTTAATT 
            GAAATGAGAACATGCTTATGTCAAACTTTGTGAATAAATTAA 
 
 
 
Figure 8.2 Graphic map of sequence contig obtained from Mutant No.7, primer tpnRL17–1 
direction. BamH1site identified on the base pair No. 1001. Each green arrow represent the length 
of sequence coverage and the figure show the level of sequence overlap between each sequence 
run.   
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| 
            |       10        20        30        40        50        60        70 
            CGGCCAAACCTTAAGCCTCTCAAGCAATTTTGAGTGACACAGGAACACTTAACGGCTGACATGGTGGGGG 
            GCCGGTTTGGAATTCGGAGAGTTCGTTAAAACTCACTGTGTCCTTGTGAATTGCCGACTGTACCACCCCC 
                    80        90       100       110       120       130       140 
            TACCGAGCTCGAATTCATCGATGATGGTTGAGATGTGTATAAGAGACAGATCTCTGCCTGAGTAATTTTT 
            ATGGCTCGAGCTTAAGTAGCTACTACCAACTCTACACATATTCTCTGTCTAGAGACGGACTCATTAAAAA 
                   150       160       170       180       190       200       210 
            CATATACAAAGTCCCTTCGTTGATCTTTAAAGTCGCTAGATAAATTTTTTATAGGGCGCACTCAACCATG 
            GTATATGTTTCAGGGAAGCAACTAGAAATTTCAGCGATCTATTTAAAAAATATCCCGCGTGAGTTGGTAC 
                   220       230       240       250       260       270       280 
            AATGGCAGGTACAGTCTCTAATAACAGAATGAAATATTATTGAGCACGTAAACCGGATTAACACAACAAG 
            TTACCGTCCATGTCAGAGATTATTGTCTTACTTTATAATAACTCGTGCATTTGGCCTAATTGTGTTGTTC 
                   290       300       310       320       330       340       350 
            TGGAACACTTAGTCTAAATAAAACTTCACCCGCGCCAACTCATCCAGAGTCCGCCTAAAAATCATATTCA 
            ACCTTGTGAATCAGATTTATTTTGAAGTGGGCGCGGTTGAGTAGGTCTCAGGCGGATTTTTAGTATAAGT 
                   360       370       380       390       400       410       420 
            AGACAAATCCATATATCTTACTCTTCCAGACCATCTAACCAATCACCGAAACGAGTTCTGCCGTCAACGA 
            TCTGTTTAGGTATATAGAATGAGAAGGTCTGGTAGATTGGTTAGTGGCTTTGCTCAAGACGGCAGTTGCT 
                   430       440       450       460       470       480       490 
            TTTCAGGTCGCTCTGTCATTCCGACATAATGCTCATTACCGTCTTGCACTTACCCCTTTACCGCAGCGAG 
            AAAGTCCAGCGAGACAGTAAGGCTGTATTACGAGTAATGGCAGAACGTGAATGGGGAAATGGCGTCGCTC 
                   500       510       520       530       540       550       560 
            AAAGCTTTCTATATCACCTCCTTTATTGCTCCTATCACACACCTTGTAAACAAAGTGCTGTATTGACACC 
            TTTCGAAAGATATAGTGGAGGAAATAACGAGGATAGTGTGTGGAACATTTGTTTCACGACATAACTGTGG 
                   570       580       590       600       610       620       630 
            ACCAAAACCCATACTCATAGTTAATGCACTTTCAATTTTTAAAGATTCTGCTTGGTGCCTAACCCAATTA 
            TGGTTTTGGGTATGAGTATCAATTACGTGAAAGTTAAAAATTTCTAAGACGAACCACGGATTGGGTTAAT 
                   640       650       660       670       680       690       700 
            AAAGATGGCTCGATGGGGTTATCCAAATTTCTTGTTGGGTGTAATTTGTTCTCTTTCATTTGCAATAGAG 
            TTTCTACCGAGCTACCCCAATAGGTTTAAAGAACAACCCACATTAAACAAGAGAAAGTAAACGTTATCTC 
                   710       720       730       740       750       760       770 
            TTGCGACCACTTCTACCGTACCGGCTGCACTCAAGCCATGACCAATAATAGATTTAGTTGCATTAAGACG 
            AACGCTGGTGAAGATGGCATGGCCGACGTGAGTTCGGTACTGGTTATTATCTAAATCAACGTAATTCTGC 
                   780       790       800       810       820       830       840 
            AGCATGATCCAGTTCACAGTGTCGAAATGCTCGTAGTTCTGTCTCATCTCCAATACTAGAGCTTGTCCCA 
            TCGTACTAGGTCAAGTGTCACAGCTTTACGAGCATCAAGACAGAGTAGAGGTTATGATCTCGAACAGGGT 
                   850       860       870       880       890       900       910 
            TGGGGGATTGATGTAGTCAATCTCGCTTGCTGTTAAATTTGCGCGTTCTAAAGCATTTTTTATTGCTCTA 
            ACCCCCTAACTACATCAGTTAGAGCGAACGACAATTTAAACGCGCAAGATTTCGTAAAAAATAACGAGAT 
                   920       930       940       950       960       970       980 
            ACTTCGCCATCAAAAGAAGGGTTAGGATTCCTATTTCCATCCATTTCCACTGCCCAACCAGAAACGCGTG 
            TGAAGCGGTAGTTTTCTTCCCAATCCTAAGGATAAAGGTAGGTAAAGGTGACGGGTTGGTCTTTGCGCAC 
                   990      1000      1010      1020      1030      1040      1050 
            CATAGGGCTTCACTCTTTGCCTTAAATTAGCTCTTTCGATGACAACGACACCACAAGATTCCCCATATAT 
            GTATCCCGAAGTGAGAAACGGAATTTAATCGAGAAAGCTACTGTTGCTGTGGTGTTCTAAGGGGTATATA 
                  1060      1070      1080      1090      1100      1110      1120 
            GAATCCATCTCTCTCTTTGTCAAACGGACGACACGCCAATGCTGCTTCGTTTGCAAAACGATCTGACCCC 
            CTTAGGTAGAGAGAGAAACAGTTTGCCTGCTGTGCGGTTACGACGAAGCAAACGTTTTGCTAGACTGGGG 
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                  1130      1140      1150      1160      1170      1180      1190 
            ATAGCCCCCAAAGAACGGAATCCTTGACACTCCCAATATGACAAATCCATAAGTGCGCCGATAGCAATAC 
            TATCGGGGGTTTCTTGCCTTAGGAACTGTGAGGGTTATACTGTTTAGGTATTCACGCGGCTATCGTTATG 
                  1200      1210      1220      1230      1240      1250      1260 
            AATAATCCACCTGAGATGACTGCACCGCCTGAATCGCCTGAATGATAGCTAATTGTCCACTAGCAGATGC 
            TTATTAGGTGGACTCTACTGACGTGGCGGACTTAGCGGACTTACTATCGATTAACAGGTGATCGTCTACG 
                  1270      1280      1290      1300      1310      1320      1330 
            TCCGCCAACTGTATACGCAAATCCTCTAATATCGAACAGCTCAGTGCACAATCCACAAAGATCGCTATCC 
            AGGCGGTTGACATATGCGTTTAGGAGATTATAGCTTGTCGAGTCACGTGTTAGGTGTTTCTAGCGATAGG 
                  1340      1350      1360      1370      1380      1390      1400 
            ATGAAAGACATTCCATAGTTAGGACGCAAAAAATGAAGCCGATTTTGGTATGCGTTATGCGTTTGGATCA 
            TACTTTCTGTAAGGTATCAATCCTGCGTTTTTTACTTCGGCTAAAACCATACGCAATACGCAAACCTAGT 
                  1410      1420      1430      1440      1450      1460      1470 
            GTTCACGCTGCTGAAAATTAGATCCCCCCACTACTAAACCAATACGATAAGGATCCCATAAAAAGGGCGC 
            CAAGTGCGACGACTTTTAATCTAGGGGGGTGATGATTTGGTTATGCTATTCCTAGGGTATTTTTCCCGCG 
                  1480      1490      1500      1510      1520      1530      1540 
            TGCAAACCTTCCGCCACATTGAAATAAGGGTACACTCCCCCGACTCCGCCATGTATCCAAAATACTGGTC 
            ACGTTTGGAAGGCGGTGTAACTTTATTCCCATGTGAGGGGGCTGAGGCGGTACATAGGTTTTATGACCAG 
                  1550      1560      1570      1580      1590      1600      1610 
            GACCAACAAAGGCATTGTTAAGATGTATAAGTTCTGAGAACTTATTAGACTCTTCAAATATACGCCCTCT 
            CTGGTTGTTTCCGTAACAATTCTACATATTCAAGACTCTTGAATAATCTGAGAAGTTTATATGCGGGAGA 
                  1620      1630      1640      1650      1660      1670      1680 
            ATCTAGAGAGCCCGAAGATTTTTTGATGTTTTCATGATCACTTTTATTTGAATAAAGTTTTTTATCAGAC 
            TAGATCTCTCGGGCTTCTAAAAAACTACAAAAGTACTAGTGAAAATAAACTTATTTCAAAAAATAGTCTG 
                  1690      1700      1710      1720      1730      1740      1750 
            GCCGAAAACTCTTGTGATTGATAAGTATTTTCCCCCAACACCTTGATTTTCATTGATTGGGATATTAATA 
            CGGCTTTTGAGAACACTAACTATTCATAAAAGGGGGTTGTGGAACTAAAAGTAACTAACCCTATAATTAT 
                  1760      1770      1780      1790      1800      1810      1820 
            CGTTGCGGGGTTGTCTCACCATAAAAAAACTTGCAGTCTATTTCCCCACCGCGAACCCCAACCTGAGCTA 
            GCAACGCCCCAACAGAGTGGTATTTTTTTGAACGTCAGATAAAGGGGTGGCGCTTGGGGTTGGACTCGAT 
                  1830      1840      1850      1860      1870      1880      1890 
            TTTCATTTAATTCTTAATCAAAAGCCCTTTTACCCAACCTTTTGTTTGAAAGGTCCCAATCTGATTTCTA 
            AAAGTAAATTAAGAATTAGTTTTCGGGAAAATGGGTTGGAAAACAAACTTTCCAGGGTTAGACTAAAGAT 
                  1900      1910      1920      1930      1940      1950      1960 
            CATTTATTGGGGGGAAAAATATTTGAAATTAAAACCCGCAATGGCCAAAAATTAAAAAGGTTTTTTTTTT 
            GTAAATAACCCCCCTTTTTATAAACTTTAATTTTGGGCGTTACCGGTTTTTAATTTTTCCAAAAAAAAAA 
                  1970      1980      1990      2000      2010      2020      2030 
            GCTTTTAAGAAATTTCTGGGAGAACTTTATTTCTGGAAAATATTAAAAGTTCTATTTAAATTACTTTTTT 
            CGAAAATTCTTTAAAGACCCTCTTGAAATAAAGACCTTTTATAATTTTCAAGATAAATTTAATGAAAAAA 
                  2040      2050      2060      2070      2080      2090      2100 
            TGGGGGGTTTTTTAAAAAAAAGGTGAAAATAAACTGTCCCCACAAATGAAAATATTTTATCTATTTTTGT 
            ACCCCCCAAAAAATTTTTTTTCCACTTTTATTTGACAGGGGTGTTTACTTTTATAAAATAGATAAAAACA 
                  2110      2120      2130      2140      2150      2160         
            GGAAAAAATTTGTTAAGAAAGGCGGGCCATACAACCTTGCCCCCTTAAAACGATTTGTGGGGGTGTTA 
            CCTTTTTTAAACAATTCTTTCCGCCCGGTATGTTGGAACGGGGGAATTTTGCTAAACACCCCCACAAT 
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Figure 8.3 Graphic map of sequence contig obtained from Mutant No.8, primer tpnRL17–1 
direction. BamH1site identified on the base pair No. 1451. Each green arrow represent the length 
of sequence coverage and the figure show the level of sequence overlap between each sequence 
run.   
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8.2 Appendix (2) Blast results 
 
 
 
Figure 8.4 The BLASTX search result obtained from the partial sequencing the flanking genomic 
DNA from mutant No 8, showing that transposon had inserted into a gene, with similarity to a 
gene encoding a Polyketide synthase. 
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Figure 8.5 The blastx search result obtained from the partial sequencing the flanking genomic 
DNA from mutant No 7(13-2), showing that transposon had inserted into a gene, with similarity 
to a gene encoding a Polyketide synthase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 8.                                                                                                                                         Appendices 
 147 
 
 
 
Figure 8.6 Amino acid sequence line-ups produced from BLASTX between Serratia plymutica 
(P) using the translated mutant 5, sequence contig from primer direction 17-1(Query) and 
Polyketide synthase, from Serratia plymuthica (Sbjct). 
 
 
 
 
 
 
 
 
 
 
 
Chapter 8.                                                                                                                                         Appendices 
 148 
 
 
 
Figure 8.7 The blastx search result obtained from the partial sequencing the flanking genomic 
DNA from mutant No 7(17-1), showing that transposon had inserted into a gene, with similarity 
to a gene encoding a Polyketide synthesis.  
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